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Abstract 
Mycoplasma species can cause severe disease in cattle worldwide, most commonly associated 
with mastitis, arthritis, pneumonia and otitis media. In Australia, there has been an observed 
increase in the incidence of disease caused by Mycoplasma species in the last nine years. Despite 
this, little research has been undertaken on mycoplasma infection in Australia and thus the focus 
of the study described in this thesis was on the characterisation, diagnosis and control of 
Mycoplasma spp in Australian dairy herds.  
Whole genome sequencing of 82 Australian Mycoplasma bovis isolates collected over a 9 year 
period (2006-2015) revealed a seemingly single strain persisting throughout the country, with 
marked genomic homology (Chapter 2). With minimal variance amongst isolates from different 
anatomical locations, and from animals clinically and non-clinically affected, this suggests a 
single isolate is equally capable of causing a variety of different clinical manifestations. When 
analysing virulence factors, 50 virulence genes from the virulence factor database (VFDB) were 
identified as being well conserved in the Australian isolates. However, the presence of variable 
surface lipoprotein (vsp) genes was apparently greatly reduced compared to reference strain M. 
bovis, PG45.  
When diagnosing bovine samples for the presence of M. bovis, M. californicum and M. 
bovigenitalium, multiplex PCR was comparable to culture, with the superior method dependent 
on sample type and the need to identify multiple species per samples (Chapter 3). A high 
analytical specificity of PCR was achieved with appropriate amplification produced for all 
M.bovis, M. californicum and M. bovigenitalium isolates, and no amplification seen for other 
Mollicutes or eubacterial species analysed.  The analytical sensitivity of the PCR analysis on 
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spiked samples was best in milk [1.3 x 10
2
 (M .bovis), 6 x 10
2
 (M. californicum) and 5 x 10
5
 
cfu/mL (M. bovigenitalium)], followed by semen [1.3 x 10
5
 (M. bovis), 6 x 10
4
 (M. californicum) 
and 1.4 x 10
7
 cfu/mL (M. bovigenitalium)] and swabs (vaginal, preputial, nose and eye) [1.3 x 
10
6
 (M. bovis), 6 x 10
4
 (M. californicum) and 1.4 x 10
7
 cfu/mL (M. bovigenitalium). However 
when all three Mycoplasma species were present in a sample, the limit of detection increased for 
all species and all sample types. Upon comparison of culture and PCR for detecting mycoplasma 
in bovine field samples, significantly more swab samples were identified as culture positive (49 
%) than PCR positive (24 %). This may have been due to the analysis technique, with swabs first 
cultured onto mycoplasma agar, potentially removing significant amounts of DNA, before being 
processed for DNA extraction and PCR analysis. No significant differences were seen for semen, 
individual milk or bulk tank milk (BTM) samples, with 50 %, 50 % and 2 % culture positive 
respectively, and 50 %, 48 % and 5 % PCR positive respectively. For the identification of 
multiple species in a single sample, PCR identified five samples as having two species present. 
However culture followed by 16S-23S rRNA sequencing of positive colonies could not identify 
more than one species.  
The use of PCR and culture may also be complemented by the use of an antibody-ELISA (Bio-X 
Bio K 302, Bio-X Diagnostics, Rochefort, Belgium) on BTM samples, in identifying herds from 
which the purchase of animals may pose a higher biosecurity risk for introducing M. bovis into 
non-infected herds (Chapter 4). A multivariable linear mixed restricted maximum likelihood 
(REML) model was fitted, with the BTM ELISA optical density coefficient (ODC%) 
significantly associated with time since an initial M. bovis outbreak, and time since the start of 
the herd’s calving period. Following an initial outbreak, the BTM ELISA ODC% was highest in 
the first 8 months with a peak predicted mean ODC% of 59 at 5-8 months. In split and seasonally 
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calving herds, significantly higher BTM ELISA ODC% results were seen 5-8 weeks following 
the commencement of the calving period, with a peak predicted mean ODC% of 41. When 
investigating within herd seroprevalence, the BTM ELISA ODC% was a poor indicator. 
Comparison of BTM samples from the main herd and ‘hospital’ herd on one farm demonstrated 
a significantly higher mean ‘hospital’ herd BTM ELISA ODC% (54 ODC%) compared to the 
main herd BTM (24 ODC%). Upon comparison with the diagnostic tools of PCR and culture, the 
BTM ELISA detected a significantly higher proportion of samples as positive, with 39 % ELISA 
positive, 4 % PCR positive and 1 % culture positive. 
Milk acidification was effective at eliminating viable M. bovis and Salmonella Dublin organisms 
in milk, if the appropriate pH and exposure time was maintained (Chapter 5).  While M. bovis 
was unable to grow in non-acidified milk, Salmonella Dublin proliferated. During the 
acidification process, the pH remained stable over 24 h. When milk was treated to pH 3.5 and 4, 
no viable M. bovis organism were detected after just 1 h of exposure. This was extended to 8 h of 
exposure at pH 5. However at pH 6, viable M. bovis organisms were still detected at 24 h. For 
Salmonella Dublin, when exposed to pH 3.5 and 4, no viable organisms were detected after 2 
and 6 h, respectively. Salmonella Dublin remained viable at 24 h when exposed to pH 5 and 6. 
In summary, the genomic characteristics of Australian M. bovis isolates suggested a single strain 
persisting throughout the country with minimal genetic variance, despite differences in disease 
presentation or absence of disease. Therefore, the identification of any M. bovis isolate should be 
treated with extreme caution and considered a highly virulent pathogen, with the disease 
outcome likely to be significantly affected by host factors and environmental (including 
management) practices. As such, while control methods should be tailored towards the disease 
and herd scenario, a control approach aimed at manipulating these factors should be instigated if 
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M. bovis is found to be present within a herd. For identifying important Mycoplasma spp. 
including M. bovis, M.californicum and M. bovigenitalium in bovine samples, multiplex probe 
PCR and traditional culture were comparable. Therefore additional factors such as cost, urgency, 
sample handling and storage prior to analysis, and test availability need to be considered when 
deciding between the two options. When analysing BTM samples prior to the purchase and 
introduction of animals from those herds, either PCR or culture may also be complimented by 
the use of a BTM antibody-ELISA to identify higher risk herds with past-exposure to M. bovis. 
To improve the sensitivity of the BTM antibody-ELISA assay, where possible, sampling should 
be targeted 5-8 weeks following the commencement of the calving season.  The ‘hospital’ BTM 
also potentially provides a more sensitive sample type and should be sampled when possible. 
Lastly, if M. bovis is introduced into a herd, the risk of transmission from cow to calf can be 
reduced through the use of milk acidification using the acidifying agent Salstop SD, which is 
also effective on Salmonella Dublin. For the most effective results, pH 4 should be achieved and 
held for a minimum of 6 hrs prior to calf consumption to ensure no viable M. bovis or 
Salmonella Dublin organisms are present. While much work is still needed on this debilitating 
pathogen, the overall findings of this study regarding the genomic characteristics of Australian 
M. bovis isolates, the timely use of available diagnostic methodologies in analyzing appropriate 
samples, and the  potential control options aimed in particular at manipulating host and 
environmental (including management) factors provide useful guidelines for managing the 
serious challenge posed by the emergence of Mycoplasma spp. infection in Australian dairy 
herds.    
9 
 
Table of Contents 
Declaration ...................................................................................................................................... 2 
Acknowledgments........................................................................................................................... 3 
Abstract ........................................................................................................................................... 5 
Table of Contents ............................................................................................................................ 9 
List of Figures ............................................................................................................................... 14 
List of Tables ................................................................................................................................ 16 
List of peer reviewed publications ................................................................................................ 18 
List of conference presentations ................................................................................................... 19 
List of awards and grants .............................................................................................................. 21 
Disclosure and author contributions ............................................................................................. 22 
Abbreviations ................................................................................................................................ 27 
CHAPTER 1: LITERATURE REVIEW ...................................................................................... 32 
1.1 Introduction ........................................................................................................................ 32 
1.2 Mycoplasma species isolated from dairy cattle ................................................................ 33 
1.3 Disease in cattle caused by Mycoplasma species .............................................................. 37 
1.4 Pathogenesis of Mycoplasma species isolated from dairy cattle ....................................... 42 
1.5 Risk factors and transmission of mycoplasma infection.................................................... 45 
1.6 Mycoplasma isolate typing and whole genome sequencing .............................................. 48 
10 
 
1.7 Diagnostics of Mycoplasma species in cattle ..................................................................... 52 
1.8 Milk treatment as a biosecurity strategy ............................................................................ 72 
1.9 Scope of thesis ................................................................................................................... 82 
1.10 References .......................................................................................................................... 83 
CHAPTER 2: GENETIC CHARACTERIZATION OF AUSTRALIAN MYCOPLASMA BOVIS 
ISOLATES THROUGH WHOLE GENOME SEQUENCING ANALYSIS ............................ 108 
2.1 Abstract ............................................................................................................................ 109 
2.2 Introduction ...................................................................................................................... 110 
2.3 Material and methods ....................................................................................................... 111 
2.4 Results .............................................................................................................................. 118 
2.5 Discussion ........................................................................................................................ 125 
2.6 Conclusion ....................................................................................................................... 129 
2.7 Conflicts of interest .......................................................................................................... 130 
2.8 Acknowledgments............................................................................................................ 130 
2.9 References ........................................................................................................................ 131 
2.10 Supplementary material ................................................................................................... 136 
CHAPTER 3: COMPARISON OF CULTURE AND A MULTIPLEX PROBE PCR FOR 
IDENTIFYING MYCOPLASMA SPECIES IN BOVINE MILK, SEMEN AND SWAB 
SAMPLES................................................................................................................................... 142 
3.1 Abstract ............................................................................................................................ 143 
11 
 
3.2 Introduction ...................................................................................................................... 144 
3.3 Material and methods ....................................................................................................... 146 
3.4 Results .............................................................................................................................. 153 
3.5 Discussion ........................................................................................................................ 158 
3.6 Conclusion ....................................................................................................................... 163 
3.7 Conflicts of interest .......................................................................................................... 164 
3.8 Acknowledgments............................................................................................................ 164 
3.9 References ........................................................................................................................ 164 
CHAPTER 4: BULK TANK MILK ANTIBODY-ELISA AS A BIOSECURITY TOOL FOR 
DETECTING DAIRY HERDS WITH PAST EXPOSURE TO MYCOPLASMA BOVIS ......... 171 
4.1 Abstract ............................................................................................................................ 172 
4.2 Introduction ...................................................................................................................... 173 
4.3 Materials and methods ..................................................................................................... 176 
4.4 Results .............................................................................................................................. 185 
4.5 Discussion ........................................................................................................................ 193 
4.6 Conclusions ...................................................................................................................... 201 
4.7 Conflicts of interest .......................................................................................................... 202 
4.8 Acknowledgements .......................................................................................................... 202 
4.9 References ........................................................................................................................ 203 
12 
 
4.10 Supplementary material ................................................................................................... 208 
CHAPTER 5: MILK ACIDIFICATION TO CONTROL THE GROWTH OF MYCOPLASMA 
BOVIS AND SALMONELLA DUBLIN IN CONTAMINATED MILK .................................... 211 
5.1 Abstract ............................................................................................................................ 212 
5.2 Introduction ...................................................................................................................... 213 
5.3 Materials and methods ..................................................................................................... 215 
5.4 Results .............................................................................................................................. 221 
5.5 Discussion ........................................................................................................................ 228 
5.6 Conclusion ....................................................................................................................... 233 
5.7 Acknowledgments............................................................................................................ 234 
5.8 References ........................................................................................................................ 235 
CHAPTER 6: GENERAL DISCUSSION .................................................................................. 240 
6.1 Introduction ...................................................................................................................... 240 
6.2 Genetic characterisation of Australian Mycoplasma bovis isolates through whole genome 
sequencing analysis ..................................................................................................................... 240 
6.3 Comparison of culture and a multiplex probe PCR for identifying Mycoplasma species in 
bovine milk, semen, and swab samples ...................................................................................... 249 
6.4 Bulk tank milk antibody-ELISA as a biosecurity tool for detecting dairy herds with past 
exposure to Mycoplasma bovis ................................................................................................... 253 
13 
 
6.5 Milk acidification to control the growth of Mycoplasma bovis and Salmonella Dublin in 
infected milk ............................................................................................................................... 258 
6.6 Conclusion ....................................................................................................................... 262 
6.7 References ........................................................................................................................ 264 
APPENDICES ............................................................................................................................ 270 
Genetic characterisation of Australian Mycoplasma bovis isolates through whole genome 
sequencing analysis ..................................................................................................................... 270 
Comparison of culture and a multiplex probe PCR for identifying Mycoplasma species in bovine 
milk, semen and swab samples ................................................................................................... 279 
Milk acidification to control the growth of Mycoplasma bovis and Salmonella Dublin in 
contaminated milk ....................................................................................................................... 294 
  
14 
 
List of Figures 
Figure 2.1 Neighbor-joining consensus phylogenetic tree created from 75 M. bovis WGS 
sequences and SNP analysis. The consensus support (%) of the phylogenetic tree as determined 
by the bootstrap test (70 replicates) is indicated at each node. The scale bar indicates the % of 
SNPs within a sequence. ............................................................................................................. 120 
Figure 2.2 Distribution of pairwise genetic distances from 75 M. bovis WGS sequences and SNP 
analysis. ....................................................................................................................................... 121 
Figure 2.3 Clusters obtained by Gengraph depicting three distinct clades, and three outliers. The 
numbers on the lines indicate the amount of SNPs between isolates. ........................................ 122 
Figure 4.1. Model-based mean bulk tank milk Mycoplasma bovis ELISA ODC%, with model-
based minimum and maximum ODC% for individual herds for time since initial Mycoplasma 
bovis outbreak, and adjusted for time since the start of calving season. Model-based means for 
time categories not sharing the same superscript are significantly different (P<0.05). .............. 188 
Figure 4.2. Model-based mean bulk tank milk ELISA ODC%, with model-based minimum and 
maximum ODC% for individual herds for time since the start of calving period, and adjusted for 
time since initial Mycoplasma bovis outbreak. Model-based means for calving categories not 
sharing the same superscript are significantly different (P<0.05). ............................................. 190 
Figure 4.3. Scattergraph of the proportion of cows within Mycoplasma bovis exposed and 
uninfected herds that were ELISA positive and the bulk tank milk Mycoplasma bovis ELISA 
ODC%. ........................................................................................................................................ 192 
Figure S4.1. Flow chart of the number of herds included for each component of the study ..... 210 
15 
 
Figure 5.1 Mycoplasma bovis proliferation in milk at varying incubation temperatures over 56 h. 
Results are expressed as the mean counts (cfu/mL; ± SE) of triplicates from 2 independent 
experiments. ................................................................................................................................ 222 
Figure 5.2 Salmonella Dublin proliferation in milk at varying incubation temperatures over 56 h. 
Results are expressed as the mean counts (cfu/mL; ± SE) of triplicates from 2 independent 
experiments. ................................................................................................................................ 223 
 
  
16 
 
List of Tables 
Table 1.1 Mycoplasma species isolated from dairy cattle ............................................................ 35 
Table 1.2 Herd prevalence of Mycoplasma species from bulk tank milk samples ...................... 39 
Table 1.3 Overview of the characteristics of the described PCR methods used for diagnosing 
Mycoplasma species in cattle. ....................................................................................................... 63 
Table 1.4 Strengths and limitations of mycoplasma diagnostic methods .................................... 70 
Table 2.1 Sequences of primers and probes used for species identification .............................. 114 
Table S2.1 Australian Mycoplasma bovis isolates used for Whole Genome Sequencing (WGS) 
analysis ........................................................................................................................................ 136 
Table S2.2 Virulence genes and Blast Score Ratio (BSR) values for Australian (AUS) 
Mycoplasma bovis isolates combined, Mycoplasma bovis HB0801, Mycoplasma bovis Hubei-1 
and Mycoplasma bovis PG45 ...................................................................................................... 140 
Table 3.1. Primer and probe sequences used for multiplex probe PCR and culture speciation 
(Parket et al., 2016) ..................................................................................................................... 148 
Table 3.2. Mollicute and other bacterial species used for testing analytical specificity of the 
multiplex probe PCR assay ......................................................................................................... 154 
Table 3.3. Multiplex probe PCR limit of detection (cfu/mL) and associated mean cycle threshold 
(±SE) for different spiked sample types. Single target species present per sample (A) and 
multiple target species present per sample (B) and the concentration of each target species in the 
sample at the limit of detection (read from left to right)............................................................. 155 
17 
 
Table 3.4. Comparison of culture and multiplex PCR for detecting bovine field samples as 
positive or negative for M. bovis, M. californicum or M. bovigenitalium. ................................. 156 
Table 4.1. Descriptive statistics for analysis of factors affecting bulk tank milk (BTM) ELISA 
optical density coefficient (ODC%) in 19 previously exposed herds (185 samples). ................ 186 
Table 4.2. P values for the univariable models, multivariable model with interaction term and 
final multivariable model for the analysis of factors affecting bulk tank milk (BTM) ELISA 
optical density coefficient (ODC%)............................................................................................ 186 
Table 4.3. Back-transformed variances and effect estimates (estimated ratios of geometric 
means) for the final model of bulk tank milk (BTM) ELISA optical density coefficient (ODC%).
..................................................................................................................................................... 187 
Table 4.4. Descriptive statistics for the analysis of the association between the proportion of 
cows that were ELISA positive and the bulk tank milk (BTM) ELISA optical density coefficient 
(ODC%) from 23 herds (28 samplings). ..................................................................................... 191 
Table 4.5. Descriptive statistics for analysis of the agreement between ELISA vs PCR and 
Culture from 25 herds (192 observations); samples used per herd, and the distribution of bulk 
tank milk (BTM) ELISA optical density coefficient (ODC%) values between PCR and culture 
results. ......................................................................................................................................... 193 
Table S4.1. Dairy herd study population.................................................................................... 208 
Table 5.1 Viability of Mycoplasma bovis in milk over 24 h following pH treatment with the 
commercially available milk acidifier Salstop (Impextraco, Heist-op-den-Berg, Belgium)
a ..... 225 
Table 5.2 Viability of Salmonella Dublin in milk over 24 h following pH treatment with the 
commercially available milk acidifier Salstop (Impextraco, Heist-op-den-Berg, Belgium)
a ..... 227  
18 
 
List of peer reviewed publications 
Parker, A. M., J. K. House, M. S. Hazelton, K. L. Bosward, and P. A. Sheehy. 2017. 
Comparison of culture and a multiplex probe PCR for identifying Mycoplasma species in 
bovine milk, semen and swab samples. PLoS ONE 12(3):e0173422. 
Parker, A. M., A. Shukla, J. K. House, M. S. Hazelton, K. L. Bosward, B. Kokotovic, and P. A. 
Sheehy. 2016. Genetic characterization of Australian Mycoplasma bovis isolates through 
whole genome sequencing analysis. Vet. Microbiol. 196:118-125. 
doi.org/10.1016/j.vetmic.2016.10.010 
Parker, A. M., J. K. House, M. S. Hazelton, K. L. Bosward, V. L. Mohler, F. P. Maunsell, and 
P. A. Sheehy. 2016. Milk acidification to control the growth of Mycoplasma bovis and 
Salmonella Dublin in contaminated milk. J. Dairy Sci. 99(12):9875-9884. 
doi.org/10.3168/jds.2016-11537 
Papers accepted and awaiting publication  
Parker, A. M., J. K. House, M. S. Hazelton, K. L. Bosward, J. M. Morton, and P. A. Sheehy. 
Bulk Tank Milk Antibody-ELISA as a Biosecurity Tool for Detecting Dairy Herds with 
Past Exposure to Mycoplasma bovis. 
  
19 
 
List of conference presentations 
Parker, A. M., J. K. House, M. S. Hazelton, K. L. Bosward, and P. A. Sheehy. Comparison of 
Culture and a Multiplex Probe PCR in Identifying Mycoplasma Species in Bovine Milk, 
Semen and Swab Samples. 12
th
 Annual Meeting of the Australian Association of 
Veterinary Laboratory Diagnosticians, November 23
rd
-24
th
, 2016. Darwin, Australia. 
Parker, A. M., A. Shukla, J. K. House, M. S. Hazelton, K. L. Bosward, B. Kokotovic, and P. A. 
Sheehy. Genetic characterization of Australian Mycoplasma bovis isolates through whole 
genome sequencing analysis. University of Sydney, Faculty of Veterinary Science 
Postgraduate Conference, November 9
th
-10
th
, 2016. Sydney, Australia (3 minute thesis 
and poster) 
Parker, A. M., K. L. Bosward, J. K. House, M. S. Hazelton, and P. A. Sheehy. Milk 
acidification to control the growth of Salmonella Dublin in infected milk. 17
th
 AAAP 
Animal Science Congress, August 22
nd
-25
th
, 2016. Fukuoka, Japan. 
Parker, A. M., A. Shukla, J. K. House, M. S. Hazelton, K. L. Bosward, B. Kokotovic, and P. A. 
Sheehy. Genetic characterization of Australian Mycoplasma bovis isolates through whole 
genome sequencing analysis. Australian Society of Microbiology Conference, July 3
rd
-
6
th
, 2016. Perth, Australia.  (3 minute thesis and poster session) 
Parker, A.M., K.L. Bosward, J.K. House, M.S. Hazelton, P.A. Sheehy. Milk acidification to 
control Mycoplasma bovis growth in infected milk. Dairy Research Foundation 
Symposium, June 16
th
 –18th, 2015. Camden, Australia. 
20 
 
Parker, A.M. Development of biosecurity procedures to control and prevent Mycoplasma spp 
infection in Australian dairy production systems.  University of Sydney, Faculty of 
Veterinary Science Postgraduate Conference, November 5
th
-6
th
, 2014. Sydney, Australia.  
21 
 
List of awards and grants 
Dairy Australia Postgraduate Grant (2014-2017) 
Young Scientist Award/JSAS Excellent Presentation Award, 17
th
 Asian-Australasian Association 
of Animal Production (AAAP) Animal Science Congress (2016) 
ASM 3 Minute Thesis Award, Australian Society of Microbiology Conference (2016) 
TJ Robinson Travelling Bequest (2016) 
Postgraduate Research Support Scheme (2016) 
Stock and Meat Industries Grant-In-Aid (2015) 
James King of Irrawang Travelling Scholarship (2015) 
William and Catherine Mcllrath Grant-In-Aid (2015) 
Stock and Meat Industries Grant-In-Aid (2014)  
22 
 
Disclosure and author contributions 
Chapters 2, 3 and 5 are published in peer-reviewed journals. Chapter 4 is currently under review. 
Chapter 2 
Parker, A. M., A. Shukla, J. K. House, M. S. Hazelton, K. L. Bosward, B. Kokotovic, and P. A. 
Sheehy. 2016. Genetic characterization of Australian Mycoplasma bovis isolates through 
whole genome sequencing analysis. Vet. Microbiol. 196:118-125. 
doi.org/10.1016/j.vetmic.2016.10.010 
I, Alysia Parker, was responsible for the study design, isolate collection, laboratory work, 
genome analysis, statistical analysis, and the original preparation and editing of this 
manuscript.  
Contributions to this manuscript made by all authors are as follows: 
Task Author 
Study design AP, JH, MH, KB, PS 
Isolate collection AP, JH, MH 
Laboratory work AP 
Genome analysis AP, AS, BK 
Statistical Analysis AP 
Writing – original draft preparation AP 
Writing – review and editing AP, AS, JH, MH, KB, BK, PS 
 
23 
 
As supervisor for the candidature upon which this thesis is based, I can confirm that the 
authorship attribution statements above are correct.  
Signature:      Date: 24.03.2017 
Associate Professor Paul Sheehy  
24 
 
Chapter 3 
Parker, A. M., J. K. House, M. S. Hazelton, K. L. Bosward, and P. A. Sheehy. 2017. 
Comparison of culture and a multiplex probe PCR for identifying Mycoplasma species in 
bovine milk, semen and swab samples. PLoS ONE 12(3):e0173422. 
I, Alysia Parker, was responsible for the study design, sample collection, laboratory work, 
statistical analysis, and the original preparation and editing of this manuscript.  
Contributions to this manuscript made by all authors are as follows: 
Task Author 
Study design AP, JH, MH, KB, VM, FM, PS 
Sample Collection AP, MH, JH 
Laboratory work AP 
Statistical Analysis AP 
Writing – original draft preparation AP 
Writing – review and editing AP, JH, MH, KB, VM, FM, PS 
 
As supervisor for the candidature upon which this thesis is based, I can confirm that the 
authorship attribution statements above are correct.  
Signature:      Date: 24.03.2017 
Associate Professor Paul Sheehy  
25 
 
Chapter 4 
Parker, A. M., J. K. House, M. S. Hazelton, K. L. Bosward, J. M. Morton, and P. A. Sheehy. 
Bulk Tank Milk Antibody-ELISA as a Biosecurity Tool for Detecting Dairy Herds with 
Past Exposure to Mycoplasma bovis.  
I, Alysia Parker, was responsible for the study design, sample collection, laboratory work, 
statistical analysis, and the original preparation and editing of this manuscript.  
Contributions to this manuscript made by all authors are as follows: 
Task Author 
Study design AP, JH, MH, KB, JM, PS 
Sample Collection AP, MH, JH 
Laboratory work AP 
Statistical Analysis AP, JM 
Writing – original draft preparation AP 
Writing – review and editing AP, JH, MH, KB, JM, PS 
 
As supervisor for the candidature upon which this thesis is based, I can confirm that the 
authorship attribution statements above are correct.  
Signature:       Date: 24.03.2017 
Associate Professor Paul Sheehy  
26 
 
Chapter 5 
Parker, A. M., J. K. House, M. S. Hazelton, K. L. Bosward, V. L. Mohler, F. P. Maunsell, and 
P. A. Sheehy. 2016. Milk acidification to control the growth of Mycoplasma bovis and 
Salmonella Dublin in contaminated milk. J Dairy Sci 99(12):9875-9884. 
doi.org/10.3168/jds.2016-11537 
I, Alysia Parker, was responsible for the study design, laboratory work, statistical analysis, and 
the original preparation and editing of this manuscript.  
Contributions to this manuscript made by all authors are as follows: 
Task Author 
Study design AP, JH, MH, KB, VM, FM, PS 
Laboratory work AP 
Statistical Analysis AP 
Writing – original draft preparation AP 
Writing – review and editing AP, JH, MH, KB, VM, FM, PS 
 
As supervisor for the candidature upon which this thesis is based, I can confirm that the 
authorship attribution statements above are correct.  
Signature:      Date: 24.03.2017 
Associate Professor Paul Sheehy 
  
27 
 
Abbreviations 
A. baumannii  Acinetobacter baumannii  
AFLP Amplified fragment length polymorphism  
AR1 First autoregresive 
ATCC American type culture collection 
AUS Australia 
bMEC Bovine mammary epithelial cells 
BRS Blast score ratio 
BTM Bulk tank milk 
ᵒC Degrees celsius 
CCP Colloidal calcium phosphate  
CDS Coding sequence 
cfu Colony forming units 
cfu/mL Colony forming units per millilitre 
CI Confidence intervals 
CO2 Carbon dioxide 
Ct Cycle threshold 
DNA Deoxyribonucleic acid 
dNTPs Deoxynucleotide triphosphates 
E. coli Escherichia coli  
ECM Extracellular matrix 
ELISA Enzyme-linked immunosorbent assay 
EMAI Elizabeth Macarthur Agricultural Institute 
28 
 
GTLS Gentamicin, tylosin, lincomycin and spectinomycin 
h Hours 
IETS International embryo transfer society 
IgA Immunoglobulin A 
IgG Immunoglobulin G 
IgM Immunoglobulin M 
IOM International Organization of Mycoplasmology 
IVF In vitro fertilization 
L. monocytogenes Listeria monocytogenes 
Listeria spp.  Listeria species 
LS-BSR Large-scale blast score ratio  
LVT&RU Livestock Veterinary Teaching and Research Unit 
M. alkalescens Mycoplasma alkalescens 
M. arginini Mycoplasma arginini 
M. bovigenitalium Mycoplasma bovigenitalium 
M. bovirhinis Mycoplasma bovirhinis 
M. bovis Mycoplasma bovis 
M. bovoculi Mycoplasma bovoculi 
M. californicum Mycoplasma californicum 
M. canadense Mycoplasma canadense 
M. canis Mycoplasma canis 
M. dispar Mycoplasma dispar 
M. hyorhinis Mycoplasma hyorhinis 
M. leachii Mycoplasma leachii 
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M. mycoides subsp mycoides Mycoplasma mycoides subspecies mycoides 
M. pneumoniae Mycoplasma pneumoniae 
M. wenyonii Mycoplasma wenyonii 
M. alkalescens Mycoplasma alkalescens 
Mar March 
mg  Milligrams 
MgCl2 Magnesium chloride 
min Minute 
mL Milliliter 
MLST Multilocus sequence typing 
MLVA Multiple locus variable number tandem repeat analysis 
mM Millimolar 
mo Months 
Mtase Methyltransferase 
Mycoplasma sp. bovine group 7 Mycoplasma species bovine group 7 
Mycoplasma spp. Mycoplasma species 
NCBI National Center for Biotechnological Information 
NGS Next generation sequencing  
Nov November 
NSW New South Wales 
ODC Optical density coefficient 
PBMC Peripheral blood mononuclear cells 
PBS Phosphate-buffered saline 
PCI Posterior credibility intervals 
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PCR Polymerase chain reaction 
PECT Primary embryonic calf turbinate 
PFGE Pulsed field gel electrophoresis 
pH Potential of hydrogen 
PLC Plate loop count 
QLD Queensland 
RAST Rapid Annotation using Subsystem Technology 
REML Restricted maximum likelihood 
rRNA Ribosomal ribonucleic acid 
rt-PCR Real-time polymerase chain reaction 
s Second 
S. agalactiae Streptococcus agalactiae 
S. aureus Staphylococcus aureus 
S. enteritidis Salmonella enteritidis  
S. uberis Streptococcus uberis 
SA South Australia 
Salmonella Dublin Salmonella enterica subspecies enterica serovar Dublin 
Salmonella spp. Salmonella species 
SBA Sheep blood agar 
SE Standard error 
Sep September 
SNP Single nucleotide polymorphism 
SPC Standard plate count 
spp. Species 
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Streptococcus spp. Streptococcus species 
subsp. Subspecies 
TAS Tasmania 
TBC Total bacterial count 
tRNA Transfer ribonucleic acid 
U Units 
U.S.A United States of America 
µg Micrograms 
µL Microliter 
µM Micromolar 
USYD University of Sydney 
UV Ultraviolet 
VFDB Virulence factor database 
VIC Victoria 
vsp Variable surface protein 
w/v Weight for volume 
WGS Whole genome sequencing 
wk Weeks 
XLD Xylose lysine deoxycholate 
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CHAPTER 1: LITERATURE REVIEW 
1.1 Introduction 
Mycoplasma is a genus of bacteria which, along with nine other genera, belong to the class 
Mollicutes (Parte et al., 2011). Mollicutes are the simplest and smallest self-replicating free- 
living form of life, characterised by their low G+C content (23-40%), small genome size (0.58-
1.4Mbp) and absence of a cell wall (Parte et al., 2011). Mycoplasma species can cause severe 
disease in cattle worldwide, and are most commonly associated with mastitis, arthritis, 
pneumonia and otitis media (Maunsell et al., 2011). In cattle, Mycoplasma bovis is currently 
considered to be the most important and frequently isolated species associated with disease (Fox, 
2012). Due to its highly contagious nature and poor response to antimicrobial treatment, culling 
of infected animals with the mastitic form of the disease remains the most common and 
recommended form of disease controls (Nicholas et al., 2016). 
In Australia, there has been an observed increase in the incidence of disease caused by 
mycoplasma in the last nine years. While the national prevalence of mycoplasma infection is 
relatively low in Australian dairy herds, the organism has been isolated in all states, with the 
potential to cause serious disease in infected herds (Morton et al., 2014). The following literature 
review aims to present an overview of mycoplasma infection in dairy cattle, with a particular 
focus on M. bovis. Through this literature review, Mycoplasma species of significance to the 
dairy industry, disease manifestations, pathogenesis, risk factors and transmission routes of the 
organism will be outlined, isolate typing and whole genome sequencing will be explored, current 
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options for diagnosing mycoplasma infection will be summarized, and available milk treatment 
options as a biosecurity protocol will be investigated. 
1.2 Mycoplasma species isolated from dairy cattle 
There are five genera of Mollicutes which are known to contain species of veterinary 
significance, including Mycoplasma, Ureaplasma, Acholeplasma, Anaeroplasma and 
Asteroplasma (Quinn et al., 2013). The Mycoplasma genus contains most of the animal 
pathogens as well as several which are associated with human disease, with a total of more than 
100 Mycoplasma species characterised (Mishra and Agrawal, 2012, Quinn et al., 2013). The first 
Mycoplasma species to be isolated and characterised was Mycoplasma mycoides subsp mycoides 
(formerly known as Mycoplasma mycoides subsp mycoides small colony) in 1898, the causative 
agent of contagious bovine pleuro-pneumonia (Nocard et al., 1990). Sequencing has since 
suggested that its origin dates back approximately 10,000 years, with its establishment and 
spread coinciding with the domestication of livestock (Fischer et al., 2012).  It is estimated that 
M. mycoides subsp. mycoides was introduced into Australia from Europe in 1858 via livestock 
movement, causing significant disease across the country, sparing only Tasmania (Fisher, 2006). 
In an effort to control the disease, inoculation trials began in the early 1860’s, involving the 
injection of trachea and lung exudate from infected animals into the tails of healthy animals, 
resulting in a reduction in cattle loss. To move towards eradication, by the 1930’s the Australian 
government was leading initiatives to cull all infected animals, and inoculate those that remained 
uninfected. Following further development of a vaccine, and a compliment fixation test to detect 
infected animals, in 1973 Australia was declared free of the disease (Newton, 1992). 
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Today, the most important Mycoplasma species recognized in cattle is M. bovis. Mycoplasma 
bovis was first isolated in the United States of America in 1961 from a severe case of mastitis in 
a dairy herd experiencing an outbreak, affecting more than 30% of the animals (Hale et al., 
1962). Following its discovery, global spread of M. bovis soon occurred, with the pathogen 
identified in many countries including: Israel (1964), Spain (1967), France (1974), Britain 
(1975), Czechoslovakia (1975), Germany (1977), Denmark (1981), Switzerland (1983), Morocco 
(1988), South Korea (1989), Brazil (1989), Northern Ireland (1993), Republic of Ireland (1994) 
and Chile (2000) (Nicholas and Ayling, 2003).  In 1970, M. bovis was isolated in Australia from 
bovine milk samples (Cottew, 1970), and has continued to persist within the cattle population. 
Several other Mycoplasma species are of interest in cattle, with varying degrees of significance 
with respect to disease and associated economic loss (Table 1.1). These include Mycoplasma 
californicum, Mycoplasma bovigenitalium, Mycoplasma bovirhinis, Mycoplasma bovoculi, 
Mycoplasma leachii (previously Mycoplasma sp. bovine group 7 (Manso-Silvan et al., 2009) , 
Mycoplasma dispar, Mycoplasma canis, Mycoplasma canadense, Mycoplasma alkalescens, 
Mycoplasma arginini and Mycoplasma wenyonii (Miles and Nicholas, 1998, Nicholas et al., 
2008, Strugnell and McAuliffe, 2012, Quinn et al., 2013). Species from the genus Acholeplasma 
are often isolated alongside Mycoplasma species however are not considered to be pathogenic in 
cattle.   
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Table 1.1 Mycoplasma species isolated from dairy cattle 
Species Disease Manifestation 
M. mycoides subsp. mycoides 
 
Contagious bovine pleuropneumonia (Nocard et al., 1990) 
 
M. bovis 
 
Adults 
Mastitis (Byrne et al., 2005, Wilson et al., 2007) 
Arthritis/lameness (Stalheim and Page, 1975, Wilson et al., 2007) 
 
Calves 
Arthritis/lameness (Stalheim and Page, 1975, Stipkovits et al., 2005) 
Pneumonia (Nicholas et al., 2002, Fraser et al., 2014) 
Otitis media interna (Walz et al., 1997, Maunsell et al., 2012) 
Decubital abscesses (Kinde et al., 1993) 
 
 
M. californicum 
 
Adults 
Mastitis (Jasper et al., 1981, Mackie et al., 1982, Infante-Martinez et 
al., 1999) 
 
Calves 
Arthritis, pneumonia (Hewicker-Trautwein et al., 2002) 
 
M. bovigenitalium 
 
Adults 
Reproductive tract of cows with vulvovaginitis and infertility (Brenner 
et al., 2009) 
Association with dystocia and endometritis (Ghanem et al., 2013) 
 
M. bovirhinis 
 
Calves 
Nose, lungs and trachea of healthy calves (Woldehiwet et al., 1990, ter 
Laak et al., 1992a, ter Laak et al., 1992b, Thomas et al., 2002) 
 
M. bovoculi 
 
Adults and Calves 
Conjunctivitis, keratoconjunctivitis (Rosenbusch, 1987, Naglic et al., 
1996, Levisohn et al., 2004) 
Eyes of healthy calves (Barber et al., 1986, Schottker-Wegner et al., 
1990) 
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M. leachii 
  
NOTE: Previously Mycoplasma sp. bovine group 7 (Manso-Silvan et 
al., 2009, Tardy et al., 2009, Manso-Silvan et al., 2012) 
 
Adults 
Mastitis, abortion (Hum et al., 2000, Djordjevic et al., 2001) 
 
Calves 
Polyarthritis (Hum et al., 2000, Djordjevic et al., 2001, Chang et al., 
2011) 
 
M. dispar 
 
Adults 
Respiratory disease (Ayling et al., 2004) 
 
Calves 
Pneumonia (Knudtson et al., 1986, ter Laak et al., 1992b) 
 
M. canis 
 
Calves 
Pneumonia (ter Laak et al., 1992b, Thomas et al., 2002, Ayling et al., 
2004) 
 
M. canadense 
 
Adults 
Mastitis (Infante-Martinez et al., 1999, Tamiozzo et al., 2014) 
Reproductive tract of cows with vulvovaginitis and infertility (Brenner 
et al., 2009) 
 
M. alkalescens 
 
Adults 
Isolated from mastitic milk (Hirose et al., 2001) 
Isolated from bulk tank milk (Olde Riekerink et al., 2006, Justice-
Allen et al., 2011) 
 
Calves 
Arthritis (Bennett and Jasper, 1978, Whithear, 1983) 
Pneumonia (Kokotovic et al., 2007) 
 
M. arginini 
 
Adults 
Isolated from bulk tank milk (Justice-Allen et al., 2011) 
May predispose animals to mastitis from Streptococcus dysgalactiae 
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(Stipkovits et al., 2013) 
 
Calves 
Respiratory disease and pneumonia in calves (ter Laak et al., 1992b, 
Hirose et al., 2003) 
Nose and trachea of healthy calves (Woldehiwet et al., 1990) 
Otitis media (Bernier Gosselin et al., 2012) 
 
M. wenyonii 
 
Adults 
Pyrexia, hindlimb and/or udder oedema, prefemoral lymphadenopathy 
(Strugnell and McAuliffe, 2012) 
 
 
1.3 Disease in cattle caused by Mycoplasma species 
1.3.1 Mastitis 
Clinical mastitis caused by Mycoplasma species is often characterised by multiple affected 
quarters coupled with unresponsiveness to treatment (Tolboom et al., 2008, Radaelli et al., 
2011).  A marked decrease in milk production is common, however systemic illness is rare, with 
appetite and water consumption remaining normal (Al-Abdullah and Fadl, 2006, Radaelli et al., 
2011). Milk characteristics may also change, with infected milk appearing to have a watery 
supernatant mixed with flakey or sandy sediment (Tolboom et al., 2008, Radaelli et al., 2011). 
Clinical signs appear to be most severe, and prevalence highest, following a new outbreak in a 
previously unexposed herd. Animals are often affected during the post-partum stage of lactation, 
with first lactation heifers at a higher risk (Al-Abdullah and Fadl, 2006, Radaelli et al., 2011). 
The average rate of shedding in clinical mycoplasma mastitis cases has been demonstrated to 
range from 271 to 4.25x10
9 
cfu/mL of milk, with an average of 10
8
 cfu/mL. In sub-clinical 
animals shedding can continue, however is decreased to an average of 10
6
 cfu/mL or less (Byrne 
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et al., 2005, Sachse et al., 2010). Intermittent and inconsistent shedding of mycoplasma in cows 
with naturally occurring chronic subclinical intra-mammary infection has been demonstrated, 
with mycoplasma organisms being undetectable in milk 29% of the time (Biddle et al., 2003). 
This highlights the risk of misdiagnosis if multiple milk samples are not tested.  
The prevalence of herds infected with Mycoplasma spp., as isolated from bulk tank milk (BTM) 
samples, has been estimated as low as 0% in France (Arcangioli et al., 2011) and New Zealand 
(McDonald et al., 2009), and up to 55% in Mexican herds (Miranda-Morales et al., 2008) (Table 
1.2). Although reported as high as 62% in North Queensland and Victoria, Australia (Ghadersohi 
et al., 1999), this claim has since been challenged based on more recent studies, suggesting that 
the prevalence is more likely to be 0.9% (Morton et al., 2014). Mycoplasma bovis is the most 
frequently isolated species from the BTM of infected herds, as well as individual animals with 
clinical mastitis (Justice-Allen et al., 2011, Pinho et al., 2013). Mycoplasma californicum 
(Mackie et al., 1982), M. leachii (Hum et al., 2000) and M. canadense (Infante-Martinez et al., 
1999) are less frequently isolated from mastitic cows. Mycoplasma bovis and M. californicum 
have also been demonstrated to cause mastitis through experimental inoculation (Mackie et al., 
1982, Byrne et al., 2005).  Mycoplasma bovigenitalium (Higuchi et al., 2013), M. alkalescens 
and M. arginini (Justice-Allen et al., 2011) have also been isolated from bulk milk however there 
is less evidence to suggest they cause mastitis. Mycoplasma bovigenitalium was the sole species 
isolated from an infected mammary gland of a 7 week old calf (Roy et al., 2008), and has also 
been isolated alongside M. bovis in milk from clinical mastitis cows (Baumgartner et al., 2006), 
however experimental challenges have not been explored. Studies have suggested that M. 
arginini does not cause mastitis, but significantly predisposes the animal to infection with 
Streptococcus dysgalactiae leading to severe mastitis (Stipkovits et al., 2013).   
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Table 1.2 Herd prevalence of Mycoplasma species from bulk tank milk samples 
Location 
Method of 
detection 
Herd 
prevalence of 
Mycoplasma 
spp. 
% of 
Mycoplasma 
spp. that were          
M. bovis 
Within-herd 
prevalence 
Reference 
U.S.A Culture 
Small herds: 
1.8% 
(<100) 
Medium herds: 
4.2% 
(100-499) 
Large herds: 
14.4% 
(>500)
 
N/A  
(APHIS-
USDA, 2008) 
Washington 
(U.S.A) 
Culture 20%
 
N/A  
(Fox et al., 
2003) 
Utah (U.S.A) 
Mycoplasma 
spp. PCR 
34%
 
83%  
(Justice-Allen 
et al., 2011) 
Quebec 
(Canada) 
Culture and 
Mycoplasma 
spp. PCR 
3.4%
 
N/A  
(Francoz et al., 
2012) 
Portugal Culture 3%
 
80% 2.5%-4.5% 
(Pinho et al., 
2013) 
Japan Culture 1.29%
 
43%  
(Higuchi et al., 
2011) 
Belgium 
Culture 
followed by 
M. bovis 
PCR for 
speciation 
1.5% 100%  
(Passchyn et 
al., 2012) 
New Zealand 
Culture and 
M. bovis 
PCR 
0% 0%  
(McDonald et 
al., 2009) 
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Mexico Culture 55% N/A  
(Miranda-
Morales et al., 
2008) 
Southeast 
France 
Culture and 
M. bovis 
PCR 
0% 0%  
(Arcangioli et 
al., 2011) 
Australia 
M. bovis 
PCR 
0.9% 100%  
(Morton et al., 
2014). 
 
1.3.2 Arthritis, pneumonia and otitis media 
Arthritis, pneumonia and otitis media caused by Mycoplasma species are often associated with 
cases of mycoplasma mastitis within a herd (Walz et al., 1997, Wilson et al., 2007). Clinical 
arthritis can occur in both adults and calves, with symptoms including stiffness, swelling of the 
carpal and tarsal joints, swelling of the fetlocks and forelimb lameness (Hum et al., 2000, Wilson 
et al., 2007).  In calves, the onset of clinical symptoms is typically seen following 2-3 weeks of 
housing, and may also occur after the transportation of calves over long distances (Hum et al., 
2000, Nicholas and Ayling, 2003). The predominant species isolated from arthritic animals is M. 
bovis (Stalheim and Page, 1975, Stipkovits et al., 2005, Wilson et al., 2007, Maunsell and 
Donovan, 2009). In calves, M. californicum (Hewicker-Trautwein et al., 2002), M. leachii (Hum 
et al., 2000) and M. alkalescens (Bennett and Jasper, 1978) have also been isolated from infected 
joints. 
Mycoplasma is an important cause of calf pneumonia and respiratory disease, frequently isolated 
from the lungs of affected animals (Knudtson et al., 1986, ter Laak et al., 1992b). While the role 
of mycoplasma as a primary or secondary pathogen is difficult to determine, experimental 
studies have demonstrated its ability to cause respiratory disease in cattle without the presence of 
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other pathogens (Nicholas et al., 2002). The predominant cause of mycoplasma respiratory 
disease is M. bovis and M. dispar (Knudtson et al., 1986, Thomas et al., 2002). Other species 
isolated from the respiratory tract of calves with respiratory disease include M. californicum 
(Hewicker-Trautwein et al., 2002), M. canis (Ayling et al., 2004), M. alkalescens (Kokotovic et 
al., 2007) and M. arginini (Hirose et al., 2003). Mycoplasma bovirhinis is frequently isolated 
from the respiratory system of healthy calves and is considered an opportunistic organism (ter 
Laak et al., 1992a, Thomas et al., 2002).  
Often diagnosed in concurrence with calf pneumonia (Francoz et al., 2004), otitis media can 
occur in calves following the consumption of infected milk, with symptoms including unilateral 
or bilateral ear droop, head tilt and/or head shaking, mild depression and lethargy (Maunsell et 
al., 2012). Mycoplasma bovis is the most common Mycoplasma species to cause otitis media, 
with one reported case of M. arginini being the sole species isolated from a clinically affected 
calf (Foster et al., 2009, Bernier Gosselin et al., 2012). 
1.3.3 Reproductive disorders 
The role that Mycoplasma species play in reproductive disorders of cattle is not fully understood. 
However, a strong association has been established between the occurrence of reproductive 
diseases such as endometritis, dystocia and abortion, and the isolation of M. bovis and M. 
bovigenitalium from the reproductive tract (Langford, 1975, Petit et al., 2008b, Ghanem et al., 
2013). Similarly, associations have also been observed between cows serologically positive for 
M. bovis antibodies, and longer calving to service intervals and calving to pregnancy intervals 
(Uhaa et al., 1990a). Mycoplasma bovigenitalium and M. canadense have also been isolated from 
vaginal lesions of cows with vulvovaginitis (Brenner et al., 2009). While infrequently reported, 
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Mycoplasma species have been isolated from aborted calves with M. bovis detected in the brain, 
lung, liver and placenta of an aborted foetus (Hermeyer et al., 2012), and M. leachii isolated 
from the stomach contents, lung and liver of aborted foetuses (Hum et al., 2000, Djordjevic et al., 
2001). Therefore, while a cause-effect relationship between mycoplasma and reproductive 
disorders in cattle is not well established, research suggests an association may exist. 
1.4 Pathogenesis of Mycoplasma species isolated from dairy cattle 
The initial key step in host-pathogen interaction is the ability of the pathogen to adhere to the 
host cell. While the mechanisms of cytoadhesion vary significantly amongst Mycoplasma 
species, with little known about the underlying mechanism used by M. bovis (Browning et al., 
2011), it has been suggested that surface proteins and variable surface proteins (vsps) may play 
an important role (Sachse et al., 1996, Thomas et al., 2003). Once adhered to the host cell, M. 
bovis activates an immune response causing damage to the host. This has been demonstrated in 
intrauterine infusion trials where M. bovis triggered inflammation and abnormal host 
extracellular matrix (ECM) protein expression in the endometrium (Guo et al., 2014). In the 
uterus, host ECM proteins play an important role in the establishment of the next pregnancy. 
Therefore this abnormal expression of ECM proteins may lead to reproductive disorders. A 
strong immune response of several immune factors has also been demonstrated in vitro in bovine 
mammary epithelial cells (bMEC) (Zbinden et al., 2015). However, this response was not seen 
when M. bovis was heat inactivated, suggesting that in order to activate the immune system, the 
release of metabolites by M. bovis may be necessary. While the activation of an immune 
response in the host is an important mycoplasma virulence characteristic, it is suggested that 
cytoadhesion of M. bovis to host cells is largely dependent on temperature, with their attachment 
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hindered at temperatures below 4 ᵒC and above 37 ᵒC (Sachse et al., 1996). This indicates that 
their ability to attach to the host cell is impaired in animals with an elevated body temperature. 
This may explain why not all animals that become exposed to M. bovis develop clinical disease, 
with these results suggesting that animals with strong immunity exhibit an early rise in body 
temperature and therefore have a reduced tendency to become clinically infected when exposed 
to. 
The most comprehensively investigated virulence attribute of M. bovis which are thought to 
contribute to its pathogenesis are variable surface proteins (vsps), a family of antigenically and 
structurally related surface proteins whose sequence and expression level varies in different 
growth phases (Behrens et al., 1994). Variable surface proteins including lipoproteins, 
extracellular proteins and transmembrane proteins are thought to assist the pathogen in evasion 
of the immune system (Li et al., 2011, Wise et al., 2011). Three vsp genes (vspA, vspB and 
vspC) have been characterised as exhibiting independent high frequency phase variation between 
ON/OFF expression, independent high frequency variation in size, a surface exposed N-terminal 
domain and C-terminal region providing anchorage to the membrane, extensive repetitive 
domains, and shared epitope regions (Behrens et al., 1994). While the recent complete and fully 
assembled genome sequence of type strain M. bovis PG45 confirmed the presence of 13 different 
vsp genes (Wise et al., 2011), the sequencing of additional isolates found that this was reduced to 
6 vsp genes in M. bovis HB0801 (Qi et al., 2012), while the vsp cluster in M. bovis Hubei-1 was 
completely deleted (Li et al., 2011), suggesting that vsp genes may not play a pivotal role in all 
aspects of M. bovis pathogenesis.  Other lipoproteins which have been identified across many 
pathogenic Mycoplasma species have been suggested to encode a system for the transport of 
nutrients into the mycoplasma cell and are therefore required for growth and, as such, virulence 
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(Browning et al., 2011). A membrane nuclease gene has also been suggested as playing a crucial 
role in the maintenance of a nutritional supply of nucleotides in pathogenic mycoplasmas such as 
M. bovis (Sharma et al., 2015), an important virulence attribute given that their small genome 
size and simplicity force mycoplasmas to be dependent on their host for their nutrient supply 
(Nicholas et al., 2008). 
Mycoplasma species are frequently described in the literature as being extracellular pathogens 
which adhere to the host cells. More recent studies have investigated its role as an intracellular 
pathogen, demonstrating the ability of M. bovis to invade, persist and multiply in primary 
embryonic calf turbinate (PECT) cells in vitro (Burki et al., 2015b). Mycoplasma bovis was also 
demonstrated in vitro to attach and invade bovine peripheral blood mononuclear cells (PBMC) 
and erythrocytes (red blood cells), however once invaded did not appear to affect the cells 
function (van der Merwe et al., 2010). This suggests that the intracellular invasion of M. bovis 
could assist with its transport to other sites within the host, and may provide a protective niche, 
allowing the pathogen to escape the host’s immune system as well as avoid the effects of 
antimicrobial therapy. Furthermore, this characteristic may also be what allows healthy carrier 
animals to persist within a herd allowing the spread and transmission of the pathogen (Burki et 
al., 2015b). 
It has been proposed that mycoplasma survival within the environment and the host may also be 
facilitated by biofilm formation, a process which involves bacteria attaching to each other and a 
surface, often surrounded by an extracellular matrix (McAuliffe et al., 2006). Mycoplasma bovis 
has been shown to produce prolific biofilms which are considerably more resistant to heat and 
desiccation, enabling their survival in the environment (McAuliffe et al., 2006). Moreover, 
biofilms can cause increased damage to the host as they attract phagocytes resulting in the 
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release of lysosomal enzymes, reactive nitrogen species and reactive oxygen species (Burki et 
al., 2015a). However, intraspecies variation is demonstrated by the wide variation in the ability 
of different M. bovis strains to form biofilms, with some correlation seen between the ability of 
organisms to form a biofilm and their genotype group as assessed by molecular typing 
(McAuliffe et al., 2006). 
1.5 Risk factors and transmission of mycoplasma infection 
While mycoplasma disease can occur within both small and large dairy herds, studies have 
suggested a correlation between increased herd size and the detection of mycoplasma through 
PCR and culture (Fox et al., 2003) and antibody detection (Uhaa et al., 1990b). This may be due 
to indirect factors such as management practices, hygiene, animal density and animal movement 
which may be more difficult to control with increasing herd size, and as a result mycoplasma 
pathogens may have more of an opportunity to cause disease. However, it could be assumed that 
if this is the reasoning then there would be a similar trend with other contagious mastitis 
pathogens. A nationwide survey across 534 dairies in U.S.A in 2007 found that while the 
prevalence of Mycoplasma spp. increased as herd size increased, this was not seen with the 
contagious pathogens Staphylococcus aureus and Streptococcus agalactiae (APHIS-USDA, 
2008). This suggests that increased herd size does not necessarily lead to poorer management 
and hygiene practices, resulting in an increased probability of Mycoplasma spp. infection. An 
alternative explanation may be that as herd size increases the probability of having or introducing 
at least one Mycoplasma positive animal is greater, despite good management and hygiene 
practices. Therefore, adequate biosecurity to prevent entry of mycoplasma into the herd is very 
important. 
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Due to the highly contagious nature of mycoplasma, once within a dairy herd the pathogen is 
most commonly transmitted during milking from udder to udder by fomites including milker’s 
hands, milking line units and udder wash cloths (Fox, 2012). Therefore strict hygiene practices 
during milk harvesting are very important in controlling the disease and preventing transmission. 
This includes the use of teat dips composed of compounds which M. bovis has been 
demonstrated to be highly sensitive to including 1% hydrogen peroxide, 1% chlorine dioxide, 
1% iodophor and 0.5% iodophor (Enger et al., 2015). Animals suspected of being infected by 
mycoplasma should be immediately segregated from the main herd to minimize their exposure to 
uninfected animals (Fox et al., 2005). Importantly, these hygiene practices must also be extended 
to the ‘hospital’ herd, since M. bovis has the ability to spread as the result of the introduction of a 
single cow with clinical M. bovis mastitis (Punyapornwithaya et al., 2011). 
The environment may also play a role in transmission by harbouring viable mycoplasma 
organisms. Mycoplasma species have been demonstrated to survive up to 8 months in sand 
bedding, with the concentration of organism dependent on temperature and precipitation, and a 
positive association observed between gram-negative bacterial growth and mycoplasma survival 
(Justice-Allen et al., 2010). While this suggests that recycled bedding may act as a source of 
mycoplasma transmission, further studies into this theory were not able to induce disease in 
naïve calves housed on contaminated sand bedding (Wilson et al., 2011). 
Following an outbreak of M. bovis mastitis, not only can the pathogen be isolated from milk, but 
colonization of mucosal surfaces including the eye, nasal cavity, ear and vagina can also occur 
(Biddle et al., 2005, Punyapornwithaya et al., 2010). Furthermore M. bovis can also be isolated 
from the mucosal surfaces of clinically normal and healthy dry and lactating cows, heifers and 
calves (Bennett and Jasper, 1977, Punyapornwithaya et al., 2010). This suggests that 
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transmission may also be possible through direct animal to animal contact by shedding of the 
pathogen through mucosal surfaces of a colonized to a naïve or un-colonized animal. While it 
has been reported that M. bovis can be isolated from the nares of healthy calves from herds 
apparently free of mycoplasma disease, it appears that this is far more likely in herds which are 
experiencing an outbreak (Bennett and Jasper, 1977, Punyapornwithaya et al., 2010). 
Transmission of M. bovis from the main milking herd to calves is thought to most often occur 
through the ingestion of infected milk. When milk containing viable M. bovis is fed to calves, an 
ascending infection and the development of otitis media, lower respiratory disease and arthritis 
can occur (Maunsell et al., 2012). This route of transmission can be reduced by treating the milk 
prior to consumption which will be discussed later in this review. Once a calf becomes infected, 
it is speculated that mycoplasma can be shed through respiratory secretions (Maunsell and 
Donovan, 2009), with nasal colonization persisting for several months despite contaminated milk 
no longer being fed (Bennett and Jasper, 1977). This then allows the opportunity for transmission 
of the pathogen to naive calves, again highlighting the importance of segregating infected 
animals. 
While not considered to be a high risk, research suggests that bulls may play a role in the 
dissemination of Mycoplasma species through both natural mating and artificial insemination 
(Fish et al., 1985, Petit et al., 2008a). For commercially cryopreserved semen, antibiotics are 
routinely added to act as a preventative measure against microbial contamination and 
transmission. Due to the inability of historical antibiotics including penicillin and streptomycin 
to control mycoplasma, the current international standard favors protocols which include 
gentamicin, tylosin, lincomycin and spectinomycin (GTLS) (Hopper, 2014). However, a study 
by Visser et al. (1999) of M. bovis spiked fresh bovine semen found that the addition of the 
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antibiotic mixture GTLS and storage in straws at -196ᵒC did not totally eliminate mycoplasma. 
The author concluded that while a bacteriostatic effect occurred, there was no bactericidal effect. 
Furthermore, it has also been demonstrated that M. bovis and M. bovigenitalium present in semen 
can be transmitted through in vitro fertilization (IVF) and infect embryo development (Bielanski 
et al., 2000). It was also shown that the addition of the antibiotics penicillin, streptomycin, 
linomycin and spectinomycin to the semen samples, as well as supplementation of culture media 
and embryo washing procedures as recommended by the International Embryo Transfer Society 
(IETS), did not render the embryos free from M. bovis and M. bovigenitalium. While an 
increased cost to artificial insemination programs would be incurred, testing of semen for 
Mycoplasma spp. by PCR is a feasible option as a biosecurity tool (McDonald, 2012). Therefore, 
while the relationship between mycoplasma and reproductive performance is yet to be resolved, 
research suggests that transmission via bulls and semen is possible. 
1.6 Mycoplasma isolate typing and whole genome sequencing 
1.6.1 Isolate typing 
Several tools have been used for genetic characterisation of M. bovis isolates such as pulsed field 
gel electrophoresis (PFGE), amplified fragment length polymorphism (AFLP), multiple locus 
variable number tandem repeat analysis (MLVA) and multilocus sequence typing (MLST). 
Pulsed field gel electrophoresis was developed in the early 1980s and has been widely used for 
mycoplasma strain typing and identification. During PFGE chromosomal DNA is first digested 
across a small number of sites along the chromosome using a restriction enzyme, resulting in 
large DNA fragments being separated in an agarose gel producing band patterns specific to 
different strains (Mahon and Manuselis, 2000). Pulsed field gel electrophoresis has been used in 
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several M. bovis outbreak investigations (Biddle et al., 2005, Arcangioli et al., 2012). An early 
study examining isolates from numerous body sites of cattle associated with a single herd 
outbreak found that isolates from the mammary system frequently had identical PFGE patterns to 
isolates from other body sites suggesting internal transmission of the one strain (Biddle et al., 
2005). A second study investigating an M. bovis outbreak across 6 cattle feedlots suggested, 
through identical PFGE patterns of 39 isolates that M. bovis strains follow a clonal 
epidemiological spread at the herd level and the same strain can persist in calves within the herd 
after clinical signs have disappeared (Arcangioli et al., 2012).  
Amplified fragment length polymorphism (AFLP) is a PCR-based technique also used for DNA 
fingerprinting which involves digestion of the DNA with restriction enzymes, ligation of 
adaptors, and selective amplification of a subset of restriction fragments followed by gel analysis 
of these fragments (Vos et al., 1995). This technique was used to analyse genetic variation 
among 42 M. bovis field isolates from Danish cattle over a 17 year period from 1981 to 1998 to 
monitor the spread of the disease and genetic relatedness of isolates in order to be better 
informed to formulate disease control programs (Kusiluka et al., 2000). This was done by 
identifying the likely sources of infection and transmission of the pathogen, as well as the 
possible role that host, environment and pathogen play in disease outcome. Despite Mollicutes 
being considered to be quite dynamic in their evolution (Razin et al., 1998), the study found 
remarkable genetic homogeneity amongst Danish M. bovis isolates, which were likely to be 
epidemiologically related, and had remained genetically stable for a considerable amount of 
time. The study also observed identical genetic patterns amongst M. bovis isolates from lung, 
nasal and milk samples, which was consistent with the findings of Biddle et al. (2005), 
suggesting internal transmission. It also suggests that the site of isolation may not be associated 
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with differences in the genetic profile of the organism, corresponding with the phenotypic 
findings of Thomas et al. (2003) which demonstrated no correlation between the pathological 
background of M. bovis isolates (mastitis, pneumonia, arthritis), and their ability to adhere to 
different host cell lines.  
Multilocus sequence typing (MLST) uses several genes within the genome which are analysed 
for unique sequences (Mahon and Manuselis, 2000). Based on these differences the relatedness 
of the isolates is determined. Multiple locus variable number tandem repeat analysis (MLVA) 
uses PCR to amplify regions of DNA which contain repeated sequences which tend to be 
unstable and, as such, can be used to distinguish different isolates based on the amount of repeats 
at selected loci (Mahon and Manuselis, 2000). For genotyping M. bovis isolates, it has been 
recommended that both methods are used, with MLST used first to characterise strains followed 
by MLVA for fine scale typing (Sulyok et al., 2014).  In a recent study, MLVA and MLST were 
used to analyse 60 M. bovis isolates collected in France over a 35 year period (from 1977 to 
2012) to determine population diversity (Becker et al., 2015). Based on 4 loci, the study found 
that all isolates fell into two separate clusters: those collected before the year 2000 and those 
collected after the year 2000. Interestingly, recent strains showed more homogeneity than older 
strains, which is consistent with the spread of a single clone, however is contradictory to the 
findings in Denmark which found more heterogeneity amongst more recent isolates (Kusiluka et 
al., 2000). The author of the French study hypothesizes that the loss of heterogeneity in the 
recent French strains may be due to selection of multi-resistant clones.   
In a recent global study by Rosales et al. (2015), MLST was used to characterise 137 M. bovis 
isolates from healthy and clinically infected animals from 12 different countries including 
Australia and countries located in Europe and Asia. Using a set of seven housekeeping genes, 
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MLST analysis identified two distinct population clusters. Cluster one included most of the 
British and German isolates, while cluster two contained European, Asian and Australian isolates 
which were more geographically distant and heterogeneous. This supports the hypothesis that 
once M. bovis is introduced into a country, possibly through trade, the pathogen undergoes 
geographically independent evolution. This is clearly demonstrated with Australian, Chinese and 
some Israeli isolates exhibiting genetic diversity in comparison to most of the European isolates 
characterised. The study also noted that while most of the mastitis isolates clustered largely with 
the pneumonia isolates, the seven most genetically diverse isolates which did not cluster were all 
mastitis cases, with the author suggesting this may be due to adaptation to the specific niche 
ecology of the bovine mammary gland. This is despite previous studies suggesting that the site of 
isolation may not be associated with differences in the genetic profile of the organism (Kusiluka 
et al., 2000, Thomas et al., 2003, Biddle et al., 2005). However with little information available 
in regards to the circumstances surrounding their isolation, there may be other aspects associated 
with these isolates which attributed to the genetic diversity amongst this group.  
1.6.2 Whole genome sequencing 
Whole Genome Sequencing (WGS) is becoming a widely used tool for investigating bacterial 
genome sequences as high throughput sequencing becomes faster, cheaper and more readily 
available. As suggested by the name, WGS involves sequencing the entire genome of selected 
isolates which can then be used for clinical diagnostics, disease outbreak investigation and 
controlling antimicrobial resistance (Edwards and Holt, 2013). For example, a recent study used 
WGS to analyse 145 Scottish Escherichia coli 0157 isolates to determine through single 
nucleotide polymorphism (SNP) analysis the association between cattle and pig isolates with 
clinical isolates from humans, food and the environment (Strachan et al., 2015). This allowed 
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light to be shed on the transmission and evolution of the pathogen, highlight the relevance of 
animal reservoirs, and improve the understanding of disease incidence variation internationally. 
In a similar study looking at E. coli 026, WGS was performed on 182 humans and non-human 
derived epidemiologically unrelated strains, with SNP analysis identifying clusters based on 
particular virulence profiles rather than host profile, suggesting that transmission between 
humans and cattle may occur (Norman et al., 2015). 
To date, three M. bovis isolates have had their complete genome sequenced including type strain 
M. bovis PG45 isolated in 1962 in the U.S.A (Wise et al., 2011), M. bovis Hubei-1 isolated in 
2008 in China (Li et al., 2011) and M. bovis HB0801 also isolated in 2008 in China (Qi et al., 
2012). While the complete sequencing of these isolates has provided some insight into the 
content and dynamics of the organism as well as uncovering putative virulence genes, WGS is as 
yet to be used to compare the genetic diversity between large numbers of M. bovis isolates. 
Furthermore, genetic characterisation of Australian isolates has not yet been performed. 
Therefore, further research is required in this area, in order to gain a better understanding of not 
only M. bovis as an organism on a larger scale, but also its context within Australia. This 
knowledge gap will be addressed in Chapter 2 of this thesis. 
1.7 Diagnostics of Mycoplasma species in cattle 
1.7.1 Culture detection  
Traditionally, the identification and diagnosis of mycoplasma has been performed via 
microbiological culture. Due to their simplicity, mycoplasmas are unable to synthesize amino 
acids and have complete or partial inability to synthesize fatty acids. In order to meet this high 
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nutritional demand the media used to grow mycoplasma is often highly enriched and based on 
beef heart infusion, serum, yeast extract, peptone and other supplements with a final pH of 7.3 to 
7.8 required (McVey et al., 2013).  Isolation of mycoplasma by culture can be hampered by the 
overgrowth of other faster growing bacteria, therefore the use of antimicrobials such as thallium 
acetate or antibiotics should be used (Miles and Nicholas, 1998). Culture media is incubated for 
7-10 days at 37 ᵒC and 5 % CO2, resulting in the growth of micro-colonies with a morphological 
appearance of ‘fried eggs’ visible via light microscope (Quinn et al., 2013). This appearance is 
due to the central portion of the colony embedding itself into the agar surrounded by a zone of 
surface growth (McVey et al., 2013).  
The limit of detection for culture has been reported as low as 272 cfu/mL in milk (Sachse et al., 
2010). However the common practice of inoculating plates with 10 µL volumes of milk so as to 
get maximum use of agar means that, theoretically, the minimum concentration of mycoplasma 
which can be detected by culture is 100 cfu/mL since it is unlikely to identify less than one 
colony in 10 µL (Cai et al., 2005). When mycoplasma is in low concentrations in milk, recovery 
by culture can be improved if milk is centrifuged first and suspended in a small volume of saline 
prior to culturing (Punyapornwithaya et al., 2009). 
While identification of mycoplasma via culture may be the method used more frequently, mostly 
due to its relative simplicity and low cost, it does have several limitations. Mycoplasma can be 
easily overgrown by other types of bacteria present as contaminants or even as mixed infections 
in the sample. This can result in mycoplasma identification by culture being very difficult and in 
some cases not possible. Appropriate sample collection, handling and storage is essential to 
prevent or minimize the overgrowth of other bacteria in the sample, and also to keep any 
mycoplasma organisms present in the sample viable so that it will grow on media.  Samples 
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should be collected aseptically into sterile tubes or containers (Miles and Nicholas, 1998) and 
then kept at 4 ᵒC, and transported to the laboratory for culturing as soon as possible. If culture 
cannot be performed within two days, samples should be frozen at -20°C (Maunsell et al., 2011). 
Ideally, frozen samples should be thawed at room temperature to ensure maximum recovery, 
with repeat freeze thawing causing a further decrease in viable organisms. Mycoplasma recovery 
rate decreases with increased time to processing regardless of whether they are refrigerated or 
frozen, with best recovery rates achieved when culturing is performed on fresh samples within a 
few hours of collection (Biddle et al., 2004). If samples are not collected and stored 
appropriately, this may results in false negative results being reported by culture, and 
mycoplasma going undiagnosed. 
Assuming the correct sample collection and storage protocols have been followed, mycoplasma 
still has a slow rate of growth, with results not available for 7-10 days. When dealing with 
mycoplasma a rapid diagnostic result is very important so that infected animals can be removed 
from the herd in order to minimize potential spread (Fox, 2012). Therefore, due to the extended 
time between sample submission and diagnostic result by culture, any animal suspected of being 
mycoplasma-positive should be segregated from the main herd immediately as a precaution until 
a result is received.  
In order for mycoplasma infection to be diagnosed by culture, the animal must be shedding the 
organism at the time of sample collection. Intermittent shedding is a phenomenon frequently 
reported with mycoplasma mastitis in chronically infected and subclinical cases (Biddle et al., 
2003), which can result in a failure in diagnosis. To increase the likelihood of identifying 
chronically infected and subclinical mycoplasma-positive animals, multiple samples should be 
taken. This is also true for bulk tank milk analysis, with recommendations that at least three 
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samples should be collected 3-4 days apart and cultured, with seven consecutive daily cultures 
further increasing the predictive value of negative cultures (Gonzalez and Wilson, 2002). 
The media used to grow mycoplasma generally grows several Mycoplasma species, some of 
which are known pathogens to cattle while others may be considered opportunistic. Mycoplasma 
media also grows many Acholeplasma species, an environmental contaminant and opportunistic 
organism (Nicholas et al., 2008). Given that species of both Acholeplasma and Mycoplasma have 
a gross morphological ‘fried egg’ appearance, differentiation by culture alone is very difficult 
(McVey et al., 2013), and can result in the reporting of false mycoplasma-positive samples. 
Digitonin sensitivity can be used as an additional step to distinguish Mycoplasma from 
Acholeplasma spp. On a paper disc saturated with 1.5 % digitonin a large zone of inhibition will 
surround mycoplasma, with a small to non-existent zone of inhibition for acholeplasma 
(Boonyayatra et al., 2012b). However interpretation of digitonin sensitivity can be subjective. 
Ideally to ensure an accurate diagnosis, PCR should be used as confirmation on any positive 
culture result to identify the species grown. 
1.7.2 PCR detection 
1.7.2.1 Conventional PCR detection 
The use of PCR to detect Mycoplasma species from various samples has demonstrated a higher 
efficiency, specificity and sensitivity for laboratory diagnosis when compared to conventional 
culture based diagnostic methodologies (Sachse et al., 1993). Analysis via PCR involves the 
amplification of the DNA of the target organism (Dennis Lo, 1998) and, as such, the organism 
must be present in the sample with non-degraded DNA for amplification to occur. However 
unlike culture, the organism does not have to be viable. Assays have been developed to detect 
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individual Mycoplasma species of interest, while some have been developed to identify several 
Mycoplasma species, followed by post-PCR speciation. The development of conventional PCR 
methods to detect M. bovis began in the 1990’s targeting the 16s rRNA gene (Gonzalez et al., 
1995, Hotzel et al., 1996). The 16S rRNA gene is one of the most common genes targeted for 
bacterial identification due its presence in all bacteria and its function remaining unchanged over 
time (Janda and Abbott, 2007). The 16S rRNA gene is a small subunit within prokaryotic 
ribosomes, containing highly conserved regions as well as variable regions which can be species 
specific, making it ideal for bacterial identification (Kolbert and Persing, 1999). The limit of 
detection of these early PCR assays was reported as 4 x 10
2
 cfu/mL in broth cultures (Gonzalez 
et al., 1995), and 5 x 10
2
 cfu/mL in milk samples following a DNA extraction process (Hotzel et 
al., 1996). Results were produced within 24 h, rendering the PCR method much more rapid than 
traditional culture. However, while the specificity of these PCR assays targeting the 16s rRNA 
gene of M. bovis appeared to be adequate against most Mycoplasma species, cross amplification 
was seen with M. agalactiae (Gonzalez et al., 1995), a species affecting small ruminants (Kumar 
et al., 2014).  
As M. bovis is not the only Mycoplasma species of interest, further development of PCR assays 
allowed the detection of several species. A PCR targeting the 16S-23S rRNA spacer region was 
designed to allow the identification of Mycoplasma spp. and Acholeplasma spp. contaminants in 
cell cultures (Tang et al., 2000). The 16S-23S rRNA intergenic spacer region is a structural 
region situated between two ribosomal RNAs which are essential for protein synthesis (Anton et 
al., 1998). While this design was not specific for mycoplasma associated with cattle, it provided 
an alternative and broader approach. Following DNA amplification, the resulting product could 
then be digested and run on a gel, with the banding pattern differentiating Mycoplasma spp. from 
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Acholeplasma spp. A similar approach by McAuliffe et al. (2005) targeting the 16S rRNA gene 
used Mycoplasma-specific primers followed by separation of the PCR products using denaturing 
gradient gel electrophoresis (DGGE). This approach enabled the identification and 
differentiation of 67 Mycoplasma species of veterinary and human significance, and was useful 
in detecting mixed cultures. However with both studies, the variation between some species can 
be very subtle, making accurate and confident species specific diagnosis of mycoplasma 
difficult, an important aspect as not all Mycoplasma spp. are considered to be pathogenic.  
Another approach to identifying multiple Mycoplasma species was the use of several primer sets, 
each specific to the species of interest including M. alkalescens, M. bovigenitalium, M. 
bovirhinis and M. bovis, with speciation determined by the product size on a gel (Hirose et al., 
2001). Using this method the limit of detection in milk was reported as 1.4 x 10
3
, 1.7 x 10
2
, 1.1 x 
10
2
 and 4 x 10
2
 cfu for M. alkalescens, M. bovigenitalium, M. bovirhinis and M. bovis 
respectively, and was comparable to culture which had a limit of detection of 1.4 x 10
4
, 1.7 x 
10
2
, 1.1 x 10
3
 and 1 x 10
3 
cfu respectively. Yet when analysing clinical milk samples, while PCR 
detected 22 positive M. bovirhinis samples and two positive M. bovis samples, culture could only 
detect 8 positive M. bovirhinis samples and 1 positive M. bovis sample. 
1.7.2.2 Real time PCR detection 
While the PCR techniques discussed have proved effective, conventional PCR measures the 
amount of PCR product at the end of the cycles. Therefore gel electrophoreses is required for 
results to be analysed in the form of amplified DNA visualised as bands, requiring additional 
time and labour. As technology improved real time PCR was developed and soon utilised in 
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mycoplasma detection.  The two main approaches for real time PCR are SYBR green dye and 
fluorescent reporter probes. 
SYBR green is a cyanine dye which binds to all double stranded DNA resulting in a green light 
being emitted when excited by light at a specific wavelength. As the PCR cycles progress, the 
quantity of target double stranded DNA increases and, as such, the amount of light being emitted 
from the dye increases proportionately, allowing real time detection of the PCR product (Wong, 
2013).  As SYBR green is not specific to the target sequence, this provides a much cheaper real 
time PCR analysis option. However, because SYBR green does bind to all double stranded 
DNA, it can create an increase in background signal noise and reduced specificity compared to 
probe based real time PCR methodologies (Wong, 2013).  This method has been less commonly 
used to detect mycoplasma in cattle, however it was used to detect multiple Mycoplasma spp. in 
bulk tank milk samples, targeting the 16S-23S intergenic spacer region of the Mycoplasma genus 
(Justice-Allen et al., 2011). For speciation, following PCR amplification a melt dissociation 
curve was performed, with the amplified DNA of different species of mycoplasma melting at 
slightly different temperatures. When compared to traditional culture, this method was not shown 
to be significantly more sensitive, however it did allow organism speciation with several samples 
containing more than one species. 
In order to achieve greater specificity, the fluorescent reporter probe method of real time PCR 
was developed, typically utilizing a hydrolysis probe approach. In addition to primer 
hybridization, the probe binds to a targeted region internal to the primer binding sites. A 
fluorescent reporter dye and a quencher are attached to the 5’ and 3’ ends of the oligo probe. 
While the two ends remain in close proximity, the quencher prevents the release of fluorescence. 
However, as the PCR cycle progresses the probe hybridizes to its complimentary sequence which 
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then results in exonuclease activity of the DNA polymerase impacting on the probe integrity. As 
a result the fluorescent reporter dye is cleaved off and then fluoresces, excited by the specific 
wavelength of light as it is no longer quenched by the specific quencher module at the 3 ‘ end of 
the probe. Therefore an increase in the product being targeted by the probe causes a proportional 
increase in the fluorescence detected (Wong, 2013). Due to hydrolysis probes being specific to 
the target sequence, this can greatly reduce the background noise and increase the specificity of 
the assay. Different probes can also be conjugated to different dyes and quencher molecules, 
allowing the possibility of multiplexing assays in a single reaction, saving time and reagents. 
However, this also means that purchasing of the probes is more expensive (Wong, 2013).  Due to 
its specificity, several novel real-time PCR (rt-PCR) assays with probes for the detection of M. 
bovis have been developed (Cai et al., 2005, Clothier et al., 2010, Rossetti et al., 2010, Sachse et 
al., 2010, Boonyayatra et al., 2012a). Despite probe based PCR allowing greater specificity, 
when targeting the 16s rRNA gene of M. bovis, cross amplification of M. agalactiae can still 
occur (Cai et al., 2005). As such, the use of alternative genes began to be explored.  
The uvrC gene has been demonstrated to be a better PCR target for M. bovis, with no cross 
amplification with non-M. bovis species including M. agalactiae (Clothier et al., 2010, Rossetti 
et al., 2010). The uvrC gene encodes deoxyribodipyrimidine photolyase, an enzyme which is 
essential for replication as it is involved with DNA repair making it a highly stable gene (Sancar 
et al., 1984). It is a well conserved gene in both M. bovis and M. agalactiae however also differs 
significantly between the two species making it a much more specific target gene than 16S rRNA 
(Subramaniam et al., 1998). Validation of the uvrC gene as a target for identifying M. bovis 
using rt-PCR has been demonstrated on clinical lung, milk, joint fluid, nasal swabs, 
bronchoalveoolar lavage fluid, tracheal wash fluid and ear swabs (Clothier et al., 2010). In pure 
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culture, milk and lung samples, detection limits were as low as 2.4 x 10
1
, 2.4 x 10
2
 and 2.4 x 10
2
 
cfu/ml respectively.   
The use of the oppD gene and an M. bovis specific probe has also been demonstrated to add a 
further element of specificity into a PCR assay, again with no cross-amplification with non-M. 
bovis species including M. agalactiae (Sachse et al., 2010). The oppD gene encodes an 
oligopeptide permease and is a member of the ABC-transporter family.  It facilitates transport of 
short peptides across the bacterial cell membrane and is therefore essential for many processes 
(Orchard and Goodrich-Blair, 2004). The use of this gene for detecting M. bovis has been 
validated in milk samples and nasal swabs, with a limit of detection as low as 100 cfu/mL in 
milk (Sachse et al., 2010). When compared to culture, 12 of the PCR positive samples were 
negative on culture, while 3 culture positive samples were negative on PCR.  
Probe based PCR assays have also been developed for other Mycoplasma species of interest in 
cattle including M. californicum and M. bovigenitalium, both of which are also consistently 
isolated from bovine samples (Jasper, 1979, Kirk et al., 1997).  A recent study developed 3 
individual probe based PCR assays to detect these 3 common mycoplasma pathogens in 268 
isolates from bovine sources including milk (n=228) and other organs (n=60) (Boonyayatra et 
al., 2012a). Three different target genes were selected for each species. For M. bovis the targeted 
gene was fusA encoding for elongation factor G which is required during the translation process 
of mRNA into proteins (Hirashim.A and Kaji, 1973). For M. californicum the target gene was 
rpoB encoding for RNA polymerase β subunit which is an enzyme responsible for catalyzing the 
synthesis of RNA during transcription in which DNA is copied (Ebright, 2000). Lastly for M. 
bovigenitalium, the target gene was the 16S-23S rRNA intergenic spacer region. Specificity 
assessment demonstrated no cross-amplification with other Mollicutes including M. agalactiae. 
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The detection limit in spiked milk was as low as 10 ± 0 (SE) cfu/ml, 22.4 ± 20 (SE) CFU/ml and 
20 ± 0 (SE) CFU/ml for M. bovis, M. californicum and M. bovigenitalium respectively. This was 
significantly more sensitive than previously described PCR assays (Clothier et al., 2010, Sachse 
et al., 2010), and was the first study of its kind to speciate M. bovis, M. californicum and M. 
bovigenitalium, with approximate time to completion of the assay being 4 h. The assays even 
proved to be more accurate than the partial 16s rRNA  gene sequencing used as the gold standard 
for comparison, with four samples being found to contain both M. bovis and M. bovigenitalium 
by the probe PCR assays, confirmed by subsequent amplicon sequencing.   
Commercial PCR assays targeting Mycoplasma species are also available, providing results 
within 4 hours. This includes several PathoProof™ assays by Thermo Fisher Scientific™ which 
allow the simultaneous detection of target species in milk samples. The PathoProof™ Major-4 
assay currently offered commercially in Australia by Dairy Technology Services (DTS, 
Melbourne, Australia) allows the identification of S. aureus, S. agalactiae, Streptococcus uberis 
and M. bovis. The PathoProof™ Major-3 assay allows the identification of S. aureus, S. 
agalactiae and M. bovis, with validation suggesting a detection limit of 1.6 M. bovis genomes 
per PCR reaction, and 21.8 M. bovis cfu/mL of mastitic milk with accurate quantification 
(Silvennoinen et al., 2010). Sensitivity of this PCR was also demonstrated as being higher than 
the 7 day culturing protocol in spiked mastitic milk samples with 10-fold dilution series 
performed. While studies investigating the analytical sensitivity and specificity for M. bovis have 
not been performed, analysis of PathoProof™ PCR assays amplifying other bacterial organisms 
found in milk have a demonstrated analytical sensitivity and specificity of 100 % and 99-100 %, 
respectively (Koskinen et al., 2009). The PathoProof™ Major-3 kit has been used for latent class 
analysis of BTM samples for herd level diagnosis, detecting a nation-wide apparent prevalence 
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of 1.6 % in Danish herds (Nielsen et al., 2015). While the PathoProof™ PCR assays provide 
commercially available PCR options, their use is targeted to milk samples only, and research into 
their infield use is limited.  
1.7.2.3 Overview of current PCR methods 
Table 1.3 provides an overview of the characteristics of the described PCR methods used for 
diagnosing Mycoplasma species in cattle. Due to the importance of M. bovis in the dairy 
industry, a large focus has been on developing PCR assays targeting M. bovis in milk samples. 
Few studies have investigated PCR assays on other sample types and their limit of detection, or 
for other important Mycoplasma species in the dairy industry. Given that mycoplasma infection 
is not limited to mastitis, and may also present clinically in the form of arthritis, otitis media, and 
reproductive disorders, as well as being isolated from mucosal surfaces, it is important that other 
sample types are further investigated. While M. bovis is currently considered the most important 
mycoplasma pathogen in cattle, there are several other species which can cause significant 
disease and as such should not be overlooked. Therefore further research is required in this area, 
which will be addressed in Chapter 3 of this thesis, in order to allow better diagnosis of 
mycoplasma infection in dairy cattle. 
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Table 1.3 Overview of the characteristics of the described PCR methods used for diagnosing 
Mycoplasma species in cattle. 
  Conventional PCR 
Real time PCR 
SYBR green dye 
Real time PCR 
fluorescent reporter probe 
Overview 
 
Measures the amount of 
PCR product at the end of 
the PCR reaction, therefore 
requires gel electrophoresis 
to visualise amplified DNA 
 
Measures PCR 
amplification as the PCR 
reaction occurs 
 
Measures PCR 
amplification as the PCR 
reaction occurs 
  
Dye binds to all double 
stranded DNA. As the 
quantity of target double 
stranded DNA increases, 
the amount of light emitted 
by the dye increases 
proportionally. 
 
Probe binds to a specific 
targeted region internal to 
the primer binding sites. As 
the PCR cycles progress, 
the reporter dye is cleaved 
off and fluoresces. An 
increase in PCR product 
targeted by the probe causes 
a proportional increase in 
fluorescence. 
 
Is semi-quantitative through 
comparison of gel band 
intensities 
 
 
Is quantitative 
 
Is quantitative 
  
Increase in background 
noise due to dye binding to 
all double stranded DNA 
 
Commercial Assays 
available including 
PathoProof™  Major-3 by 
Thermo Fisher Scientific™ 
 
Specificity 
 
Often targeted 16S rRNA 
gene, therefore cross 
amplification seen between 
M. bovis  and M. agalactiae 
(Gonzalez et al., 1995) 
 
Melt dissociation curve can 
be used to differentiate 
between species or non-
specific amplification 
(Justice-Allen et al., 2011) 
 
Alternative target genes and 
the use of a specific internal 
fluorescent probe allowed 
for greater specificity (Cai 
et al., 2005, Clothier et al., 
2010, Rossetti et al., 2010, 
Sachse et al., 2010, 
Boonyayatra et al., 2012a) 
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Can differentiate amongst 
Mycoplasma spp. based on 
gel banding patterns 
following product digest 
step (Tang et al., 2000), or 
product size on a gel 
(Hirose et al., 2001) 
 
   
Allows multiplexing to 
detect multiple targets in a 
single reaction 
Sensitivity 
 
~10
2
 – 103 cfu in milk 
(Hirose et al., 2001) 
 
Less commonly used to 
detect mycoplasma in cattle; 
sensitivity not reported 
 
~10
1
 cfu/mL in milk  
samples for M. bovis, M. 
californicum and M. 
bovigenitalium 
(Boonyayatra et al., 2012a) 
  
 
~10
2
 cfu/mL in lung 
samples for M. bovis 
(Clothier et al., 2010) 
 
  
1.7.3 Serological assessment of plasma and milk 
1.7.3.1 Individual animals 
While culture and PCR diagnosis rely on identifying the presence of the mycoplasma organism, 
an indirect enzyme-linked immunosorbent assay (ELISA) is available to identify the presence of 
anti-mycoplasma antibodies in samples including sera and milk. The purpose of this analysis is 
to identify animals that have had past exposure to mycoplasma and have had time to mount a 
humoral immunological response. A commercial M. bovis antibody ELISA kit produced by 
Belgium’s Bio-X Diagnostics Company is available ((Bio-X Bio K 302, Bio-X Diagnostics, 
Rochefort, Belgium), using a recombinant protein from M. bovis as the antigen for the antibody 
capture ELISA assay. According to the datasheet within the kit, validation of the kit includes 
data from milk and serum samples collected from 270 Belgium cows across 27 farms, with 
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suggestions of a 2 week seroconversion post exposure, and a sensitivity and specificity of 100 %. 
A positive correlation between sera and milk (R
2
=0.432) is reported by the manufacturer, with 
serum samples producing higher readings than milk.  
One aspect of an ELISA which is very difficult to evaluate and which is not mentioned in the 
product information enclosed with the Bio-X kit is cross-reactivity of the ELISA with other 
pathogens which may lead to false positives. The potential for cross-reactivity of an M. bovis 
specific ELISA with other common pathogens found in cattle and ruminants is difficult to assess 
but is an important factor to consider from a diagnostic perspective. There are several ways this 
issue has been addressed, including aligning the sequence of the M. bovis protein being used 
with other mycoplasma and bovine pathogens through online databases such as NCBI to identify 
the theoretical cross-reaction potential (Fu et al., 2014, Sun et al., 2014, Wawegama et al., 2014). 
In vitro analysis using western blots have also been used to investigate the presence of reactive 
proteins in other pathogens of interest (Ghadersohi et al., 2005, Fu et al., 2014). Western blot is 
often used in concurrence with sequence alignment to provide both an in vitro analysis and 
theoretical analysis of the potential for cross-reactivity of the ELISA (Parija, 2014).  
An indirect ELISA assessing the immune response of animals to M. bovis can prove to be a 
complementary tool which overcomes some of the challenges of culture and PCR analysis 
including intermittent shedding of the organism. While culture and PCR rely on the animal 
shedding the organism at the time of sampling, an ELISA measures past exposure to the 
organism in the form of a humoral antibody response and therefore does not require  detection of 
an organism that is not currently being shed or is no longer present. As a result, when these 
diagnostic methods are used concurrently there is often a much higher prevalence of M. bovis 
positive animals as detected by ELISA than by PCR or culture (Nunez et al., 2008, Akan et al., 
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2014). The ability of an antibody ELISA to measure exposure to M. bovis is an important aspect 
to take into account when interpreting results, as it does not necessarily indicate that an animal is 
harboring viable M. bovis. This was demonstrated in an M. bovis mastitis outbreak scenario 
where all clinical cows were culled from the herd, however all remaining cows (with the 
exception of three animals) tested ELISA positive despite being free from disease (Byrne et al., 
2000). Once the clinical animals were removed, the herd recovered from its outbreak despite 
ELISA positive animals remaining.  This demonstrates that while the number of animals exposed 
to M. bovis may be high, the proportion of animals which succumb to disease may be much 
lower. Furthermore it suggests that culling of animals based on ELISA results alone may not be 
beneficial in controlling an outbreak, and may result in over culling.  
While an antibody ELISA may not be affected by intermittent shedding of M. bovis, one 
challenge which can provide false negative results is time to seroconversion after exposure of M. 
bovis as well as antibody persistence. Several trials have demonstrated that seroconversion takes 
2-3 weeks post exposure (Nicholas et al., 2002, Wawegama et al., 2014). In addition, there is 
also the question of how long anti-M. bovis antibodies remain detectable in an animal following 
exposure. In a study following an outbreak of M. bovis in a small dairy herd, 94 % of animals 
remaining in the herd were positive for M. bovis antibodies in sera 27 weeks after the outbreak 
began and 15 weeks after the last clinical case (Byrne et al., 2000). However, while antibody 
persistence in sera may be quite extended, this may not be the case in milk samples. In the same 
study, composite milk samples collected from the same animals just two weeks prior to the sera 
samples (25
th
 week) revealed only 2 % of animals were positive for M. bovis antibodies in milk 
(Byrne et al., 2000). Furthermore, in individual quarter milk samples collected from six animals 
with clinical M. bovis mastitis, all quarters from all animals were positive for M. bovis antibodies 
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at the 9th week, however at the 20
th
 week four of these animals were antibody positive in the 
previously infected quarters only. This suggests that M. bovis antibody levels may be much 
lower or possibly undetectable in milk samples as compared to serum samples. This may be due 
to the way in which antibodies in the blood infiltrate and are then secreted in the mammary 
gland. While serum contains approximately 1400, 1300, 39 and 380 mg/100mL of IgG1, IgG2, 
IgA and IgM respectively, this is reduced to just 40, 6, 11 and 9 mg/100uL in milk whey 
(Andrews et al., 2008). Some immunoglobulins including IgM and IgA are produced locally in 
the mammary gland, however IgG which is often targeted by an ELISA, is produced in the blood 
and transferred into the milk (Hurley and Theil, 2011). Therefore it is not surprising that M. 
bovis antibodies as detected by ELISA are higher in sera compared to milk samples. Milk 
immunoglobulin concentration can also be affected by production factors with a significant 
increase in milk IgG1 concentrations as lactation number increases (Liu et al., 2009). A decrease 
in milk IgG1, IgG2, IgM and IgA concentrations can also be seen as the number of days in 
lactation increases, with an increase in concentration again in the late stages of lactation 
coinciding with a drop in milk production (Guidry et al., 1980a, Liu et al., 2009). Milk 
immunoglobulin levels have also been shown to increase during udder inflammation (Guidry et 
al., 1980b, Hurley and Theil, 2011). It is therefore important to know when interpreting results 
that milk samples may produce lower than expected readings compared to serum, and may be 
dependent on the previous M. bovis clinical status, lactation number, stage of lactation, and 
current health status in regards to mastitis.  
1.7.3.2 Bulk tank milk samples 
As an M. bovis antibody ELISA detects past exposure to the pathogen, it can be difficult to use 
this test alone to decide whether an animal is ‘positive’ for M. bovis and as such is a risk to the 
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herd and should be culled. However, the test may be more useful on a herd level to determine if a 
herd has been exposed to M. bovis. This may be of importance when considering biosecurity 
risks when purchasing animals from a particular herd. Due to its ease and simplicity in 
collection, representation of the lactating herd, and avoidance of animal use, the bulk tank milk 
(BTM) is commonly used for PCR and culture analysis as a surveillance tool to identify the herd 
level prevalence of Mycoplasma spp. across different regions and countries (APHIS-USDA, 
2008, Higuchi et al., 2011, Justice-Allen et al., 2011, Pinho et al., 2013). Recent studies have 
now begun evaluating the use of the Bio-X Diagnostics M. bovis antibody ELISA kit on BTM 
samples for herd-level diagnostics of M. bovis (Nielsen et al., 2015, Petersen et al., 2016). It has 
been suggested that the % ODC cut-off recommend by the kit may be too low when used on bulk 
milk, and as such should be increase from 37 % ODC to 50 % ODC in order to achieve fewer 
false positives without compromising the negative predictive value, however this does decrease 
the sensitivity from 60.4 % to 43.5 % (Nielsen et al., 2015). As with individual serum samples, 
discrepancies have also been found between PCR and ELISA BTM results, with significantly 
higher proportions of samples being positive by ELISA than by PCR (Nielsen et al., 2015). Yet 
given that the tests are detecting two separate aspects of the disease, presence of the pathogen 
(PCR) and the herd immune response to the pathogen (ELISA), this is not unexpected. 
When considering using the BTM for antibody detection it is also important to get an 
understanding of the factors which may be associated with its variation. A study by Petersen et 
al. (2016) demonstrated that the M. bovis antibody positive prevalence of lactating cows was 
significantly associated with the BTM ELISA optical density measurement in Danish dairy 
herds, yet prevalence of antibody-positive young stock and herd size was not. Due to the limited 
published literature on this commercially available ELISA, additional work is required to further 
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evaluate factors which may affect the BTM ELISA ODC%, in order to understand its usefulness 
as a diagnostic biosecurity tool at the herd level. This is the basis for the work performed in 
Chapter 4 of this thesis. 
1.7.4 Comparison of culture, PCR and serology for the detection of 
Mycoplasma in dairy cattle 
Mycoplasma can cause serious disease within cattle herds, particularly when there is a delay in 
its detection and diagnosis. As such it is necessary that the diagnostic tools available are rapid, 
accurate, and allow ongoing monitoring of a herd. While no single test is perfect, their combined 
use may complement each other in their strengths and limitations, as outlined in Table 1.3.   
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Table 1.4 Strengths and limitations of mycoplasma diagnostic methods 
 Culture PCR Antibody ELISA 
 
Strengths 
 
Inexpensive (costs may 
vary between countries 
and laboratories) 
 
Can detect most 
Mycoplasma species 
(McVey et al., 2013) 
 
Organism does not have to 
be viable as it targets the 
DNA of the organism 
(Dennis Lo, 1998) 
 
Quick diagnosis 
turnaround of several 
hours (Sachse et al., 1993) 
 
Can discriminate between 
different Mycoplasma spp. 
(Tang et al., 2000, 
Boonyayatra et al., 2012a) 
 
Can discriminate 
Mycoplasma spp. from 
Acholeplasma spp. 
(Boonyayatra et al., 
2012b) 
 
 
Measures antibody 
response, therefore animal 
does not need to be 
shedding the organisms at 
the time of sample 
collection (Bio-X Bio K 
302, kit insert) 
 
Only blood or milk sample 
required to assess immune 
response (Bio-X Bio K 
302, datasheet) 
 
Longevity of antibody 
expression is possibly 
several months (Byrne et 
al., 2000, Nicholas and 
Ayling, 2003)  
 
 
Limitations 
 
Fastidious growth 
requirements (McVey et 
al., 2013) 
 
Diagnosis turnaround of 
up to 10 days (Quinn et 
al., 2013) 
 
Unable to discriminate 
 
Higher cost 
 
Many mycoplasma PCRs 
are species specific, 
therefore eliminating the 
detection of other species 
(Cai et al., 2005, Rossetti 
et al., 2010) 
 
 
Uncertainty around cross-
reactivity with other 
organisms 
 
Seroconversion may take 
2-3 weeks before 
antibodies can be detected 
(Wawegama et al., 2014, 
Bio-X Bio K 302, 
datasheet).  
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between Mycoplasma spp. 
and Acholeplasma spp., 
which may lead to false 
positives (McVey et al., 
2013) 
 
Unable to discriminate 
between different 
Mycoplasma species 
(McVey et al., 2013) 
 
Organism must be viable, 
therefore storage and 
handling of the sample is 
important (Miles and 
Nicholas, 1998, Maunsell 
et al., 2011) 
 
Animal must be shedding 
the organism at the time 
the sample was taken 
(Gonzalez and Wilson, 
2002, Biddle et al., 2003) 
Animal must be shedding 
the organism at the time 
the sample was taken 
(Gonzalez and Wilson, 
2002, Biddle et al., 2003) 
 
Identification of non-
viable organisms may lead 
to insignificant positive 
results 
 
 
Suggestions of poor 
sensitivity (Nielsen et al., 
2015, Wawegama et al., 
2016) 
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1.8 Milk treatment as a biosecurity strategy 
1.8.1 Introduction 
Bacterial growth in colostrum and milk to be fed to calves can be difficult to control, as there are 
many sources of contamination from the point of harvest through to feeding. A study in 2005 
identified that colostrum aseptically collected from the mammary gland of 41 recently calved 
cows produced very low or zero bacteria plate counts with a mean value of 10
1.44 
cfu/mL 
(Stewart et al., 2005). However, subsequent samples taken from the milking buckets and 
esophageal feeder tubes produced mean bacterial counts of 10
4.99 
cfu/mL and 10
4.66 
cfu/mL 
respectively. This was despite a standard procedure of equipment sanitization being in place 
which included disassembly of all equipment, rinsing with lukewarm water, placing in hot water 
with detergent, scrubbing all exterior and interior surfaces, rinsing with hot water containing acid 
sanitizer, and finally allowing all equipment to air dry. Although this study was limited by only 
evaluating the practices of one farm, it has identified that while colostrum straight from the 
mammary gland may exhibit low bacterial numbers it can quickly become contaminated with 
bacteria which may proliferate, posing a potential health risk to calves. Furthermore, it is not an 
uncommon practice for waste milk that is not able to enter the human food chain, to be routinely 
fed to calves, often without prior treatment before being fed. An observational study in 1997 first 
suggested a link between ingestion of M. bovis infected milk from a shedding herd, and the 
development of pneumonia and otitis media in calves (Walz et al., 1997). This observation was 
later demonstrated during an experimental trial when oral ingestion of M. bovis infected 
colostrum by calves induced upper respiratory tract infection and otitis media (Maunsell et al., 
2012). Despite posing a high risk for disease, impacting calf growth and health, milk with 
varying levels of bacteria is routinely fed to calves.  Although the safest and recommended 
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method is not to feed waste milk to calves, on farms where it may be necessary, several 
treatment methods are currently available to reduce the bacterial load before consumption, 
including heat pasteurisation, ultraviolet (UV) treatment, and acidification. 
1.8.2 Heat treatment 
In recent years it has been suggested that heat pasteurisation of milk to be fed to calves can 
prevent mycoplasma infection by rendering the bacterium unviable. This was demonstrated on a 
dairy farm which implemented the use of pasteuriser following problems with mastitis in cows, 
and polyarthritis in calves being fed discard milk (Butler et al., 2000). While M. californicum 
and M. bovis were able to be isolated from the waste milk prior to pasteurisation, all samples 
were negative following heat treatment at 65 ᵒC for 1 h. The implementation of routine 
pasteurisation of discard milk also eliminated mycoplasma-associated illness in the calves. This 
study further examined the effects of pasteurisation on different Mycoplasma species at different 
temperatures and exposure times. All examined species including M. bovis, M. californicum and 
M. canadense remained viable following 30 mins of exposure at 37 ᵒC and 56 ᵒC. At 60 °C M. 
canadense remained viable after 30 min while M. bovis and M. californicum did not grow after 5 
and 10 min respectively. At 65 °C M. canadense grew following heat exposure of up to 10 min 
while M. bovis and M. californicum were not viable after 2 min. At 67.5 °C M. canadense was 
inactivated after 5 min, M. bovis after 1 min and M. californicum after 2 min. Finally at 70 °C M. 
canadense failed to produce colonies after 3 min, while M. bovis and M. californicum required 
only 1 min of heat exposure. This study demonstrated that heat pasteurisation of infected discard 
milk can inactivate Mycoplasma species, eliminating transmission to dairy calves.  It also 
revealed that of the three species examined, M. canadense appears to be the most heat resistant 
and therefore pasteurisation conditions should be implemented to the level required for its 
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inactivation. However, this study has limitations which should be highlighted. Incubation 
conditions and the agar used are not mentioned. Mycoplasma growth requires atmospheric 
conditions of 5 % CO2 and specific agar. Growth of colonies then requires 7-10 days however 
this study only allowed 48 h before mycoplasma colonies were examined. It is therefore possible 
that viable colonies were not detected when examined at 48 h. 
A similar study investigated the effects of heat treating colostrum with a commercial on-farm 
batch heat pasteurisation system following inoculation with M. bovis, Listeria monocytogenes, 
Escherichia coli O157:H7 and Salmonella enteritidis (Godden et al., 2006). Upon reaching the 
desired temperature of 60 ᵒC, which took 30 min, M. bovis was no longer viable, a finding 
consistent previous studies (Butler et al., 2000). For E. coli O157:H7, no growth was observed 
after 15 min of heat exposure at 60 ᵒC, while S. enteritidis and L. monocytogenes required 30 
min of 60 °C heat exposure to eliminate all viable organisms. Furthermore the mean IgG 
concentration was assessed by a turbidometric-immunoassay, a tool which measures the turbidity 
of a sample following the interaction of bovine antibodies with anti-bovine antibodies, resulting 
in a precipitation (Quigley, 2008). Results found no significant difference between raw and 
pasteurised colostrum suggesting that the antibody quality may not be compromised by such 
treatment. This study highlights that not only is pasteurisation a safe and effective method for 
eliminating M. bovis, but it may also serves as a tool for preventing the transmission of other 
pathogens which have increased heat resistance.  
While the previous study suggested that the concentration of antibodies is not affected by 
pasteurisation, the structure and therefore function of the antibodies was not explored. To further 
investigate this aspect, changes in IgG concentration and absorption of low, medium and high 
quality colostrum following heat treatment versus non-heat treatment have been explored 
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(Gelsinger et al., 2014a). Using a hydrometer which measures the density of a liquid, of which 
antibody contents are a function, numerical decrease in IgG concentration was observed, with a 
greater change seen in the higher quality colostrum.  However a significant increase was 
observed in IgG1, IgG2, total IgG and total protein concentrations in the plasma of calves that 
received heat treated colostrum, compared to those that received untreated colostrum. Previous 
studies have also found that although IgG concentration in colostrum may be reduced by 
pasteurisation, this does not affect the serum IgG concentration in calves following feeding 
(Teixeira et al., 2013). Results also suggested that feeding heat treated medium quality colostrum 
which is within a range of 50-100 mg/mL IgG results in similar IgG plasma concentration as 
feeding untreated high quality colostrum. This may be due to the ability of calves to only absorb 
a finite amount of antibodies, and as such anything above this amount is redundant. 
1.8.3 Ultra violet (UV) treatment 
More recent technology has seen the introduction of ultraviolet (UV) pasteurisers being used on 
dairy farms, with manufacturers and retailers claiming that they are superior to conventional heat 
pasteurisers in terms of their ability to eliminate viable bacteria yet maintain immunoglobulins, 
proteins and vitamins. However, few studies have evaluated their efficacy on bacterial viability 
and IgG concentration, with no study yet to examine its effects on Mycoplasma species. In a 
2014 study, sampling occurred on nine farms in Pennsylvania which all used the same UV 
treatment system (UV Pure, GEA Farm Technologies Inc) (Gelsinger et al., 2014b). For 15 days 
waste milk samples were collected from each farm both before and after UV treatment and 
stored at -20 °C. Each sample taken (n=544) was analysed for Staphylococcus aureus, 
Streptococcus agalactiae, other environmental and contagious Streptococci spp., standard plate 
count (SPC), non-coliform gram-negative bacteria and coliforms. Following UV treatment 
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samples contained significantly fewer bacteria for all bacterial types. Percentage log reductions 
were 82, 63, 72, 29, 53 and 58 % for S. aureus, S. agalactiae, environmental and contagious 
Streptococci, SPC, non-coliform gram-negative bacteria and coliforms respectively. 
A second study in 2014 compared the effects of UV treatment on milk and colostrum in regards 
to bacterial viability and IgG concentration (Pereira et al., 2014). Milk and colostrum were 
inoculated with Listeria spp., Salmonella spp., Escherichia coli, S. aureus, Acinetobacter 
baumannii and Streptococcus spp.. Following UV light exposure of the milk for 7.5 min, the 
bacterial count significantly reduced by 3.2, 3.7, 2.8, 3.4, 2.8 and 3.4 log cfu/mL for Listeria 
spp., Salmonella spp., E. coli, S. aureus, A. baumannii and Streptococcus spp., respectively. For 
colostrum samples, the bacterial count significantly reduced by 1.4, 1.0 and 1.1 log cfu/mL for 
Listeria spp., Salmonella spp. and A. baumannii, however no significant decrease was observed 
for E. coli, S. aureus and Streptococcus spp. The UV treatment was found to have a negative 
linear association with IgG concentration in colostrum, as assessed by ELISA. 
Through the examination of these studies, it appears heat treatment of milk may be more 
effective and consistent at reducing bacterial counts than UV treatment. While studies on UV 
treatment of milk and colostrum are yet to include Mycoplasma species in their analysis, they 
highlight that UV treatment may not be equally effective on all types of bacteria, particularly 
when it involves colostrum. While results vary between studies it is suggested that IgG 
concentrations can be negatively affected by both forms of pasteurisation however this is not 
always statistically significant. Despite this decrease however it has also been demonstrated that 
pasteurisation does not affect the serum IgG concentration of calves following consumption and 
may even improve its absorption.  As UV pasteurisers become increasingly more popular 
throughout Australian dairies, it is important to verify their efficacy in reducing or eliminating 
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viable Mycoplasma species fed to naïve pre-weaned calves, and therefore their role as an 
effective tool in breaking the mycoplasma cycle by reducing the opportunity of calf exposure. 
1.8.4 Milk acidification 
1.8.4.1 Bactericidal effects 
While heat and UV treatment have been demonstrated to reduce the bacterial load in 
contaminated milk and colostrum, there is the potential for the milk to become re-inoculated 
once placed into collection and feeding equipment, thus rendering the treatment of limited health 
benefit. A treatment approach which may combat this issue is milk acidification. This involves 
lowering the pH of the milk to a level which is unsuitable for bacterial growth and survival 
(Anderson, 2008), providing a preservative effect which is maintained, on condition that the pH 
remains at the appropriate level. 
In a neutral to slightly alkaline pH range, most bacterial pathogens will thrive, with very few 
tolerating acid conditions, and unable to survive at pH values less than 4.5 (Anderson, 2008, 
Hogg, 2013). Due to milk’s approximate pH of 6.6 and its nutritional content, it makes for a 
suitable bacterial growth medium (Fox et al., 2015).  While studies have not investigated the 
ability of Mycoplasma species to proliferate in milk, it is known that they can be isolated from 
milk which can act as a transport media, providing nutrients and conditions conducive to 
bacterial survival, enabling infection of calves following ingestion (Walz et al., 1997, Maunsell 
et al., 2012). In regards to pH sensitivity, it may be speculated that due to their absence of a cell 
wall, and there sensitivity to disinfectants, Mycoplasma species are likely to be sensitive to 
changes in pH.  Most Mycoplasma species experience optimal growth in media at pH 7-8, with a 
decrease in pH to less than 6.5 causing limited growth and subsequent cell death (Nicholas et al., 
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2008).  This was demonstrated in porcine Mycoplasma hyorhinis, with significantly less colonies 
grown on media at pH 6.5, compared to media at the optimal pH of 7.8 (Dinter and Taylor-
Robinson, 1969). While these parameters suggest that milk acidification may be an effective 
method of reducing bacterial load, very limited research has been done to test this hypothesis and 
to the best of our knowledge no research specifically looking at Mycoplasma spp. has been 
performed. 
A small pilot trial investigated the effects of milk acidification on total plate loop counts (PLC) 
in raw bulk tank milk stored at room temperature following the addition of formic acid (65%) to 
achieve a pH of 4.1 (Anderson, 2005). While both acidified and non-treated milk had a starting 
bacterial concentration of 1 x 10
3 
cfu/mL, at 3 h the acidified milk had a reduced bacterial load of 
3 x 10
2 
cfu/mL, and at 21 h there was no observed growth. However, for milk which was not 
treated with formic acid, by 21 h there were too many bacterial colonies to count and a foul odor 
was evident. While just a small pilot trial, this study provides evidence that bacterial growth in 
milk is reduced when the pH is lowered, however bacterial growth may occur when left 
untreated at room temperature. It also highlights that this effect is not instant and a certain 
amount of contact time is required. It is important to also note however that there are several 
limitations to this trial. Firstly, the milk used had an elevated starting pH of 8 for an unspecified 
reason. This may have been because the milk was mastitic or due to there being a significant 
contribution to the bulk tank by cows at the end of their lactation resulting in a higher pH in the 
bulk tank (Fox et al., 2015). This may have therefore affected the growth of bacteria in the 
control group. Secondly, the milk had a relatively low starting bacterial load and therefore the 
acidification treatment may not have been challenged sufficiently. Thirdly, while ‘no growth’ 
was achieved when the milk was at pH 4, between 27-45 h post-treatment the pH of the acidified 
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milk had dropped down to 2.8 for unspecified reasons.  One reason for this drop in pH may be 
that the type of acid used (formic) may not be stable over an extended time period.  Due to its 
many acid and basic groups, milk has a buffering action over quite a large pH range with the 
main buffering constituents including soluble phosphate, colloidal calcium phosphate (CCP), 
citrate, bicarbonate and casein. When milk is acidified, maximum buffering occurs at pH 5.1 due 
to complete solubilisation of CCP (Fox et al., 2015). This means that during acidification the pH 
of milk will initially decrease rapidly before slowing down. As the pH is decreased the milk also 
begins to separate due to casein precipitation (Kruif, 1996). As a result casein, which is a 
buffering constituent, is no longer in solution which may affect the buffering capacity of milk at 
low pH ranges. Therefore in order to obtain a stable pH at low levels, the addition of a buffering 
agent with the acid may be necessary.  
While this study provides a guide to the pH and exposure time requirement for milk acidification 
on total bacterial counts, it would be beneficial for further research to be done which investigates 
specific microbial agents which are known bovine pathogens, including Mycoplasma species. 
This would provide evidence that milk acidification is an effective method for preventing cow to 
calf transmission of Mycoplasma species through infected milk. Furthermore, research is needed 
that is aimed at investigating a range of pH values over regular sampling points in order to assist 
in providing more precise guidelines for pH and exposure time requirements for an effective 
result.  This knowledge gap will be addressed in Chapter 5 of this thesis. 
1.8.4.2 Calf performance 
While in vitro studies may suggest a possible health benefit of feeding acidified milk by reducing 
bacterial load, it is important to ensure that altering the pH of the milk does not negatively 
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impact calf performance and health. When open pail fed, there are mixed results in regards to 
calf feed intake of acidified milk, with some studies suggesting feed intake is not significantly 
affected (Jaster et al., 1990, Guler et al., 2006), while others suggest that it is, with calves 
drinking smaller volumes more frequently (Metin et al., 2006). In those studies where feed intake 
was affected, it was also noted that as the days during pre-weaning increased, the frequency and 
total time needed to feed decreased, suggesting that the calves become accustomed to the taste of 
acidified milk. In an open bucket ad libitum situation, it appears that consumption of acidified 
milk may be depressed, with several calves requiring nipple pails for them to drink readily (Bush 
and Nicholson, 1987). Despite the uncertainty surrounding feed intake, acidified milk does not 
appear to negatively impact the growth and weight gain of calves (Jaster et al., 1990, Guler et al., 
2006, Metin et al., 2006). Furthermore, several positive outcomes have also been noted, with 
studies finding that calves fed acidified milk have a significantly lower faecal score, and 
experience significantly less days with scours (Jaster et al., 1990, Guler et al., 2006, Metin et al., 
2006), which may be indicative of the bacteriostatic or bactericidal effects of milk acidification. 
Milk acidification has also presented issues involving the practicalities of feeding. One study 
noted that treating whole milk with propionic acid to a pH of 5.3 caused milk separation after 
standing for 3-4 h, therefore requiring mixing 2-3 times per day (Bush and Nicholson, 1987). 
This is because as the pH of milk is reduced casein precipitates into a solid mass causing 
separation which not only affects the pH buffering capacity of milk (as outlined in 1.8.4.1 above) 
but also affects the consistency of the milk (Kruif, 1996). The casein component of milk is a 
series of proteins which makes up approximately 80 % of total milk proteins by mass, with 20 % 
of total proteins by mass remaining in the whey, including immunoglobulins (Fox et al., 2015).  
If acidified milk is agitated too vigorously, complete separation of the casein and whey 
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component will occur with a cottage cheese like consistency which cannot be resuspended into 
solution (Anderson, 2008).  As a result appropriate set up needs to be taken into account if 
considering implementing milk acidification. For example, in an automated system were milk is 
delivered to the calves through pipes over large distances, it is likely that excessive agitation of 
the milk may occur and could result in complete separation of milk constituents. This may lead 
to calves only receiving the whey component of the milk and as such reduced protein 
consumption. Therefore, a simple system in which acidified milk is prepared and then 
transported to the calves manually with little agitation may be ideal. Other considerations to 
reduce the risk of complete milk separation include using milk at < 20 ᵒC with adequate stirring 
of the milk while adding the acid. 
The effects of acidification on colostrum should also be considered as it is an essential aspect of 
nutrient and immune transfer however is also frequently contaminated with bacteria. The ideal 
total bacterial count (TBC) is considered to be < 10
5 
cfu/mL, however many farms feed 
colostrum that exceeds this level (McGuirk and Collins, 2004). Not only does this directly 
contribute to disease in calves, but studies have also suggested that it may negatively impact 
immunoglobulin uptake in the intestines of neonatal calves (James et al., 1981). A study 
investigating acidification of colostrum found that while the total bacterial plate count and 
coliform plate count was significantly lower compared to untreated colostrum, there was a 
significant reduction in 24 h colostral intake and IgG intake in calves receiving ad libitum 
acidified colostrum compared to calves receiving non-acidified colostrum ad libitum and, as a 
result, serum IgG levels in the first group of calves were significantly lower (Collings et al., 
2011). This was attributed to the palatability of the colostrum following acidification.  Given that 
both groups of calves did not consume the same quantities of colostrum, the effects of 
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acidification on IgG absorption cannot be fully evaluated, though it suggests acidification of 
colostrum may not be practical in an ad libitum feeding system. Similarly, studies investigating 
the feeding of naturally fermented colostrum, reported that while minimal breakdown of 
colostral gamma-globulin and IgG occurred, concentrations of total serum proteins, gamma-
globulin and IgG in calf serum were lower (Foley et al., 1978). Despite the finding of lower 
serum IgG levels in calves fed acidified colostrum due to lower total colostrum volume intake, it 
has been demonstrated that gain efficiencies are higher, suggesting vital nutrient absorption is 
not compromised (Muller et al., 1976).   
While studies have investigated the effects of acidified milk and colostrum on feed intake, 
nutrient absorption and calf performance, some aspects of these results are confounding and 
often dependent on the system being used. Furthermore, milk acidifications effects on nutrients 
and their absorption are often measured indirectly through calf performance. Therefore further 
research is needed to ensure that calf health is not compromised if considering implementing a 
calf feeding system involving milk acidification.  
1.9 Scope of thesis 
Mycoplasma species are serious and important pathogens of cattle worldwide. Due to the 
organism’s highly contagious nature, lack of response to conventional treatment and the role of 
undetected subclinical carrier animals in spreading disease, eradication is difficult. Therefore, 
research directed at the development of biosecurity strategies to prevent and control Mycoplasma 
spp. infection is urgently needed, particularly in regards to an Australian dairy production 
context where mycoplasmosis is a debilitating emerging disease. The studies within this thesis 
aim to build upon the knowledge already available in this area, with a focus on the 
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characterisation, diagnosis and control of Mycoplasma spp. in Australian dairy production 
systems. Therefore the objectives of this thesis were to: 
1. Use whole genome sequencing to determine the degree of genetic diversity among 
Australian Mycoplasma bovis isolates collected over a nine year period from various 
geographical locations, anatomical sites, and from animals with and without clinical 
disease. 
2. Develop and optimise a multiplex probe based PCR to detect three important 
Mycoplasma species, including Mycoplasma bovis, Mycoplasma californicum and 
Mycoplasma bovigenitalium, and compare its diagnostic capabilities with traditional 
culture on bovine milk, semen and swab samples. 
3. Evaluate the use of a commercially available Mycoplasma bovis ELISA kit (Bio-X Bio K 
302) on bulk tank milk samples as a biosecurity tool for identifying dairy herds with past 
exposure to M. bovis. 
4. Evaluate the use of milk acidification at various pH levels and exposure times to 
eliminate viable Mycoplasma bovis and Salmonella Dublin organisms in infected milk. 
Salmonella Dublin was included in this objective to represent and allow comparison to a 
more commonly occurring bacterial pathogen associated with dairy production. 
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2.1 Abstract 
Mycoplasma bovis is a major pathogen in cattle causing mastitis, arthritis and pneumonia. First 
isolated in Australian cattle in 1970, M. bovis has persisted causing serious disease in infected 
herds. To date, genetic analysis of Australian M. bovis isolates has not been performed. With 
whole genome sequencing (WGS) becoming a common tool for genetic characterization, this 
method was utilized to determine the degree of genetic diversity among Australian M. bovis 
isolates collected over a nine year period (2006–2015) from various geographical locations, 
anatomical sites, and from clinically affected and non-clinical carrier animals. Eighty-two M. 
bovis isolates underwent WGS from which single nucleotide polymorphism (SNP) analysis, 
comparative genomics and analysis of virulence genes was completed. SNP analysis identified a 
single M. bovis strain circulating throughout Australia with marked genomic similarity. 
Comparative genomics suggested minimal variation in gene content between isolates from 
clinical and carrier animals, and between isolates recovered from different anatomical sites. A 
total of 50 virulence genes from the virulence factors database (VFDB) were identified as highly 
similar in the Australian isolates, while the presence of variable surface lipoprotein (vsp) genes 
was greatly reduced compared to reference strain M. bovis PG45. These results highlight that, 
while the introduction of multiple M. bovis strains has been prevented, elimination of the current 
strain has not been successful. The persistence of this strain may be due to the significant role 
that carrier animals play in harboring the pathogen. The similarity of clinical and non-clinical 
isolates suggests host and environmental factors play a significant role in determining host 
pathogen outcomes. 
110 
 
2.2 Introduction 
Mycoplasma bovis is currently recognized as one of the most important mycoplasma pathogens 
in cattle. It has been demonstrated as a causative agent of mastitis and arthritis in adult animals, 
while in calves clinical signs include pneumonia, arthritis and otitis media (Maunsell et al., 
2011). Mycoplasma bovis was first isolated in the United States in 1961 from an outbreak of 
severe mastitis which affected more than 30 % of the animals in the dairy herd at the centre of 
the outbreak (Hale et al., 1962). Following its initial discovery, global spread soon occurred with 
infection currently being reported throughout the world causing substantial economic loss 
(Nicholas and Ayling, 2003). In 1970, M. bovis was first isolated in Australian cattle from milk 
samples (Cottew, 1970) and has continued to persist within the country. While the national 
prevalence of infection in Australian dairy herds is relatively low, M. bovis has been isolated in 
all states, causing serious disease in infected herds (Morton et al., 2014).  
Several studies have attempted to characterize M. bovis isolates in terms of their genetic 
relatedness and diversity. Such studies have enabled a greater understanding of the spread of the 
pathogen, the number of circulating strains and the possible source of introduction, which has 
informed disease control programs. Methods used have included pulsed field gel electrophoresis 
(PFGE) (Biddle et al., 2005), amplified fragment length polymorphism (AFLP) (Kusiluka et al., 
2000), multiple locus variable number tandem repeat analysis (MLVA) (Becker et al., 2015) and 
multilocus sequence typing (MLST) (Register et al., 2015, Rosales et al., 2015). While studies 
utlising these methods have deemed these techniques as successful, these methodologies are 
limited in that they only provide information on banding patterns and analysis of a limited 
number of housekeeping genes.  
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Microbial whole genome sequencing (WGS) is rapidly becoming a common method for genetic 
characterization, allowing access to a much higher level of detail. It is an invaluable tool for 
comparative genomic studies through the analysis of single nucleotide polymorphisms (SNPs) 
and gene based comparative methods (Edwards and Holt, 2013). To date, three M. bovis isolates 
have had their complete genomes sequenced and analyzed including type strain M. bovis PG45, 
isolated in 1962 in the USA (Wise et al., 2011), M. bovis Hubei-1 isolated in China in 2008 (Li 
et al., 2011) and M. bovis HB0801 also isolated in China in 2008 (Qi et al., 2012). While the 
complete sequencing of these isolated strains has provided further insight into the genomic 
content of the organism, as well as uncovering putative virulence genes, to date, WGS is yet to 
be used to compare the genetic content between a large number of M. bovis isolates. 
Furthermore, genetic analysis and characterization of Australian M. bovis isolates has not yet 
been performed. The aim of this study was, therefore, to utilize WGS to determine the degree of 
genetic diversity among Australian M. bovis isolates collected over a nine year period (2006–
2015) from various geographical locations, anatomical sites, and from animals with and without 
clinical disease. 
2.3 Material and methods 
2.3.1 Bacterial isolates 
A total of 94 M. bovis isolates from cattle were selected and successfully resuscitated from a 
bank of isolates stored on Cryobeads™ at -80 ᵒC. The isolates were originally obtained from 
samples taken from animals with clinical M. bovis disease and submitted to the Livestock 
Veterinary Teaching and Research Unit Milk Quality Laboratory, Faculty of Veterinary Science 
at the University of Sydney and also from apparently healthy ‘carrier’ animals located in 
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different states within Australia. As per standard procedure, upon submission samples were 
cultured, with several colonies of growth selected and subcultured. From the subcultured 
isolates, several colonies were then selected and stored on Cryobeads™. The isolates were 
chosen in order to ensure representation from different anatomical locations of the animal. 
Isolates from swabs of the nose, prepuce, semen or vagina were all classified as carrier isolates, 
with these animals being non-clinical at the time of sampling. Isolates from the joint, lung, milk 
and pulmonary lymph node were classified as clinical isolates. For comparison over time, 
historic and recent isolates on a national scale, and historic and recent isolates within a single 
herd were selected (see Table S2.1 in the Supplementary material). 
2.3.2 Culture, DNA extraction and PCR analysis for species verification 
Mycoplasma bovis isolates were inoculated onto Mycoplasma agar [Mycoplasma agar base 
(Oxoid CM0401); Milli-Q water; 0.2 % w/v calf thymus DNA (Sigma D1501); Mycoplasma 
Selective Supplement G (Oxoid SR0059C); prepared by Elizabeth Macarthur Agricultural 
Institute (EMAI); NSW Department of Primary Industries, NSW, Australia] and incubated at 37 
ᵒC in candle jars for elevated CO2 levels for 5 to 10 days. Following positive clean growth on 
agar, several colonies from each isolate were selected and placed in PBS from which they were 
subcultured into 4 mL Mycoplasma broth [Mycoplasma broth base (Oxoid CM0403); Milli-Q 
water; 0.2% w/v calf thymus DNA (Sigma D1501); Mycoplasma Selective Supplement Q 
(Oxoid SR0059C); 0.4% Phenol Red (Sigma P-3532); prepared by EMAI] at 37 ᵒC for 4 days. 
Broths were frozen at -20 ᵒC for short term storage while awaiting species-specific verification. 
The whole bacterial cells suspended in PBS were utilized in two ‘in house’ PCR assays to verify 
the Mycoplasma species. The first assay was a species specific real time probe based multiplex 
PCR assay modified from Clothier et al. (2010) and Boonyayatra et al. (2012) targeting M. bovis, 
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Mycoplasma californicum and Mycoplasma bovigenitalium (Table 2.1). Reaction mixtures 
contained 0.5 mM of dNTPs, 5 mM of MgCl2, 0.5U GoTaq polymerase, 1 mM of each primer, 
0.25 mM of probe, 2.0 mL of 5x Buffer and 2 mL DNA template in a final volume of 10 mL. 
Cycling conditions were 95 ᵒC for 60 s, followed by 40 cycles of 95 ᵒC for 30 s, 60 ᵒC for 30 s 
and 72 ᵒC for 30s. The assay was performed on a RotorGene™ 3000 RT-PCR System Thermo-
cycler (QIAGEN Pty Ltd, Chadstone Centre, VIC, Australia). The second assay was an ‘in-
house’ developed universal Mycoplasma spp. conventional PCR assay modified from Tang et al. 
(2000). The PCR products from this assay were confirmed as M. bovis via Sanger Sequencing 
(Australian Genome Research Facility Ltd, Sydney, NSW, Australia). Reaction mixtures 
contained 0.25 mM dNTPs, 2.5 mM MgCl2, 1.5U of GoTaq, 0.25 mM of each primer (Table 
2.1), 8 mL of 5x Buffer and 5 mL DNA template in a final volume of 40 mL. Cycling conditions 
were 94 ᵒC for 5 min, followed by 35 cycles of 94 ᵒC for 30 s, 55 ᵒC for 30 s, 72 ᵒC for 1 min, 
and a final extension of 72 ᵒC for 5 min. The assay was performed on a Bio-Rad-T100 
Thermocycler (Bio-Rad Laboratories Pty Ltd, Gladesville, NSW, Australia). Table 2.1 includes 
the sequences of all primers and probes used for species verification. 
Following species verification, DNA was extracted from 1 mL of broth culture using the 
DNeasy® Blood and Tissue kit (QIAGEN Pty Ltd, Chadstone Centre, VIC, Australia) following 
manufacturer’s instructions for Gram-Negative Bacteria. Purity and concentration of the 
extracted DNA was assessed by a spectrophotometer (SimpliNanoTM; GE Healthcare Life 
Sciences, Silverwater, NSW, Australia). 
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Table 2.1 Sequences of primers and probes used for species identification 
Name Sequence Target 
MbovF 5’-TCTAATTTTTTCATCATCGCTAATGC-3’ 
 
uvrC gene of Mycoplasma bovis 
(GenBank accession no. 
AF003959) (Clothier et al., 2010) MbovR 5’-TCAGGCCTTTGCTACAATGAAC-3’ 
 
MbovP 5’-FAM-AACTGCATCATATCACATACT-BHQ-1-
3’ 
McalF 5’-GCACTTAGACGAAAGAGGGATT-3’ 
 
rpoB gene of Mycoplasma 
californicum (no accession no. 
provided) (Boonyayatra et al., 
2012) 
McalR 5’-GGATTATCATCACCTTTGGGACT-3’ 
 
McalP 5’-CAL Fluor Orange 560-
CGTGTTGGTTCGGAAGTGGTTCCAG-BHQ-1-3’ 
MbvgF 5’-CTTTCTACGGAGTACAAAGCTAAT-3’ 
 
16S-23S rRNA intergenic spacer 
region of Mycoplasma 
bovigenitalium (no accession no. 
provided) (Boonyayatra et al., 
2012) 
MbvgR 5’-GAGAGAATTGTTCYCTCAAAACTA-3’ 
 
MbvgP 5’-CAL Fluor Red 610- 
TATCGTCATGGCTTGGTTAGGTCCCA-BHQ-2-
3’ 
MycoF  5’- GGGGATGGATTACCTCCTTT -3’ 
 
16S-23S rRNA intergenic spacer 
region of Mycoplasma spp. –‘in-
house’ (GenBank accession no. 
AY729934) (adapted from Tang 
et al. (2000)) 
MycoR  5’- TTCCAGACCCAGGCATC -3’ 
 
2.3.3 Next generation sequencing 
Extracted DNA from all 94 M. bovis isolates was submitted to the Ramaciotii Centre of 
Genomics (The Ramaciotti Centre, University of New South Wales, Randwick, NSW, Australia) 
for Next Generation Sequencing (NGS) using the Illumina1 Nextera XT DNA library 
preparation kit (Illumina1, Scoresby, VIC, Australia) and Illumina1 MiSeq sequencer platform 
(Illumina1, Scoresby, VIC, Australia) with 250 base paired-end sequencing. Following library 
preparation, two samples failed quality control analysis and were therefore excluded from 
sequencing. This resulted in 92 isolates being successfully sequenced. Using the FASTQ Toolkit 
created by Illumina BaseSpace Labs (https:basespace.illumina.com/apps/706706/FastQ) and 
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FastQC 0.11.4 (www.bioinformatics. babraham.ac.uk/projects/) the quality of all 92 sequenced 
isolates was assessed, and any isolate with less than 10x average sequence depth was eliminated 
from further analysis. This resulted in 82 isolates progressing for analysis (see Table S2.1 in the 
Supplementary material for average sequencing depth). 
2.3.4 SNP analysis 
SNP analysis was performed using the Novel SNP Procedure web tool as described and made 
available by Kaas et al. (2014). Using this tool, the raw sequencing files of all M. bovis isolates 
were aligned to the reference genome M. bovis strain ATCC1 25523™/ PG45 (GenBank 
accession no. CP002188). Single nucleotide polymorphisms (SNPs) analysis was then performed 
with the following parameters to ensure high confidence intervals and reproducibility across 
different sequencing platforms: minimum depth at SNP position set at 15x, relative depth at SNP 
position set at 10x, minimum distance between SNPs set at 10, minimum SNP quality and 
minimum mapping quality set at 25, and a minimum Z-score of 1.96 corresponding to a P value 
of 0.05. Any isolate with valid nucleotide positions that covered < 70 % of the reference genome 
was eliminated from SNP analysis. This resulted in the final analysis of 75 isolates. From the 
output a phylogenetic tree was created using Geneious 7.1.9 (Biomatters Ltd, Auckland, New 
Zealand) which was later visualized using FigTree 1.4.2 (Institute of Evolutionary Biology, 
University of Edinburgh, UK). The phylogenetic tree was bootstrapped 70 times to ensure high 
confidence intervals (Hillis and Bull, 1993). Upon completion, BioEdit 7.1.9 (Ibis Biosciences, 
Carlsbad, CA, USA) was used to edit the phylogenetic tree and create an SNP matrix of all 
isolates. Using the R software (R Core Team, 2015) further analysis of the SNP output was 
completed including distribution of pairwise genetic distances and identification of clusters using 
the gengraph function (http://adegenet.r- forge.r-project.org/files/seqTrack-practical.1.3.pdf). 
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2.3.5 Genome analysis 
Using CLC Main Workbench 7.0 (CLC bio, Taipei, Taiwan), De novo assembly of paired 
contigs was performed on each of the 82 isolate. The consensus for contigs sequence was then 
extracted and uploaded onto RAST server 2.0 (National Microbial Pathogen Data Resource, 
Chicago, USA) for genome annotation to identify possible genes, with M. bovis strain PG45 
selected as the reference genome (see Table S2.1 in Supplementary material for genome sizes). 
This generated a nucleic acid file for each isolate, containing a single sequence for each 
identified gene, which was then concatenated into one continuous sequence using Geneious 
7.1.9. The nucleotide sequence of reference strain M. bovis PG45, obtained from the National 
Center for Biotechnological Information [(NCBI); National Center for Biotechnological 
Information, Bethesda, MD, USA], was also uploaded onto RAST server 2.0 generating a 
nucleic acid file containing its coding sequences (CDSs) as well as a full annotation of these 
CDSs. The annotation file was used to determine what each CDS coded for. The concatenated 
nucleic acid files (genomes) and the defined set of coding sequences (CDSs) from reference 
strain M. bovis PG45 were used in the large-scale blast score ratio (LS-BSR) method to analyze 
the genetic content of all 82 M. bovis isolates (Sahl et al., 2014). This analysis created a blast 
score ratio (BSR) matrix describing the relatedness of the CDSs of M. bovis PG45 with the 
genomes of the analyzed isolates. A BSR value between 0.0 and 1.0 was given for each CDS for 
each genome, with the BSR matrix visualized using MeV 4.8.1 (TM4 Microarray Software 
Suite, Boston, MA, USA).  
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2.3.6 Comparison of defined populations 
Using the generated BSR matrix of all isolates, comparisons between several defined populations 
were made to investigate whether there were certain regions in the genome that were specific to a 
particular group. A gene was considered present if a BSR value of ≥ 0.7 was achieved (Rasko et 
al., 2005). The first population comparison compared M. bovis isolates from carrier animals (n = 
13) with those from clinical animals (n = 14). All isolates from carrier animals were from one 
particular state in Australia. Therefore the clinical isolates used for comparison were also chosen 
from this state. The second population comparison looked at the effect of anatomical sample 
location and compared isolates from milk (n = 10), joint (n = 8) and swab samples from mucosal 
surfaces (prepuce, vaginal, nose) (n = 10). All available swab and joint isolates were from 
animals located in one particular state of Australia. As such, the milk isolates chosen for 
comparison were also obtained from animals located in this state (see Table 2.2 in the 
Supplementary material).  
Statistical analysis was performed on binary values, with any BSR value < 0.7 allocated a ‘0’, 
while any BSR value ≥ 0.7 was allocated a value of ‘1’. Analysis was done through the R 
software using the Fisher’s exact test. Significance was declared at a value of P < 0.05. 
2.3.7 Virulence factors 
The nucleotide sequences of all known M. bovis variable surface proteins (vsps) for the M. bovis 
reference strain PG45 genome (including vspE, vspI, vspO, vspJ, vspN, vspK, vspL, vspM, 
vspB, vspG, vspA, vspH and vspF) (Qi et al., 2012) were obtained from NCBI. Integrase-
recombinase gene xerC from M. bovis Chinese strain Hubei-1 (Li et al., 2011) was also included. 
Using the LS-BSR method, all M. bovis genomes were analyzed against the set of 14 vsp genes 
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creating a second BSR matrix. A gene was considered present if a BSR value of ≥0.7 was 
achieved.  
The ‘DNA sequences of full dataset’ containing the nucleotide sequences of all known and 
predicted virulence factors of bacterial pathogens was obtained from the Virulence Factor 
Database (VFDB) (MOH Key Laboratory of Systems Biology of Pathogens, Institute of 
Pathogen Biology, Beijing, China) (Chen et al., 2016). The LS-BSR method was then used to 
analyze all M. bovis genomes against the virulence factor dataset creating a third BSR matrix. 
Due to this type of analysis not having been done before on any previously published M. bovis 
genome sequences, the complete genomes of M. bovis Chinese strain HB0801, M. bovis Chinese 
strain Hubei-1 and M. bovis strain PG45 were also included in the analysis. A gene was 
considered present if a BSR value of ≥ 0.7 was achieved. 
2.4 Results 
2.4.1 SNP analysis 
Within the 75 Australian isolates analyzed a maximum of 50 SNPs were observed between any 
two isolates. Through phylogenetic tree analysis all isolates could be traced back to Mb07, a 
milk sample from New South Wales (NSW) in 2007 (Fig. 2.1). The isolate with the most genetic 
change was Mb41 with 13.5 SNPs per 100 bases, which was isolated in a milk sample from 
Victoria (VIC) in 2014.  
Distribution of pairwise genetic distances suggests the existence of one large clade and a second 
smaller clade, both with normal distribution, with the possibility of a small third clade (Fig. 2.2). 
Further cluster analysis using the Gengraph function confirmed this observation with three 
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distinct clades and three outlier isolates (Fig. 2.3). The largest clade contained 68 isolates, with 
clade two and three containing just six and five isolates respectively. 
While some clusters can be seen to be associated with herd of origin, in the broader context of 
geographical location by state, little association was observed with isolates evenly distributed 
across the tree. A large group is present in the center of the tree (Mb30–Mb80) containing 
isolates from Tasmania (TAS) however all isolates in this group are from herds in a small area of 
the state where there is movement of animals between herds (Fig. 2.1). This is with the exception 
of isolates Mb44-Mb46 which are from a single dairy in VIC. Isolates from other geographical 
locations within TAS are distributed in other sections of the tree. Similarly, isolates Mb18, 
Mb19, Mb33, Mb76 and Mb92 from South Australia (SA) are grouped together however all 
isolates in this group were obtained from a single herd over a period of four years (Fig. 2.1). 
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Figure 2.1 Neighbor-joining consensus phylogenetic tree created from 75 M. bovis WGS sequences and SNP analysis. The consensus support (%) 
of the phylogenetic tree as determined by the bootstrap test (70 replicates) is indicated at each node. The scale bar indicates the % of SNPs within 
a sequence.  
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Figure 2.2 Distribution of pairwise genetic distances from 75 M. bovis WGS sequences and SNP 
analysis.   
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Figure 2.3 Clusters obtained by Gengraph depicting three distinct clades, and three outliers. The numbers 
on the lines indicate the amount of SNPs between isolates. 
 
No clusters were observed based on the anatomical location from which the isolates were 
collected with an even distribution of all isolates across the tree. For several isolates which were 
collected from different anatomical locations in the same herd, SNP analysis demonstrated that 
they are very closely related and, in one case, identical. This includes isolates Mb82 and Mb83 
which were found to be identical however were obtained from a milk and joint sample 
respectively. Similarly, no clear trend could be seen from isolates collected from clinical animals 
compared with those from healthy ‘carrier’ animals. In one instance, an isolate obtained from a 
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preputial swab of a healthy bull (Mb94) was identical to two isolates obtained from mastitic milk 
samples (Mb55 and Mb57). 
Little genetic variation was observed in the M. bovis isolates collected across time from 2006 to 
2015. While the isolates with the least amount of genetic diversity included some of the earliest 
isolates from 2007, and those with the most genetic diversity included some of the most recent 
isolates from 2014, no clear pattern of genetic change of isolates was evident based on time of 
collection on a national scale. In isolates which were collected from the same herd, a clearer 
pattern was demonstrated with more recent isolates showing greater genetic diversity when 
compared to earlier isolates. To investigate genetic evolution on a herd scale, two herds had 
isolates sequenced which were collected several years apart. Herd A (Mb18, Mb19, Mb33, Mb76 
and Mb92) was a closed dairy herd of approximately 2000 animals, and had isolates sequenced 
from 2011 (n = 2), 2013 (n = 2) and 2014 (n = 1). A maximum of 4 SNPs occurred between any 
two isolates, demonstrating a very small amount of genetic divergence over a three year period 
within a single herd. Herd B (Mb03-Mb05, Mb47, Mb48 and Mb93) was an expanding dairy 
herd of approximately 4000 animals, and had isolates sequenced from 2007 (n = 3) and 2014 (n 
= 3). A maximum of 38 SNPs between any two isolates was observed in this herd, demonstrating 
the ability of a single genotype to remain within a herd for seven years. 
2.4.2 Genome analysis 
2.4.2.1 Comparison of defined populations 
When comparing the gene content of isolates from clinical animals to those from healthy carrier 
animals, the Fisher’s exact test identified only two CDSs which were significant. The CDS 865 
sequence, coding for a hypothetical protein (as identified through the annotated CDSs file), was 
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identified in 100 % of clinical isolates and 69 % of carrier isolates (P = 0.04). The CDS 158 
sequence, coding for a tRNA methyltransferase (tRNA:m(5)U-54 MTase), was identified in 64 
% of clinical isolates and 100% of carrier isolates (P = 0.04). When comparing the gene content 
of isolates from different anatomical locations including milk, joints and swabs (prepuce, 
vaginal, nose), the Fisher’s exact test also identified two CDSs which were significant. These 
included the sequences CDS 181 (P = 0.04) and CDS 184 (P = 0.01), both of which code for a 
mobile element protein. The CDS 181 sequence was identified in 50 % (4/8) of joint samples, 20 
% (2/10) of swab samples and 0 % (0/ 10) of milk samples. The CDS 184 sequence was 
identified in 63 % of joint samples, 20 % of swab samples and 0 % of milk samples.  
2.4.2.2 Virulence factors 
Genome analysis of defined populations could not identify genes which separated the different 
sample types suggesting a single conserved strain. Therefore, to further investigate the virulence 
attributes of this strain, known M. bovis virulence genes were examined. Comparison of the 
Australian M. bovis genomes with known vsp genes from M. bovis strain PG45 demonstrated a 
large reduction in the identity of these genes across all isolates. The maximum BSR of any vsp 
gene for any isolate was 1.0, 0.71, 0.57, 0.57, 0.48, 0.45, 0.41, 0.4, 0.31, 0.26, 0.24, 0.18, 0.16 
and 0.1 for xerC, vspL, vspE, vspK, vspG, vspH, vspF, vspM, vspI, vspA, vspO, vspB, vspJ and 
vspN respectively. The integrase-recombinase xerC gene had a BSR of 1.0 in 34% (n = 28) of 
isolates however they were not specific to any particular geographical location or anatomical site 
and included samples from all five states, twenty-two milk samples, four joint samples and two 
nose swab samples. One isolate was considered to contain the vspL gene with a BSR ≥ 0.7, and a 
further eight isolates could be considered to contain the vspL gene if the BSR cutoff was reduced 
to ≥ 0.6. All other vsp genes had a BSR ≥ 0.6 across all isolates. 
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Due to such a reduction in the identity of vsp genes across all analyzed M. bovis isolates, further 
investigations were made into virulence genes which have yet to be described in M. bovis. 
Analysis of the Australian M. bovis isolates against the VFDB identified 50 virulence genes with 
a BSR ≥ 0.7 (see Table S2.2 in Supplementary material). The three genes with the highest BSRs 
included clpC, tufA and MAG006 with a maximum BSR of 1.17, 1.0 and 0.94 respectively for 
any isolate. Gene clpC had a BSR of ≥ 0.7 in 95 % (n = 78) of isolates, gene tufa had a BSR of ≥ 
0.7 in 99 % (n = 81) of isolates, and gene MAG006 had a BSR of ≥ 0.7 in 78 % (n = 64) of 
isolates. No association between the presence of these genes and clinical disease, anatomical site, 
geographical location or collection date was found. 
2.5 Discussion 
The utilisation of whole genome sequencing methodologies has enabled, for the first time, an 
analysis of the degree of genetic diversity and divergence occurring among Australian M. bovis 
isolates collected between 2006 and 2015. From the SNP analysis of 75 isolates and the 
construction of a phylogenetic tree, the presence of a single M. bovis strain throughout the 
country was identified. With a maximum of only 50 SNPs occurring between any two isolates, 
and a maximum genetic change of only 13.5 %, the overall genetic diversity and evolutionary 
change observed was minimal despite variations in geographical location, anatomical sampling 
site, animal disease status and time of collection. However, given that the isolates sequenced in 
this study were not clonally derived, though unlikely there is the potential of more than one 
genotype per isolate which may over or under estimate the amount of genetic diversity reported. 
This is in contrast to a recent study that revealed a total of 122 SNPs between two Chinese 
strains M. bovis HB0801 and M. bovis Hubei-1 despite the strains being isolated in the same 
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province during the same year (Qi et al., 2012). Similar findings to the current study were 
observed in Danish M. bovis isolates using amplified fragment length polymorphism (AFLP) 
(Kusiluka et al., 2000), with field isolates collected over a 17 year period showing remarkable 
genetic stability, despite Mollicute chromosomes being considered as evolutionarily dynamic 
(Razin et al., 1998). With both the Danish study and the current Australian study demonstrating a 
modest amount of genetic variation and evolution occurring in M. bovis isolates over an 
extended period of time within a single country, this suggests that SNPs are unlikely to be 
playing a significant role in the increased incidence of disease observed over the last decade. 
Cluster analysis of the data confirmed a lack of divergence with 81% of the isolates falling into a 
single clade despite being isolated from various anatomical locations, time points and 
geographical locations within Australia. Two additional clades were also formed containing just 
six and five isolates which were grouped by herd of origin. This clustering pattern is supported 
by previous studies which have demonstrated clustering of M. bovis isolates on a global scale 
based on geographical origin, with suggestions that M. bovis populations evolve separately when 
geographically isolated (Amram et al., 2013, Rosales et al., 2015).  
The finding of a single strain circulating throughout Australia in isolates collected between 2006 
and 2015 in the current study may suggest that current biosecurity practices have prevented the 
introduction of multiple strains over time. Strict national quarantine regulations and the expense 
required for the importation of livestock may have resulted in minimal numbers of potentially 
infected animals entering Australia. Australia’s global isolation and lack of shared borders may 
also minimize the introduction of multiple strains. However, with M. bovis first being isolated in 
Australia as far back as 1970 (Cottew, 1970) which predates samples collected in the current 
study by 36 years, there would have been a considerable number of older isolates present in 
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Australia. Unfortunately, to the best of the authors’ knowledge, no isolates identified prior to 
2006 were stored and therefore were not available to be analyzed. It is therefore impossible to 
determine if these older isolates represented different strains to those present after 2006. 
While the introduction of multiple strains over time may be limited, this analysis also highlights 
that elimination of the currently identified strain has not been successful. This is despite growing 
awareness of the disease and the implementation of a common control method of identifying and 
culling infected animals from infected herds. While unlikely to be due to SNPs, the persistence 
and pathogenicity of the Australian strain may be due to the presence of virulence factors. While 
speculative in relation to their functional role within M. bovis, investigation of potential 
pathogenicity from virulence factors from the VFDB revealed 50 virulence genes with a 
consistent BSR ≥ 0.7 across most isolates. The three genes with the highest BSRs included ClpC, 
tufA and MAG006. The ClpC gene codes for an ATPase which has previously been observed in 
Listeria monocytogenes in response to stress, and is thought to promote early bacterial escape 
from macrophages (Rouquette et al., 1998). It has also previously been described in M. bovis 
Hubei-1 (Li et al., 2011). The tuf gene encodes the EF-tu elongation factor which plays an 
important role during translation. While found in most microbial genomes including 
Mycoplasma spp., Escherichia coli and Salmonella typhimurium (Lathe and Bork, 2001) it is 
considered a virulence factor in Francisella tularensis playing a role in host cell attachment 
(Barel and Charbit, 2014). The MAG006 gene codes for the P48 protein found in Mycoplasma 
agalactiae PG2. The protein P48 is a Mycoplasma spp.-derived immunomodulatory molecule 
which has been previously described in M. bovis with suggestions of its use as a marker of 
infection (Robino et al., 2005). However, given that 22 % (n=18) of the Australian isolates had a 
BSR < 0.7 for this gene, its usefulness may be questioned in the Australian context. Interestingly, 
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the identification of vsp genes found in M. bovis PG45 was greatly reduced across all Australian 
isolates. This is an important finding given the vsp cluster has previously been considered a 
characteristic virulence factor of M. bovis (Lysnyansky et al., 1999). While this may be due to a 
lack of sequencing coverage in this area, these results are not necessarily unexpected. While M. 
bovis PG45 has been found to contain 13 vsp genes, this is reduced to 6 vsp genes in M. bovis 
HB0801, with the vsp cluster completely deleted in M. bovis Hubei-1 (Qi et al., 2012). The 
findings of the current study support the suggestion that vsp genes may not necessarily play a 
pivotal role in the pathogenesis of disease caused by all M. bovis strains.  
While past studies have demonstrated the ability to isolate M. bovis from the mucosal surfaces of 
clinically healthy dry and lactating cows, heifers and calves, genomic analysis of these isolates 
has not been undertaken (Bennett and Jasper, 1977, Punyapornwithaya et al., 2010). In this 
study, both SNP and genome analysis confirmed a lack of genetic diversity separating isolates 
from clinically affected animals and from those isolated from apparently healthy carrier animals. 
This suggests that, at the genome level, isolates from carrier animals are similarly virulent to 
those obtained from clinically affected animals and are capable of causing disease given the right 
opportunity. For example, the stress and physiological demands associated with calving may be 
factors playing a role in the expression of clinical disease caused by M. bovis that occurs during 
the immediate post-partum stage of lactation in animals already carrying the pathogen (Al-
Abdullah and Fadl, 2006, Radaelli et al., 2011). The finding that M. bovis isolates in clinically 
unaffected animals are potentially equally virulent, highlights the important role that carrier 
animals have in harboring M. bovis and, as such, allowing transmission and recurrent disease 
events; a long suggested theory (Maunsell et al., 2011). This is demonstrated in the clustering of 
the Australian isolates collected from a single closed herd from the separate time points of 2011 
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(n=2), 2013 (n=2) and 2014 (n=1). Rather than M. bovis being brought into the herd on each 
occasion, the isolate from the initial outbreak in 2011 is likely to have remained within the herd 
in carrier animals, awaiting the opportunity to result in future disease events. The presence of 
carrier animals may also, in part, explain the difficulty in eliminating the pathogen from 
Australia. 
Comparison of isolates from different anatomical locations also revealed a lack of variance 
between the three defined groups of milk samples (n=10), joint samples (n=8) and swab samples 
obtained from mucosal surfaces (prepuce, vaginal, nose) (n=10). Similarly, studies using pulsed 
field gel electrophoresis (PFGE), amplified fragment length polymorphism (AFLP) and multiple 
locus variable number tandem repeat (MLVA) analysis frequently found identical patterns of 
isolates from the mammary system and other body sites (Kusiluka et al., 2000, Biddle et al., 
2005). This corresponds with phenotypic findings by Thomas et al. (2003) which showed no 
correlation between host cell line (embryonic bovine lung, embryonic bovine trachea, maden 
darby bovine kidney and rabbit kidney cells) and cytadherence of M. bovis isolates with different 
pathological presentations (pneumonia, arthritis and mastitis). This further suggests that a single 
isolate is equally capable of causing a variety of different clinical manifestations and, as such, 
host factors and management practices may play a major role in the clinical form that M. bovis 
infection takes. This provides evidence to support the view that the same approach to control 
should be instigated regardless of the type of disease presentation. 
2.6 Conclusion 
This study is the first of its kind to genetically characterize and compare large numbers of 
Australian M. bovis isolates. Whole genome sequencing analysis has revealed a single strain 
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circulating throughout the country between 2006 and 2015 with marked genomic similarity. 
Minimal genomic variation was observed between M. bovis isolates sampled from different 
anatomical locations, as well as between isolates obtained from animals with clinical disease and 
healthy carrier animals. While the presence of vsp genes was greatly reduced as compared to 
those described in M. bovis PG45, 50 putative virulence genes from the VFDB were identified as 
being highly similar. These results highlight that while the introduction of multiple M. bovis 
strains may be limited, elimination of the current identified strain has not been successful. This 
may be due to the significant role that carrier animals play in harboring the pathogen as well as 
the potential virulence factors identified. It also suggests that host and environmental factors may 
play a significant role in determining disease outcome. 
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2.10 Supplementary material  
Table S2.1 Australian Mycoplasma bovis isolates used for Whole Genome Sequencing (WGS) analysis  
NSW – New South Wales (7 herds); QLD – Queensland (2 herds);  
SA – South Australia (1 herd); VIC – Victoria (7 herds); TAS – Tasmania (13 herds). 
Isolate 
Id 
Sample Date State Disease Status 
Analysis 
Performed 
Average 
Sequencing 
Depth 
Genome size 
(bp) 
% of 
Reference 
Genome 
Genbank 
Accession # 
Mb01 Milk 8-Nov-06 NSW Clinical SNP; LS-BSR 52 874565 87 SAMN05444184 
Mb02 Milk 26-Feb-07 NSW Clinical SNP; LS-BSR 140 923155 92 SAMN05444185 
Mb03
B
 Milk 26-Feb-07 NSW Clinical SNP; LS-BSR 60 884588 88 SAMN05444186 
Mb04
B
 Milk 26-Feb-07 NSW Clinical SNP; LS-BSR 56 874360 87 SAMN05444187 
Mb05
B
 Milk 26-Feb-07 NSW Clinical SNP; LS-BSR 78 901692 90 SAMN05444188 
Mb06 Milk 9-Aug-07 NSW Clinical SNP; LS-BSR 56 877848 87 SAMN05444189 
Mb07 Milk 9-Aug-07 NSW Clinical SNP; LS-BSR 50 899980 90 SAMN05444190 
Mb08 Milk 9-Aug-07 NSW Clinical SNP; LS-BSR 52 868121 87 SAMN05444191 
Mb09 Milk 7-Nov-07 NSW Clinical SNP; LS-BSR 46 909038 91 SAMN05444192 
Mb10 Milk 7-Nov-07 NSW Clinical SNP; LS-BSR 66 898893 90 SAMN05444193 
Mb11 Milk 7-Nov-07 NSW Clinical SNP; LS-BSR 38 857178 85 SAMN05444194 
Mb12 Milk 2-Sep-08 NSW Clinical SNP; LS-BSR 50 886562 88 SAMN05444195 
Mb13 Milk 9-Mar-09 QLD Clinical SNP; LS-BSR 58 870208 87 SAMN05444196 
Mb14 Milk 9-Mar-09 QLD Clinical SNP; LS-BSR 56 867848 86 SAMN05444197 
Mb15 Milk 9-Mar-09 QLD Clinical SNP; LS-BSR 48 899864 90 SAMN05444198 
Mb16 Milk 9-Sep-09 QLD Clinical SNP; LS-BSR 60 876470 87 SAMN05444199 
Mb17 Milk 9-Sep-09 QLD Clinical SNP; LS-BSR 52 877337 87 SAMN05444200 
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Mb18
A
 Milk 16-Nov-11 SA Clinical SNP; LS-BSR 62 887636 88 SAMN05444201 
Mb19
A
 Milk 16-Nov-11 SA Clinical SNP; LS-BSR 74 912475 91 SAMN05444202 
Mb21 Milk 18-Sep-12 NSW Clinical SNP; LS-BSR 52 868123 87 SAMN05444203 
Mb22 Milk 18-Sep-12 NSW Clinical SNP; LS-BSR 64 905586 90 SAMN05444204 
Mb23 Milk 18-Sep-12 NSW Clinical SNP; LS-BSR 54 883372 88 SAMN05444205 
Mb24 Milk 31-Oct-12 QLD Clinical LS-BSR 48 876626 87 SAMN05444206 
Mb25 Milk 5-Mar-13 VIC Clinical SNP; LS-BSR 64 890200 89 SAMN05444207 
Mb26 Milk 5-Mar-13 VIC Clinical SNP; LS-BSR 62 884026 88 SAMN05444208 
Mb27 Milk 22-Apr-13 NSW Clinical SNP; LS-BSR 56 890130 89 SAMN05444209 
Mb28 Milk 22-Apr-13 NSW Clinical SNP; LS-BSR 64 898244 90 SAMN05444210 
Mb29 Milk 22-Apr-13 NSW Clinical SNP; LS-BSR 70 896524 89 SAMN05444211 
Mb30 Joint 23-May-13 TAS Clinical
CD
 SNP; LS-BSR 50 907480 90 SAMN05444212 
Mb31 Joint 30-May-13 TAS Clinical
CD
 SNP; LS-BSR 54 901151 90 SAMN05444213 
Mb32 Joint 30-May-13 TAS Clinical
CD
 SNP; LS-BSR 64 912865 91 SAMN05444214 
Mb33
A
 Milk 18-Jul-13 SA Clinical SNP; LS-BSR 54 916454 91 SAMN05444215 
Mb34 
Pulmonary 
Lymph node 
15-Oct-13 VIC Clinical SNP; LS-BSR 
46 885595 88 SAMN05444216 
Mb35 Lung 15-Oct-13 VIC Clinical SNP; LS-BSR 50 879303 88 SAMN05444217 
Mb36 Lung 4-Nov-13 VIC Clinical LS-BSR 36 870213 87 SAMN05444218 
Mb37 Milk 11-Nov-13 VIC Clinical SNP; LS-BSR 52 874535 87 SAMN05444219 
Mb39 Milk 7-May-14 VIC Clinical SNP; LS-BSR 50 894451 89 SAMN05444220 
Mb40 Milk 20-May-14 VIC Clinical SNP; LS-BSR 46 889414 89 SAMN05444221 
Mb41 Milk 20-May-14 VIC Clinical SNP; LS-BSR 54 870701 87 SAMN05444222 
Mb42 Milk 3-Jun-14 VIC Clinical SNP; LS-BSR 40 869062 87 SAMN05444223 
Mb43 Milk 16-Jul-14 VIC Clinical SNP; LS-BSR 52 873657 87 SAMN05444224 
Mb44 Milk 22-Jul-14 VIC Clinical SNP; LS-BSR 66 895657 89 SAMN05444225 
Mb45 Milk 22-Jul-14 VIC Clinical SNP; LS-BSR 66 899251 90 SAMN05444226 
Mb46 Milk 22-Jul-14 VIC Clinical SNP; LS-BSR 50 888540 89 SAMN05444227 
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Mb47
B
 Lung 30-Oct-14 NSW Clinical SNP; LS-BSR 54 887124 88 SAMN05444228 
Mb48
B
 Milk 3-Nov-14 NSW Clinical SNP; LS-BSR 56 893634 89 SAMN05444229 
Mb50 Unknown 2010 TAS Clinical SNP; LS-BSR 66 904288 90 SAMN05444230 
Mb52 Nose Swab 20-Aug-13 TAS 
Carrier/Non-
Clinical
CD
 
SNP; LS-BSR 
50 912770 91 SAMN05444231 
Mb53 Nose Swab 20-Aug-13 TAS 
Carrier/Non-
Clinical
CD
 
SNP; LS-BSR 
56 915369 91 SAMN05444232 
Mb54 Nose Swab 21-Aug-13 TAS 
Carrier/Non-
Clinical
CD
 
SNP; LS-BSR 
44 895962 89 SAMN05444233 
Mb55 Milk 12-Aug-13 TAS Clinical
CD
 SNP; LS-BSR 54 917285 91 SAMN05444234 
Mb56 Milk 31-Jul-13 TAS Clinical
CD
 SNP; LS-BSR 50 906526 90 SAMN05444235 
Mb57 Milk 5-Aug-13 TAS Clinical
CD
 SNP; LS-BSR 102 937684 93 SAMN05444236 
Mb59 Joint 15-Aug-13 TAS Clinical
CD
 LS-BSR 30 817693 81 SAMN05444237 
Mb60 
Semen 
Culture 
12-Sep-13 TAS 
Carrier/Non-
Clinical
C
 
SNP; LS-BSR 
72 899081 90 SAMN05444238 
Mb61 
Semen 
Culture 
13-Sep-13 TAS 
Carrier/Non-
Clinical
C
 
SNP; LS-BSR 
164 933086 93 SAMN05444239 
Mb63 
Semen 
Culture 
13-Sep-13 TAS 
Carrier/Non-
Clinical
C
 
LS-BSR 
30 890286 89 SAMN05444240 
Mb64 
Vaginal 
Swab 
24-Sep-13 TAS 
Carrier/Non-
Clinical
CD
 
LS-BSR 
28 860642 86 SAMN05444241 
Mb65 
Vaginal 
Swab 
24-Sep-13 TAS 
Carrier/Non-
Clinical
CD
 
SNP; LS-BSR 
76 926880 92 SAMN05444242 
Mb67 Nose Swab 24-Sep-13 TAS 
Carrier/Non-
Clinical
CD
 
SNP; LS-BSR 
210 932401 93 SAMN05444243 
Mb68 Nose Swab 24-Sep-13 TAS 
Carrier/Non-
Clinical
CD
 
SNP; LS-BSR 
90 916742 91 SAMN05444244 
Mb69 Nose Swab 24-Sep-13 TAS 
Carrier/Non-
Clinical
CD
 
SNP; LS-BSR 
48 919247 92 SAMN05444245 
Mb71 Milk 12-Nov-13 TAS Clinical
CD
 SNP; LS-BSR 70 910606 91 SAMN05444246 
Mb72 Joint fluid 5-Nov-13 TAS Clinical
CD
 SNP; LS-BSR 302 939823 94 SAMN05444247 
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Mb74 Milk 27-Nov-13 TAS Clinical
CD
 LS-BSR 28 844108 84 SAMN05444248 
Mb75 Joint fluid 27-Nov-13 TAS Clinical
CD
 SNP; LS-BSR 238 933672 93 SAMN05444249 
Mb76
A
 Milk 2-May-14 SA Clinical LS-BSR 90 914886 91 SAMN05444250 
Mb77 Milk 20-May-14 TAS Clinical
CD
 SNP; LS-BSR 74 921458 92 SAMN05444251 
Mb79 Milk 19-May-14 TAS Clinical
CD
 SNP; LS-BSR 56 905404 90 SAMN05444252 
Mb80 Joint fluid 27-May-14 TAS Clinical
CD
 SNP; LS-BSR 46 877849 87 SAMN05444253 
Mb81 Nose Swab 11-Sep-14 TAS 
Carrier/Non-
Clinical
CD
 
SNP; LS-BSR 
80 923945 92 SAMN05444254 
Mb82 Milk 17-Oct-14 TAS Clinical
D
 SNP; LS-BSR 82 896742 89 SAMN05444255 
Mb83 Joint fluid 21-Oct-14 TAS Clinical
D
 SNP; LS-BSR 130 911145 91 SAMN05444256 
Mb84 Milk 20-Jan-15 TAS Clinical
D
 LS-BSR 30 842498 84 SAMN05444257 
Mb85 Milk 20-Jan-15 TAS Clinical
D
 SNP; LS-BSR 102 927029 92 SAMN05444258 
Mb87 Milk 6-Apr-11 VIC Clinical SNP; LS-BSR 44 762386 76 SAMN05444259 
Mb89 Milk 14-Jun-11 VIC Clinical SNP; LS-BSR 128 919352 92 SAMN05444260 
Mb90 Milk 14-Jun-11 VIC Clinical SNP; LS-BSR 256 922026 92 SAMN05444261 
Mb91 Milk 16-Oct-12 QLD Clinical SNP; LS-BSR 46 876608 87 SAMN05444262 
Mb92
A
 Milk 18-Jul-13 SA Clinical SNP; LS-BSR 80 919535 92 SAMN05444263 
Mb93
B
 Milk 27-Aug-14 NSW Clinical SNP; LS-BSR 86 914819 91 SAMN05444264 
Mb94 Penile Swab 12-Sep-13 TAS 
Carrier/Non-
Clinical
CD
 
SNP; LS-BSR 
118 919001 92 SAMN05444265 
A
Farm A; 
B
Farm B; 
C
Population Comparison of Clinical vs Carrier Isolates; 
D
Population Comparison of 
Anatomical Locations 
   SNP = single nucleotide polymorphism 
analysis 
       LS-BSR = large scale blast score ratio 
analysis 
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Table S2.2 Virulence genes and Blast Score Ratio (BSR) values for Australian (AUS) Mycoplasma bovis 
isolates combined, Mycoplasma bovis HB0801, Mycoplasma bovis Hubei-1 and Mycoplasma bovis PG45 
Virulence Gene M.bovis HB0801 AUS M.bovis combined M.bovis Hubei-1 M.bovis PG45 
MYPU_7630 0.71 0.71 0.71 0.71 
clpB2 0.71 0.71 0.71 0.71 
PA14_01100 0.72 0.72 0.72 0.72 
Pmen_2331 0.72 0.72 0.72 0.71 
clpV1 0.72 0.72 0.72 0.72 
PLES_00911 0.73 0.73 0.73 0.72 
PSPA7_0162 0.73 0.73 0.73 0.73 
cts1V 0.73 0.73 0.73 0.72 
BTH_II0864 0.75 0.75 0.75 0.75 
clpV3 0.75 0.75 0.75 0.74 
EC042_0215 0.76 0.76 0.76 0.76 
ECS88_0237 0.76 0.76 0.76 0.76 
LF82_018 0.76 0.76 0.76 0.76 
NRG857_01105 0.76 0.76 0.76 0.76 
aec27/clpV 0.76 0.76 0.76 0.76 
clpV 0.76 0.76 0.76 0.76 
EC55989_0223 0.77 0.77 0.77 0.77 
ECO103_0218 0.77 0.77 0.77 0.77 
ECO55CA74_01080 0.77 0.77 0.77 0.77 
ECP_0229 0.77 0.77 0.77 0.77 
EcE24377A_0231 0.77 0.77 0.77 0.77 
O3M_20365 0.77 0.77 0.77 0.77 
cts2V 0.77 0.77 0.77 0.76 
ECO111_0223 0.78 0.78 0.78 0.78 
ECO26_0224 0.78 0.78 0.78 0.78 
O3M_04480 0.79 0.79 0.79 0.79 
tuf 0.79 0.79 0.79 0.79 
clpV/aaiP 0.8 0.8 0.8 0.79 
clpV2 0.8 0.8 0.8 0.8 
clpE 0.82 0.83 0.82 0.82 
clpV/vasG 0.82 0.83 0.82 0.82 
ECP_2806 0.85 0.85 0.85 0.85 
LF82_432 0.85 0.85 0.85 0.85 
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MbECO1_3712 0.86 0.86 0.86 0.86 
ECNA114_2860 0.86 0.86 0.86 0.86 
ECO103_3363 0.86 0.86 0.86 0.86 
c3392 0.86 0.86 0.86 0.85 
EcE24377A_3129 0.87 0.87 0.87 0.86 
PP_3095 0.87 0.87 0.87 0.86 
PputGB1_2769 0.87 0.87 0.87 0.87 
Pput_2627 0.87 0.87 0.87 0.86 
Psyr_4958 0.87 0.87 0.87 0.87 
evpH 0.87 0.87 0.87 0.87 
PputW619_2505 0.88 0.88 0.88 0.88 
clpB1 0.88 0.88 0.88 0.87 
pdhB 0.88 0.88 0.88 0.88 
EC55989_3334 0.89 0.89 0.89 0.89 
MAG006 0.94 0.94 0.94 0.94 
tufA 1 1 1 1 
clpC 1.17 1.18 1.17 1.17 
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CHAPTER 3: COMPARISON OF CULTURE AND A 
MULTIPLEX PROBE PCR FOR IDENTIFYING 
MYCOPLASMA SPECIES IN BOVINE MILK, SEMEN 
AND SWAB SAMPLES 
 
 
 
 
 
 
This chapter appears as the following published paper in international peer reviewed, scientific 
open access journal, PLoS ONE (citation below). Only the format has been changed for the 
purposes of consistency of style in this thesis.  
 
Parker, A. M., J. K. House, M. S. Hazelton, K. L. Bosward, and P. A. Sheehy. 2017. 
Comparison of culture and a multiplex probe PCR for identifying Mycoplasma species in bovine 
milk, semen and swab samples. PLoS ONE 12(3):e0173422. 
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3.1 Abstract 
Mycoplasma spp. are a major cause of mastitis, arthritis and pneumonia in cattle, and have been 
associated with reproductive disorders in cows. While culture is the traditional method of 
identification the use of PCR has become more common. Several investigators have developed 
PCR protocols to detect M. bovis in milk, yet few studies have evaluated other sample types or 
other important Mycoplasma species. Therefore the objective of this study was to develop a 
multiplex PCR assay to detect M. bovis, M. californicum and M. bovigenitalium, and evaluate its 
analytical performance with traditional culture of bovine milk, semen and swab samples. The 
PCR specificity was determined and the limit of detection evaluated in spiked milk, semen and 
swabs. The PCR was then compared to culture on 474 field samples from individual milk, bulk 
tank milk (BTM), semen and swab (vaginal, preputial, nose and eye) samples. Specificity 
analysis produced appropriate amplification for all M. bovis, M. californicum and M. 
bovigenitalium isolates. Amplification was not seen for any of the other Mollicutes or eubacterial 
isolates. The limit of detection of the PCR was best in milk, followed by semen and swabs. 
When all three Mycoplasma species were present in a sample, the limit of detection increased. 
When comparing culture and PCR, overall there was no significant difference in the proportion 
of culture and PCR positive samples. Culture could detect significantly more positive swab 
samples. No significant differences were identified for semen, individual milk or BTM samples. 
PCR identified five samples with two species present. Culture followed by 16S-23S rRNA 
sequencing did not enable identification of more than one species. Therefore, the superior 
method for identification of M. bovis, M. californicum and M. bovigenitalium may be dependent 
on the sample type being analyzed, and whether the identification of multiple target species is 
required. 
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3.2 Introduction 
Mycoplasma species belong to the class Mollicutes and are characterised by their lack of cell 
wall, low G+C content (23-40%) and small genome size (0.58-1.4Mbp), making them the 
simplest and smallest self-replicating and free-living form of life (Trachtenberg, 2005). 
Following its initial isolation in 1961 from a case of severe mastitis in the USA (Hale et al., 
1962), Mycoplasma bovis is one of the most important mycoplasma pathogens in cattle 
worldwide (Nicholas and Ayling, 2003). Mycoplasma bovis has been demonstrated as a 
causative agent of mastitis and arthritis in adults (Wilson et al., 2007), as well as pneumonia 
(Fraser et al., 2014), arthritis (Stipkovits et al., 2005) and otitis media (Maunsell et al., 2012) in 
calves. Several other Mycoplasma species are of interest in cattle with varying degrees of 
significance. Mycoplasma californicum appears to be the second most common cause of 
mycoplasma-associated disease (Kirk et al., 1997) and is associated with mastitis in adults 
(Mackie et al., 1982, Infante-Martinez et al., 1999) and arthritis and pneumonia in calves 
(Hewicker-Trautwein et al., 2002). Mycoplasma bovigenitalium can be isolated from the 
reproductive tract of cows, and has been associated with vulvovaginitis and infertility (Brenner et 
al., 2009), as well as dystocia and endometritis (Ghanem et al., 2013).  
The traditional method of mycoplasma identification is by culture. Due to their simplicity and as 
such high nutritional demands, specialized and highly enriched media is required for their growth 
(McVey et al., 2013). However assuming the appropriate growth media and atmospheric 
conditions of 37 ᵒC and 5 % CO2 are used, the majority of Mycoplasma spp. are not intrinsically 
difficult to grow. While this method of identification is relatively cheap and simple, there are 
several limitations. Due to its slow rate of growth of 7-10 days (Quinn et al., 2013), Mycoplasma 
spp. can be easily overgrown by other bacteria which may contaminate the sample, resulting in 
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identification being very difficult or not possible. At the same time it is also important to keep 
the mycoplasma organism viable for growth. Therefore appropriate sample handling and storage 
is necessary, with the recovery rate of Mycoplasma spp. decreasing with increased time to 
processing. As such, samples must be stored at 4 ᵒC and cultured as soon as possible to avoid 
potential false negative results (Maunsell et al., 2011). An extended interval from sampling to 
determination of results can also be an issue for producers who have submitted samples for 
mycoplasma culture. Due to the highly contagious nature of the pathogen and the impact it can 
have within a herd, it is important to receive diagnostic results quickly so that the infected 
animals can be removed from the herd to minimize spread (Fox, 2012). Lastly, culture also 
allows the growth of Acholeplasma species which are often isolated alongside Mycoplasma 
species however are not considered to be pathogenic (Ayling et al., 2004). Differentiating 
Acholeplasma from Mycoplasma species of interest is very difficult by culture as they both 
present with ‘fried egg’ colony morphology (McVey et al., 2013). While Acholeplasma species 
can be distinguished using biochemical tests, results can be subjective and as such difficult to 
determine (Boonyayatra et al., 2012b). This can result in the reporting of false mycoplasma 
positive samples. Therefore positive cultures should be followed up with PCR to identify the 
species grown to ensure an accurate diagnosis. 
In recent years, PCR has become a common method for Mycoplasma spp. diagnosis. Several 
Pan-mycoplasma PCRs have been developed to detect Mycoplasma spp. (Tang et al., 2000, 
Justice-Allen et al., 2011). Due to M. bovis being the most commonly isolated species, numerous 
M. bovis specific probe based PCRs have also been developed to increase specificity (Clothier et 
al., 2010, Rossetti et al., 2010, Boonyayatra et al., 2012a). Diagnosis by PCR is a much more 
rapid method, with a turnaround of 1-2 days, however it does often incur a higher cost compared 
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to culture. Due to PCR identifying the DNA of the target organism, viability of the organism and 
as such sample handling and storage conditions are of less importance. The introduction of PCR 
has also allowed the successful identification of Mycoplasma spp. with no amplification of 
Acholeplasma spp. observed (Gonzalez et al., 1995, Subramaniam et al., 1998, Boonyayatra et 
al., 2012b), minimizing the risk of false positive observations due to a lack of specificity.  
Commonly, PCR is performed directly on the sample following DNA extraction. Given the 
clinical nature of mycoplasma in the dairy industry, the most common bovine sample type for 
Mycoplasma spp. diagnosis is milk. Several studies have developed effective DNA extraction 
protocols for milk samples, with a detection limit as low as 10
2
 cfu/mL being reported for M. 
bovis PCR assays (Clothier et al., 2010, Sachse et al., 2010). However, few studies have 
investigated extraction methods and the limit of detection of mycoplasma in other sample types, 
or for other important Mycoplasma species. Therefore the objective of this study was to develop 
a real-time multiplex PCR assay to detect three important Mycoplasma species, M. bovis, M. 
californicum and M. bovigenitalium, and evaluate its analytical performance with traditional 
culture of bovine milk, semen and swab samples.  
3.3 Material and methods 
3.3.1 Multiplex probe PCR 
A species specific multiplex probe PCR assay modified from Clothier et al. (2010) and 
Boonyayatra et al. (2012a) was developed and optimized targeting M. bovis, M. californicum and 
M. bovigenitalium. Reaction mixtures consisted of 0.5 mM of dNTPs, 5 mM of MgCl2, 0.5 U 
GoTaq polymerase, 1 µM of each primer set, 0.25 µM of each probe, 2.0 µL of 5x Buffer and 2 
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µL of DNA template in a final volume of 10 µL. Cycling conditions were 95 ᵒC for 60 s, 
followed by 40 cycles of 9 5ᵒC for 30 s, 60 ᵒC for 30 s and 72 ᵒC for 30 s (Parker et al., 2016). 
The assay was performed on a RotorGene
TM
 3000 RT-PCR System Thermocycler using the 
green, yellow and orange channels for M. bovis, M. californicum and M. bovigenitalium 
respectively (QIAGEN Pty Ltd, Chadstone Centre, VIC, Australia). Acquisition of the data 
occurred during the 72 ᵒC extension step. Each PCR run contained a no template control (DNA-
free water) and a positive control for each targeted Mycoplasma species including field strain M. 
bovis 07-249, M. californicum 08-2152 and M. bovigenitalium 12-1511. To validate DNA 
extractions from bovine samples, a separate ‘in-house’ developed control PCR assay targeting 
Bos Taurus mitochondrial cytochrome B gene was also used with the same reaction mixture, 
cycling conditions and instrument. Each PCR run contained a no template control (DNA-free 
water) and a positive Bos Taurus control from DNA extracted from bovine milk. All samples 
were run in triplicate reactions for the mycoplasma assay and in single reactions for the Bos 
Taurus assay, and were considered positive if a cycle threshold (Ct) <40 was achieved. Primer 
and probe sequences are shown in Table 3.1. 
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Table 3.1. Primer and probe sequences used for multiplex probe PCR and culture speciation (Parket et al., 
2016) 
Name Sequence Target 
MbovF 5’-TCTAATTTTTTCATCATCGCTAATGC-3’ 
uvrC gene of Mycoplasma bovis (GenBank accession 
no. AF003959) (Clothier et al., 2010) 
MbovR 5’-TCAGGCCTTTGCTACAATGAAC-3’ 
MbovP 
5’-FAM-AACTGCATCATATCACATACT-BHQ-1-
3’ 
McalF 5’-GCACTTAGACGAAAGAGGGATT-3’ 
rpoB gene of Mycoplasma californicum (no accession 
no. provided) (Boonyayatra et al., 2012) 
McalR 5’-GGATTATCATCACCTTTGGGACT-3’ 
McalP 
5’-CAL Fluor Orange 560-
CGTGTTGGTTCGGAAGTGGTTCCAG-BHQ-1-3’ 
MbvgF 5’-CTTTCTACGGAGTACAAAGCTAAT-3’ 
16S-23S rRNA intergenic spacer region of 
Mycoplasma bovigenitalium (no accession no. 
provided) (Boonyayatra et al., 2012) 
MbvgR 5’-GAGAGAATTGTTCYCTCAAAACTA-3’ 
MbvgP 
5’-CAL Fluor Red 610- 
TATCGTCATGGCTTGGTTAGGTCCCA-BHQ-2-
3’ 
CytbF 5’-GAGGCGGATTCTCAGTAGACAAAG-3’ 
Bos Taurus Mitochondrial Cytochrom B gene 
(Genbank accession no. GQ358783.1) 
CytbR 5’-GAGCCTGTTTCGTGGAGGAATA-3’ 
CytbP 
5’-CAL Fluor Orange 560 – 
CCCTTACCCGATTCTTCGCTTTCCA – BHQ-1-3’ 
MycoF  5’- GGGGATGGATTACCTCCTTT -3’ 16S-23S rRNA intergenic spacer region of 
Mycoplasma spp. –‘in-house’ (GenBank accession no. 
AY729934) (adapted from Tang et al. (2000)) 
MycoR  5’- TTCCAGACCCAGGCATC -3’ 
    
 
3.3.2 PCR analytical specificity 
For determining the analytical specificity of the multiplex PCR probe assay, 29 Mollicutes and 
10 other eubacterial isolates were used (Table 3.2). These were obtained from field samples 
submitted to the Livestock Veterinary Teaching and Research Unit Milk Quality Laboratory, 
Faculty of Veterinary Science at the University of Sydney (USYD, Camden, NSW, Australia), 
from the American Type Culture Collection (ATCC, Manassas, VA, USA), or from the 
International Organization for Mycoplasmology (IOM, Towson, MD, USA). 
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3.3.3 DNA extraction 
For DNA extractions on swab samples, the swab was removed from its Amies transport medium 
(FL Medical FL26068) and the tip cut off into 400 µL of sterile PBS in a 1.5 mL Eppendorf tube 
using heat sterilized forceps. Following thorough vortexing, 200 µL of the PBS solution was 
transferred into a fresh 1.5 mL Eppendorf tube from which the DNA extraction process was 
continued using the DNeasy® Blood and Tissue kit (QIAGEN Pty Ltd, Chadstone Centre, VIC, 
Australia) following manufacturer’s instructions for Purification of Total DNA from Animal 
Tissues (Spin-Column Protocol).  
For DNA extractions on semen, 200 µL of semen was combined with 200 µL of 2% Triton X 
100 (Sigma Aldrich 23472-9) in TE Buffer (pH8) (Amresco E112). The sample was thoroughly 
vortexed followed by centrifugation at 13,000 x g for 5 min and discarding of the supernatant. 
The DNA extraction process was then continued on the remaining pellet using the DNeasy® 
Blood and Tissue kit (QIAGEN Pty Ltd, Chadstone Centre, VIC, Australia) following 
manufacturer’s instructions for Purification of Total DNA from Animal Tissues (Spin-Column 
Protocol), with centrifuge times increased to 3 min. 
For DNA extractions on milk samples, 1 mL of milk was centrifuged at 13,000 x g for 5 min 
followed by the removal of fat and supernatant. The remaining pellet was resuspended in 90 µL 
of Buffer ATL (QIAGEN Pty Ltd, Chadstone Centre, VIC, Australia) and 10 µL of Proteinase K 
(QIAGEN Pty Ltd) and incubated at 56 ᵒC for 1-3 h with occasional vortexing. The DNA 
extraction process was then continued using the BioSprint® 96 One-For-All Vet kit (QIAGEN 
Pty Ltd) following manufacturer’s instructions for purification of viral nucleic acids and bacterial 
DNA from animal tissue homogenates, serum, plasma, other body fluids, swabs and washes. 
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Each extraction plate included a blank containing sterile PBS which was run on the PCR as 
extraction blanks.  
3.3.4 PCR limit of detection 
The limit of detection of the multiplex PCR was determined for swabs, semen and milk sample 
types. This was first done with a single target Mycoplasma species present per sample, and then 
with all three target species present per sample. Broth cultures from control field isolates M. 
bovis 07-249, M. californicum 08-2152 and M. bovigenitalium 12-1511 were used for spiking 
samples (data not shown). The highest concentration grown in broth for each species was used 
for spiking samples for both a single target species present per sample, and with all three target 
species present per sample. For each dilution, three extractions were performed to give three 
extraction series which including a negative control (non-spiked sample). Each extraction series 
was evaluated on a separate PCR run (between-run precision). Each extraction was evaluated in 
three replicates (within-run precision). This gave a total of nine replicates across three PCR runs 
for each dilution. The limit of detection was determined as the lowest concentration when nine 
out of the nine replicates across three PCR runs were positive for a given dilution. 
For swabs, broth culture was spiked into sterile PBS and a 10 fold serial dilution series 
performed with sterile PBS. For each concentration, a swab (FL Medical FL26068) was removed 
from its casing, swirled in the spiked PBS, and then inserted into its Amies transport medium. 
For semen, broth culture was spiked into pooled semen from bulls which were culture negative 
for mycoplasma, and a 10 fold serial dilution series performed with the semen. For milk, broth 
culture was spiked into a bulk tank milk (BTM) sample which was culture negative for 
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mycoplasma, and a 10-fold serial dilution series performed with the milk. DNA extractions were 
performed as previously described. 
3.3.5 Mycoplasma culturing 
All bovine field samples were inoculated onto Mycoplasma agar [Mycoplasma agar base (Oxoid 
CM0401); Milli-Q water; 0.2 % w/v calf thymus DNA (Sigma D1501); Mycoplasma Selective 
Supplement G (Oxoid SR0059C); prepared by Elizabeth Macarthur Agricultural Institute 
(EMAI); NSW Department of Primary Industries, NSW, Australia] and incubated at 37 ᵒC in 
candle jars in elevated CO2 levels for 5 to 10 days. Following positive mycoplasma growth, 
several colonies from each sample were selected and placed in PBS for speciation by an ‘in 
house’ developed universal Mycoplasma spp. conventional PCR assay modified from Tang et al. 
(2000). Reaction mixtures contained 0.25 mM dNTPs, 2.5 mM MgCl2, 1.5 U of GoTaq, 0.25 µM 
of each primer (Table 3.1), 8 µL of 5x Buffer and 5 µL DNA template in a final volume of 40 
µL. Cycling conditions were 94 ᵒC for 5 min, followed by 35 cycles of 94 ᵒC for 30 s, 55 ᵒC for 
30 s, 72 ᵒC for 1 min, and a final extension of 72ᵒC for 5 min (Parker et al., 2016). The assay was 
performed on a Bio-Rad-T100 Thermocycler (Bio-Rad Laboratories Pty Ltd, Gladesville, NSW, 
Australia). The PCR products from this assay were then speciated via Sanger Sequencing 
(Australian Genome Research Facility Ltd, Sydney, NSW, Australia). 
3.3.6 Bovine field samples 
A set of 474 field samples from bovine sources submitted to the Livestock Veterinary Teaching 
and Research Unit Milk Quality Laboratory, Faculty of Veterinary Science at the University of 
Sydney (USYD), were selected for analysis. All animal sample collection was approved by The 
University of Sydney Animal Ethics Committee (protocol number 2013/6046). All samples were 
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cultured and speciated for mycoplasma upon arrival as previously described, followed by 
freezing of the samples at -20 ᵒC. Samples were stored at -20 ᵒC for a range of 5 days to 3 years 
prior to DNA extraction and PCR analysis. To validate the PCR against culture, the following 
sample types were chosen. All culture positive samples chosen had been previously speciated as 
M. bovis, M. californicum or M. bovigenitalium as previously described.  
 Swab samples (n=95) including vaginal, preputial, nose and eye: 48 culture negative and 
47 culture positive samples 
 Semen samples (n=44): 22 culture negative and 22 culture positive samples 
 Individual milk samples (n=114): 57 culture negative and 57 culture positive samples 
 Bulk Tank Milk (BTM) samples (n=221): not chosen based on culture results but rather 
by what was available in storage  
All swab, semen and individual milk samples were collected from animals from dairy herds with 
a history of clinical mycoplasma-associated disease diagnosed by culture or PCR within the 
previous 2 years of sample collection. Of the 221 BTM samples, 215 were from dairy herds with 
a history of clinical mycoplasma-associated disease diagnosed by culture or PCR within the 
previous 2 years of sample collection, and 6 were from dairy herds with no clinical signs of 
mycoplasma-associated disease within the last 5 years of sample collection. 
3.3.7 Statistical analysis 
Each bovine sample was classified as either positive or negative by culture and multiplex probe 
PCR. Samples were further classified as either ≥ 2 species identified or < 2 species identified. 
Statistical analysis using a two-sample binomial test of proportions and the Kappa coefficient 
(Genstat 16
th
 Edition, VSN International, UK) was then performed separately for each 
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classification method. The level of agreement between culture and PCR was calculated as the 
percentage of samples which had the same result for both tests. This was performed both 
individually for each sample type, as well as a whole on all samples. Statistical significance was 
declared at P <0.05. 
3.4 Results 
3.4.1 PCR specificity and limit of detection 
Specificity results are shown in Table 3.2. All M. bovis, M. californicum and M. bovigenitalium 
isolates produced appropriate amplification. Amplification was not seen for any of the other 
Mollicutes or eubacterial isolates. The limit of detection concentration (mean Ct ± SE) for each 
species in different sample types is shown in Table 3.3. For all three species, the limit of 
detection was best in milk samples, followed by semen samples and swab samples. Overall, the 
species M. californicum had the best limit of detection, followed by M. bovis and M. 
bovigenitalium. When all three species were present per sample, the limit of detection was poorer 
for all species in all sample types. In semen and swab samples, when all three species were 
present per sample, M. bovigenitalium was not detectable at the highest concentration.  
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Table 3.2. Mollicute and other bacterial species used for testing analytical specificity of the multiplex 
probe PCR assay 
    Multiplex Probe PCR 
Organism Lab ID M. bovis M. californicum M. bovigenitalium 
Mycoplasma bovis USYD 07-249  +  -  - 
Mycoplasma bovis ATCC® 25523  +  -  - 
Mycoplasma bovis USYD 339  +  -  - 
Mycoplasma bovis USYD 582  +  -  - 
Mycoplasma californicum USYD 08-2152  -  +  - 
Mycoplasma californicum USYD DA13-10900   -  +  - 
Mycoplasma californicum USYD DA14-1.1470   -  +  - 
Mycoplasma californicum USYD DA14-1526   -  +  - 
Mycoplasma californicum USYD DA14-1554   -  +  - 
Mycoplasma bovigenitalium USYD 12-1511  -  -  + 
Mycoplasma bovigenitalium USYD DA14-3784   -  -  + 
Mycoplasma bovigenitalium USYD DA14-3806   -  -  + 
Mycoplasma bovigenitalium USYD DA14-995   -  -  + 
Mycoplasma bovirhinis USYD DA13-3.5005  -  -  - 
Mycoplasma bovirhinis USYD DA13-3.5011  -  -  - 
Mycoplasma bovoculi USYD DA13-8470  -  -  - 
Mycoplasma bovoculi USYD DA13-3.9238  -  -  - 
Acholeplasma granularum USYD DA14-4688   -  -  - 
Acholeplasma granularum USYD DA14-6019   -  -  - 
Acholeplasma granularum USYD DA14-6301   -  -  - 
Acholeplasma laidlawii USYD DA14-3.3033  -  -  - 
Mycoplasma zaradii USYD DA14-3.2996  -  -  - 
Mycoplasma zaradii USYD DA13-1.6828  -  -  - 
Mycoplasma zaradii USYD DA13-1.6838  -  -  - 
Mycoplasma dispar ATCC® 27140  -  -  - 
Mycoplasma agalactiae IOM PG2  -  -  - 
Mycoplasma alkalescens  IOM D12  -  -  - 
Mycoplasma Leachii  IOM PG50  -  -  - 
Mycoplasma mycoides subsp. 
capri  IOM PG3 
 -  -  - 
Nocardia spp. USYD Nocardia  -  -  - 
Staphylococcus aureus USYD S.aureus  -  -  - 
Staphylococcus aureus ATCC 25923  -  -  - 
Streptococcus agalactiae USYD Strep ag  -  -  - 
Streptococcus uberis USYD Strep ub  -  -  - 
Streptococcus dysgalactiae 
USYD Strep dysgalactiae 
100 
 -  -  - 
Enterrococcus faecalis USYD E.faecalis  -  -  - 
Escherichia coli USYD E.coli  -  -  - 
Corynebacterium spp. USYD Corynebacterium 931  -  -  - 
Klebsiella spp. USYD Klebsiella  -  -  - 
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Table 3.3. Multiplex probe PCR limit of detection (cfu/mL) and associated mean cycle threshold (±SE) 
for different spiked sample types. Single target species present per sample (A) and multiple target species 
present per sample (B) and the concentration of each target species in the sample at the limit of detection 
(read from left to right).  
 
 
Concentration of Mycoplasma species in sample 
(cfu/mL) 
A. Single species per sample 
 
M. bovis M. californicum M. bovigenitalium
c 
Milk 
M. bovis  
(CT ± SE) 
1.3 x 10
2
  
(35.0 ± 0.1) 
0 0 
M. californicum  
(Ct ± SE) 
0 
6 x 10
2
  
(31.8 ± 0.7) 
0 
M. bovigenitalium  
(CT ± SE) 
0 0 
5 x 10
5
  
(28.8 ± 0.2) 
Semen 
M. bovis 
 (Ct ± SE) 
1.3 x 10
5 
(30.8 ± 0.7) 
0 0 
M. californicum  
(CT ± SE) 
0 
6 x 10
4
  
(31.1 ± 0.6) 
0 
M. bovigenitalium 
 (CT ± SE) 
0 0 
1.4 x 10
7
  
(24.6 ± 0.7) 
Swabs 
M. bovis  
(CT ± SE) 
1.3 x 10
6
  
(31.3 ± 1.2) 
0 0 
M. californicum 
 (CT ± SE) 
0 
6 x 10
4
  
(33.5 ± 1.9) 
0 
M. bovigenitalium  
(CT ± SE) 
0 0 
1.4 x 10
7
  
(32.0 ± 1.0) 
     
  
Concentration of Mycoplasma species in sample 
(cfu/mL) 
B. Multiple species per sample 
 
M. bovis M. californicum M. bovigenitalium
c 
Milk 
M. bovis  
(CT ± SE) 
1.3 x 10
5
  
(30.2 ± 0.03) 
6 x 10
3
 5 x 10
4
 
M. californicum 
 (CT ± SE) 
1.3 x 10
6
 
6 x 10
4
  
(29.9 ± 0.9) 
5 x 10
5
 
M. bovigenitalium
a 
 (CT ± SE) 
1.3 x 10
8
 6 x 10
6
 
5 x 10
7
  
(34.7 ± 2.0) 
Semen 
M. bovis 
 (CT ± SE) 
1.3 x 10
7
  
(27.7 ± 1.1) 
6 x 10
5
 1.4 x 10
6
 
M. californicum  
(CT ± SE) 
1.3 x 10
7
 
6 x 10
5
  
(33.0 ± 0.6) 
1.4 x 10
6
 
M. bovigenitalium
b
  
(CT ± SE) 
1.3x10
8
 6x10
6
 1.4x10
7
 
Swabs 
M. bovis 
 (CT ± SE) 
1.3 x 10
7
  
(28.2 ± 0.4) 
6 x 10
5
 1.4 x 10
6
 
M. californicum 
 (CT ± SE) 
1.3 x 10
7
 
6 x 10
5 
 (33.3 ± 1.6) 
1.4 x 10
6
 
M. bovigenitalium
b
  
(CT ± SE) 
1.3 x 10
8
 6 x 10
6
 1.4 x 10
7
 
a 
only seven out of nine replicates were positive across three PCR runs at the highest concentration tested 
b
 PCR could not detect M. bovigenitalium in semen or swabs when multiple Mycoplasma species were present. Values 
given are the highest concentrations tested.  
c
The concentration of M. bovigenitalium differs between spiked milk, and spiked semen and swabs due to a different 
culture with a different initial concentration being used in the different experiments. 
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3.4.2 Bovine Samples 
Results for classification of samples as either negative or positive by culture and PCR are shown 
in Table 3.4. When analysing all bovine samples (n=474), 27 % (n=130) were culture positive 
and 23 % (n=111) were PCR positive, with culture and PCR results in agreement for 90% 
(n=425) of samples and having a Kappa coefficient of 0.73. No significant difference was 
observed between the proportion of culture positive and PCR positive samples (P=0.156). Of the 
samples which were culture and PCR positive (n=96), a disagreement in species identification 
was observed in seven samples (excluding multiple species identification). These included two 
swabs and five semen samples, all of which were identified as M. bovigenitalium by the culture 
method, but M. californicum by the multiplex probe PCR method.  
Table 3.4. Comparison of culture and multiplex PCR for detecting bovine field samples as positive or 
negative for M. bovis, M. californicum or M. bovigenitalium. 
 
bovine sample Culture + PCR + P value Level of Agreement
a 
Kappa 
All (n=474) 27 % (n=130) 23 % (n=111) 0.156 90 % (n=425) 0.73 
swabs (n=95) 49 % (n=47) 24 % (n=23) < 0.001 75 % (n=71) 0.49 
semen (n=44) 50 % (n=22) 50 % (n=22) 1.00 73 % (n=32) 0.46 
individual milk (n=114) 50 % (n=57) 48 % (n=55) 0.791 98 % (n=112) 0.97 
BTM (n=221) 2 % (n=4) 5 % (n=11) 0.066 95 % (n=210) 0.25 
a 
percentage of samples which had the same culture and PCR result 
Of the 95 swab samples, 49 % (n=47) were culture positive while only 24 % (n=23) were found 
to be PCR positive with a significant difference observed (P < 0.001), a test result agreement of 
just 75 % (n=71) and a Kappa coefficient of 0.49. All 24 swab samples which were not in 
agreement were identified as M. bovis or M. bovigenitalium by culture, and negative by 
multiplex probe PCR. Of the culture positive swabs, 32 % (n=15) had less than six colonies of 
growth on agar (data not shown), none of which were detected as positive by PCR.  
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Of the 44 semen samples, 50 % (n=22) were culture positive and 50 % (n=22) were PCR 
positive, with no significant difference observed (P=1.00), a test result agreement of 73 % (n=32) 
and a Kappa coefficient of 0.46. Of the 12 semen samples which were not in agreement, six were 
identified as M. bovigenitalium by culture but negative by multiplex probe PCR, and six were 
identified as negative by culture but M. californicum, M. bovigenitalium, or both by multiplex 
PCR. 
For individual milk samples (n=114), 50 % (n=57) were culture positive while 48 % (n=55) were 
PCR positive, with no significant difference observed (P=0.791), a test result agreement of 98 % 
(n=112) and Kappa coefficient of 0.97. Both individual milk samples which were not in 
agreement were identified as M. bovis by culture and negative by multiplex probe PCR.  
Analysis of BTM samples (n=221) found only 2 % (n=4) of samples to be culture positive while 
5% (n=11) of samples were PCR positive, with a no significant difference observed (P=0.066), a 
test result agreement of 95 % (n=209) and a Kappa coefficient of 0.25. Of the 11 BTM samples 
which were not in agreement, two were identified as M. bovis by culture and negative by 
multiplex probe PCR, and 9 were identified as negative by culture but M. bovis or M. 
californicum by multiplex probe PCR. 
For the identification of multiple species per sample, when analysing all the sample types 
(n=474) culture followed by 16S-23S rRNA sequencing of colonies did not identify any samples 
as having ≥2 species. However PCR did identify significantly more multiple species per samples 
with 1% (n=5) of samples having two species present (P=0.025; Kappa=0). Three of these were 
from individual milk samples which all contained M. bovis and M. californicum as identified by 
the multiplex probe PCR. All three samples were culture positive for M. bovis only. The 
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remaining two samples were from a swab (vaginal) and a semen sample which both contained M. 
californicum and M. bovigenitalium as identified by the multiplex probe PCR. The swab sample 
was culture positive for M. bovigenitalium only, while the semen sample was negative on 
culture.  
3.5 Discussion 
The multiplex probe PCR limit of detection for M. bovis, M. californicum and M. bovigenitalium 
was investigated for milk, semen and swab samples. Only a single field isolate was used for each 
target species, and therefore the effect of inter-isolate variation was not assessed, however these 
results provide a guide to the expected limit of detection. Using the described extraction 
methods, the PCR limit of detection in milk for M. bovis and M. californicum was approximately 
1.3 x 10
3 
cfu/mL and 6 x 10
2
 cfu/mL respectively. This is comparable to previous studies which 
have reported the limit of detection of Mycoplasma spp. in milk to be approximately 10
2
 cfu/mL 
following DNA extractions on inoculated milk samples, and analysis by probe based PCR 
(Clothier et al., 2010, Rossetti et al., 2010) and conventional endpoint PCR (Hirose et al., 2001). 
For M. bovigenitalium the limit of detection in milk at 5 x 10
5
 cfu/mL was higher than for the 
same previously published studies. However of the three target species, M. bovigenitalium is 
potentially of less concern in milk since its role in causing mastitis is debatable although this has 
not been fully explored. The average rate of shedding of Mycoplasma spp. from animals with 
clinical mastitis is 10
8 
cfu/mL, and is reduced to10
6 
cfu/mL or less in sub-clinically infected 
animals (Byrne et al., 2005, Sachse et al., 2010). As such, detection of clinically infected animals 
would be possible for all target species, with a strong possibility for the detection of many sub-
clinical shedders.  
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When comparing culture and multiplex probe PCR, individual milk samples and BTM samples 
had the highest level of agreement of 98 % and 95 % respectively. BTM samples were the only 
sample type to have more samples identified as positive by multiplex probe PCR (n=11) than by 
culture (n=4), with the difference approaching significance (P=0.066). This is an important 
finding given that BTM is the recommended sample type for biosecurity screening and 
monitoring Mycoplasma spp. activity at the herd level (Fox, 2012, Dairy Australia Limited, 
2014), with several studies using BTM as a surveillance tool to identify herd level prevalence 
(Higuchi et al., 2011, Justice-Allen et al., 2011).  
The limit of detection and Ct values achieved at each dilution were higher in semen and swabs 
compared to milk for all three target species. For semen, this may be due to the complex nature 
of the sample type, which contains a very high level of DNA and protein, potassium ions, citric 
acid and fructose (Cole and Cupps, 2013). Bull semen samples also often contain environmental 
contamination, which can also inhibit the PCR reaction despite a thorough DNA extraction 
process (Schrader et al., 2012). This can cause a reduction in PCR efficiency, resulting in higher 
limits of detection and Ct values. Little work has been done on developing PCR assays to detect 
Mycoplasma species in bull semen, and the concentration of Mycoplasma species in naturally 
infected bull semen has not been investigated. Therefore comparisons between the limit of 
detection in semen cannot be made with previous studies. One study investigating the effects of 
inoculated bull semen on fertilization and embryo development suggested that 10
6
 and 10
4
 
cfu/mL were high and low concentrations respectively for both M. bovis and M. bovigenitalium 
(Bielanski et al., 2000). At these levels detection by the multiplex probe PCR would be possible 
for M. bovis and M. californicum, however questionable for M. bovigenitalium.  
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Previous studies have suggested bulls may play a role in Mycoplasma spp. dissemination via 
semen through both natural mating and artificial insemination (Fish et al., 1985, Petit et al., 
2008). In vitro studies have demonstrated that M. bovis and M. bovigenitalium in inoculated 
semen can be transmitted and infect embryos via in vitro fertilization (Bielanski et al., 2000). 
Associations have been demonstrated between the isolation of M. bovis and M. bovigenitalium 
from cows and reproductive disease including dystocia, endometritis and abortion (Hermeyer et 
al., 2012, Ghanem et al., 2013). As such, identifying and developing the best method of detecting 
Mycoplasma spp. in semen is of value. When analysing bovine semen samples by culture and 
multiplex probe PCR, the level of agreement was only 73 %, however equal numbers of samples 
were identified as positive by culture (n=22) and PCR (n=22). The multiplex probe PCR was 
unable to identify six culture positive samples, all of which were M. bovigenitalium. This may be 
due to the poorer limit of detection of M. bovigenitalium compared to the other target species. 
However the multiplex probe PCR was able to positively identify six samples which culture 
could not, all of which were M. bovigenitalium (n=2), M. californicum (n=3), or both (n=1). The 
inability of culture to positively identify these semen samples may be due to sample storage or 
contamination which may have prevented the growth or identification of Mycoplasma spp. on 
agar; a recognized limitation of traditional culture. As all of these semen samples were M. 
californicum or M. bovigenitalium, an additional explanation could be that the agar media used 
may not support the growth of these species in a comparable manner to its support of M. bovis 
growth.  
Swabs from mucosal surfaces can be used for identifying clinically and sub-clinically infected 
animals, with Mycoplasma spp. able to be isolated from the eye, nasal cavity, ear and vagina of 
dry and lactating cows, heifers and calves following an outbreak (Bennett and Jasper, 1977, 
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Biddle et al., 2005, Punyapornwithaya et al., 2010). As such, swabs from mucosal surfaces may 
be a useful sample type when screening for Mycoplasma spp. in the event that milk samples are 
not available (e.g. non lactating stock). In this study, the limit of detection from swabs (vaginal, 
preputial, nose and eye) was higher than milk and semen for all three species, however it was 
representative of the bacterial concentration in the solution in which the swabs were dipped into. 
As swabs only hold approximately 10 µL of liquid, the actual amount of organism present on the 
swab is likely to be at least 100 fold less than the concentration of the solution. Therefore the 
limit of detection is comparable with previous studies which could detect mycoplasma in spiked 
nasal swabs down to 2 x 10
3
 cfu (Kobayashi et al., 1998).  
When comparing culture and multiplex probe PCR, significantly more swab samples were 
identified as positive by culture (n=47) than by multiplex probe PCR (n=23) with an agreement 
of 75 %. However this may have been due to the sample analysis procedure itself with all swabs 
first being inoculated onto Mycoplasma agar before PCR extractions were performed. 
Consequently the inoculation process would have removed some DNA from the swab, with less 
available for the extraction process. This theory is supported by the fact that 32 % of the culture 
positive swabs grew less than six Mycoplasma spp. colonies on agar. While duplicate swabs 
samples could have been taken to help avoid this limitation, it could not be ensured that equal 
quantities of organism would be present on duplicate swabs in order to make an equal 
comparison. In a diagnostic situation, it is unlikely that both culture and DNA extraction 
followed by PCR would be performed on the same sample, but rather one method employed and 
so loss of DNA would not occur from the swab prior to processing to the same extent as occurred 
here.  
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When all three target species were present within a sample, the limit of detection increased by 10 
to 1000 fold, and the Ct values achieved at each dilution increased, for all species in all sample 
types. This may be due to competition for reagents to amplify multiple species within the PCR, 
causing a reduction in the PCR efficiency. The degree of change in the limit of detection may 
also be dependent on the concentrations of M. bovis, M. californicum and M. bovigenitalium in 
the sample, which was not fully investigated. For M. bovigenitalium, detection was not possible 
in semen and swab samples when M. bovis and M. californicum were also present in high 
concentrations and this would need to be taken into consideration when interpreting results. 
However, this also may be dependent on the concentration of M. bovis or M. californicum in the 
sample, as several swab samples were identified as containing M. bovigenitalium and M. 
californicum by multiplex probe PCR. Therefore while a multiplex probe PCR may allow 
benefits of identifying three Mycoplasma species in the one reaction, greater efficiency and a 
reduction in reagent use, the limit of detection may be sacrificed if all three species are present in 
the one sample. Previous studies have identified the presence of two Mycoplasma species in 
single bulk tank milk samples (Justice-Allen et al., 2011, Boonyayatra et al., 2012a), however 
greater than three species in a single sample is rarely reported. Therefore this limitation may not 
prove to be an issue. 
Of the samples analyzed, culture followed by 16S-23S rRNA sequencing of colonies was not 
able to identify more than one species present from agar growth, while the multiplex probe PCR 
was able to identify five samples as having two species. All five samples were identified by 
multiplex probe PCR as both M. bovis and M. californicum (n=3), or M. californicum and M. 
bovigenitalium (n=2). The inability of culture to identify more than one species may be due to 
the speciation technique, which involved several colonies of growth being selected for 16S-23S 
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rRNA PCR and sequencing from among potentially many colonies on a plate. This could have 
resulted in one of the species not being selected. However, it is also possible that one of the 
species did not grow on the plate despite being present in the sample due to overgrowth by more 
competent, faster growing or more numerous Mycoplasma species, or due to variations in media 
suitability between species. By performing extractions on the original sample followed by 
multiplex probe PCR, there may be a greater representation of the actual species present in the 
sample, without inadvertently selecting for certain species that can occur via culture.  
3.6 Conclusion 
This study evaluated the analytical performance of a single multiplex probe PCR assay against 
traditional culture for the detection of M. bovis, M. californicum and M. bovigenitalium in bovine 
milk, semen and swab samples. For multiplex probe PCR specificity, all M. bovis, M. 
californicum and M. bovigenitalium isolates produced appropriate amplification. Amplification 
was not seen for any of the other Mollicutes or eubacterial isolates. The limit of detection for the 
multiplex probe PCR was best in spiked milk samples, followed by semen and swab samples. 
When all three Mycoplasma species were present in spiked samples, the limit of detection 
increased by 10 to 1000 fold for all species in all sample types. M. bovigenitalium had the 
poorest limit of detection for all sample types and was not able to be identified in semen or swab 
samples when all three Mycoplasma species were present. Overall, when comparing culture and 
multiplex probe PCR, there was no significant difference in the proportion of culture and PCR 
positive field samples for all sample types. However individually, culture could detect 
significantly more positive swab samples. No significant differences were identified for semen, 
individual milk samples or BTM samples. For the identification of multiple species per sample, 
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multiplex probe PCR identified five samples with two species present however the culture 
method did not enable identification of more than one species. Therefore the method of choice 
for identification of M. bovis, M. californicum and M. bovigenitalium in bovine samples may 
involve consideration of the sample type being analyzed, and whether the identification of 
multiple target species is required. 
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4.1 Abstract 
In Australia, one of the biosecurity recommendations to assist in preventing the introduction of 
Mycoplasma bovis into a dairy herd is to utilize a PCR assay on bulk tank milk samples to 
evaluate the M. bovis infection status of potential source herds. An alternative approach is to 
assess the immunological status of the herd with respect to previous exposure to M. bovis via the 
use of an ELISA which is commercially available for use on cattle milk and serum. The 
objectives of this study were to: (1) evaluate factors potentially associated with variation in the 
ELISA bulk tank milk (BTM) optical density coefficient (ODC%) in previously exposed herds; 
(2) evaluate the association between the proportion of cows that are ELISA positive and the 
BTM ELISA ODC%; (3) assess agreement between the BTM ELISA and PCR and culture; and 
(4) compare BTM ELISA ODC% between the ‘hospital’ herd and the main lactating herd on the 
same farm.  
Bulk tank milk samples (n=192) were collected from 19 dairy herds with a history of clinical M. 
bovis disease and from six control herds (herds with no known clinical cases of mycoplasmosis). 
For 28 of the BTM samples collected, blood was also collected from 50 lactating cows 
contributing to that bulk tank sample. From one herd, concurrent paired BTM samples were 
collected from the main herd and the ‘hospital’ herd on 16 occasions. All BTM samples were 
analysed by ELISA (Bio-X Bio K 302, Bio-X Diagnostics, Rochefort, Belgium), PCR and 
culture.  
The BTM ELISA ODC% was associated with time since initial M. bovis outbreak and time since 
the start of the herd's calving period. Following an initial outbreak of M. bovis, the BTM ELISA 
ODC% was highest in the first 8 months. In split and seasonal calving herds, significantly higher 
173 
 
BTM ELISA ODC% results were observed 5-8 weeks following the commencement of the 
calving period. A significant association was observed between the within-herd seroprevalence 
for the lactating herd and BTM ELISA ODC% but within-herd seroprevalence explained little of 
the variation in BTM ELISA ODC%. When comparing the BTM ELISA with a multiplex probe 
PCR and culture followed by 16S-23S rRNA sequencing, there was virtually no agreement 
above that expected by chance; Prevalence-adjusted bias-adjusted kappa (PABAK) values were 
0.22 (95% CI 0.08 to 0.36) and 0.25 (95% CI 0.11 to 0.39) for ELISA category versus each of 
PCR category and culture, respectively. Finally, the ‘hospital’ herd BTM ELISA ODC% 
mirrored that for the main herd BTM but was significantly higher. This study demonstrates that 
this commercially available ELISA used on BTM samples may complement the use of BTM 
PCR or culture in identifying herds from which purchase of animals may pose a higher 
biosecurity risk for introduction of M. bovis into non-infected herds. 
4.2 Introduction 
Mycoplasma bovis is one of the most pathogenic species of Mycoplasma in cattle, causing 
significant economic losses in infected herds worldwide (Nicholas, 2011). In adults, clinical 
signs are predominantly associated with mastitis and arthritis, while in young calves signs 
include otitis media, arthritis and pneumonia (Maunsell et al., 2011). Mycoplasma bovis was first 
isolated in Australia in 1970 (Cottew, 1970). However in recent years there has been an increase 
in the number of outbreaks detected within the Australian dairy industry, and strategies are 
needed to curb the spread of this pathogen throughout the industry. Mycoplasma bovis is a highly 
contagious pathogen that is refractory to antimicrobials registered for treatment of lactating dairy 
cattle (Dairy Australia Limited, 2014).  This, in conjunction with the role of subclinical carrier 
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animals, makes elimination of the pathogen from a herd very difficult (Maunsell et al., 2011). As 
a result, a large focus should be placed on biosecurity measures to prevent the introduction of 
M.bovis into a herd, and on controlling clinical M. bovis disease if a herd becomes infected. 
Bulk tank milk (BTM) samples are quick and simple to collect and provide a good representation 
of the lactating herd. Therefore, one of the current biosecurity recommendations in Australia to 
reduce the risk of introduction of M. bovis into a naïve dairy herd is to assess the BTM of the 
main herd and the ‘hospital’ herd from which the purchase of animals is being considered using 
PCR or culture (Dairy Australia Limited, 2014). Both PCR and culture have been used on BTM 
samples as surveillance tools to identify the herd level prevalence of Mycoplasma species across 
different regions and countries (Higuchi et al., 2011, Justice-Allen et al., 2011). However, there 
are limitations to this approach. To obtain a positive result, infected cows in the herd must be 
contributing to the bulk tank and must be shedding the pathogen at the time the BTM sample is 
collected. Mycoplasma shedding is known to be intermittent and inconsistent in cows with intra-
mammary infection (Biddle et al., 2003), and milk from clinically affected cows is not routinely 
collected into the bulk tank (as clinically affected cows would usually be moved to the ‘hospital’ 
herd). Thus, there is potential to miss identifying infected herds if relying on culture and PCR of 
BTM samples alone. 
A commercially available antibody ELISA kit (Bio-X Bio K 302, Bio-X Diagnostics, Rochefort, 
Belgium) has been designed to detect specific antibodies against M. bovis in either milk or serum 
as an indicator of past exposure. Shedding of the pathogen at the time of BTM sample collection 
is not required for disease detection as for PCR or culture. Recent studies have evaluated the use 
of this kit for BTM and serum sample analysis. Using latent class analysis, the first study 
evaluated the performance of the ELISA as a herd-level diagnostic tool on BTM as compared to 
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PCR for detecting infected herds; medians of their estimated herd-level sensitivity and specificity 
distributions were 60.4% (95% probability interval 37.5 to 96.2) and 97.3% (95% probability 
interval 94.0 to 99.8), respectively, when using the manufacturer’s recommended cutoff optical 
density coefficient (ODC%) value of 37 (Nielsen et al., 2015). A separate study evaluated the use 
of the ELISA on serum samples from individual calves experimentally exposed to aerosols 
containing M. bovis. Relative sensitivity and specificity compared to an M. bovis-specific IgG 
ELISA were 37% (95% CI 22 to 54) and 95% (95% CI 83 to 99), respectively (Wawegama et 
al., 2016). A third study investigated factors which may affect the BTM ELISA ODC% with a 
significant positive relationship being observed between the within-herd ELISA apparent 
prevalence in lactating cows (based on individual composite milk samples) and the BTM ELISA 
ODC% (Petersen et al., 2016). Neither within-herd seroprevalence in young stock, nor herd size 
was associated with BTM ELISA ODC%. Due to the limited published literature on this ELISA 
and evaluation of its use in Australian dairy production systems, additional research is required 
to evaluate further factors which may affect the BTM ELISA ODC%. This will assist 
understanding of its usefulness as a biosecurity tool to identify herds which have been exposed to 
M. bovis and pose a biosecurity risk to unexposed herds planning to purchase and introduce new 
stock. Therefore, the objectives of this study were to: (1) evaluate factors potentially associated 
with variations in the ELISA BTM ODC% in previously exposed herds; (2) evaluate the 
association between the proportion of cows that are ELISA positive and the BTM ELISA 
ODC%; (3) assess the use of the BTM ELISA as a diagnostic tool when compared to PCR and 
culture by assessing agreement between these tests; and, (4) compare BTM ELISA ODC% 
between the ‘hospital’ herd and the main lactating herd on the same farm.  
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4.3 Materials and methods 
4.3.1 Herd selection 
The study population consisted of herds chosen from the client base of The University of Sydney 
Livestock Veterinary Teaching and Research Unit (LVT&RU) (Camden, NSW, Australia), in 
their capacity of providing veterinary services for clinical disease management. From those dairy 
herds with a history of clinical M. bovis disease diagnosed by culture or PCR within the previous 
two years, a convenience sample of 19 previously exposed herds was selected. The University of 
Sydney LVT&RU had assisted with managing the M. bovis disease within these herds (Table 
S4.1). For each herd, the first BTM sample for the current study was collected less than 24 
months after clinical M. bovis disease was evident in the herd. BTM samples contained 1 or 2 
milking sessions as milk was picked up on a daily basis from all herds, other than herd 11 where 
milking occurred continuously, most cows were milked 3 times daily, and 3 bulk tanks were 
used and emptied several times throughout the day. A convenience sample of 6 dairy herds with 
no known clinical cases of mycoplasmosis was also selected as a control group (Table S4.1). 
These herds were selected because of their long-standing close association with the University of 
Sydney LVT&RU. Our familiarity with these herds' long term disease histories provided high 
confidence that none had experienced clinical signs of M. bovis disease both within the last 5 
years of the first BTM sample collected for inclusion in this study or during the study period. Of 
the 6 control herds, 3 herds (herds 20, 21 and 23, Table S4.1) were extensively examined for the 
presence of M. bovis.  From each of these herds, nose swabs, eye swabs, vaginal swabs and 
composite milk samples were collected from 50 systematically selected cows (e.g. every 2nd 
cow for a herd of 100) contributing to the main BTM on the day of sampling. All samples were 
culture negative for M. bovis.  
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The 19 herds with a history of M. bovis were located in the states of Tasmania (n=14), New 
South Wales (n=2), Victoria (n=2) and South Australia (n=1). All control herds were located in 
New South Wales (n=6). In regards to calving system, 11 of the 19 previously exposed herds 
calved seasonally (i.e. each year all cows calved within a single restricted time period) in autumn 
(Mar-May; n=4) or spring (Sep-Nov; n=7), 5 used split calving with all cows calving in 2 
restricted periods each year in autumn (Mar-May) and spring (Sep-Nov), and 2 herds used year-
round calving. Calving system was not recorded for one herd (Table S4.1). The 6 control herds 
all used year-round calving.  
4.3.2 Sample Analysis 
For the detection of M.bovis antibodies in BTM and individual animal serum samples, the Bio-X 
Bio K 302 Mycoplasma bovis ELISA kit was used (Bio-X Diagnostics, Rochefort, Belgium) 
according to the manufacturer’s instructions. In brief, serum samples and the supplied positive 
and negative controls were diluted 1/100 in the supplied dilution buffer. Milk samples were 
centrifuged for 20 mins at 4000 x g, with the upper layer of fat removed, and the undiluted skim 
milk samples used in the wells. Samples were added in duplicate 100 µL volumes to the wells of 
the supplied ELISA plates. On each plate, blank wells (dilution buffer) were included in 
duplicate, and positive and negative controls were added in triplicate 100 µL volumes. Plates 
were incubated with a lid for 1 hr at 21ᵒC ±3ᵒC. Plates were washed 3 times with the supplied 
wash solution. The supplied conjugate was diluted 1:50 with the supplied dilution buffer, and 
100 µL added to each well followed by incubation with a lid for 1 hr at 23ᵒC ± 3ᵒC. Plates were 
washed as described above. The supplied chromogen solution was then added to each well in 100 
µL volumes, incubated for 10 mins at 21ᵒC ± 3ᵒC uncovered and protected from the light, 
followed by the addition of the supplied stop solution in 50 µL volumes to each well. The optical 
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density (OD) of each well was then read immediately at 450 nm on a microplate reader 
(FLUOstar OPTIMA, BMG LabTech, Germany). Sample coefficients were calculated as per the 
manufacturer’s instructions: ODC% = (OD sample – OD negative control) / (OD positive control 
– OD negative control) x 100. Each ELISA plate was validated using the specified OD threshold 
for the positive and negative controls. The coefficient of variation was calculated for each 
sample. For samples with an OCD% greater than 20 and a coefficient of variation greater than 
0.2, the sample was reanalyzed. As per the manufacturer’s recommendations, a sample 
coefficient ≥ 37 ODC% was considered positive, and a sample coefficient < 37 ODC% was 
considered negative for both BTM and individual serum samples.  
All cultures were performed on Mycoplasma agar [Mycoplasma agar base (Oxoid CM0401); 
distilled water; 0.2% w/v calf thymus DNA (Sigma D1501); Mycoplasma Selective Supplement 
G (Oxoid SR0059C)] and incubated at 37ᵒC in candle jars for elevated CO2 levels for 5 to 10 
days. Colonies with morphology consistent with mycoplasma were placed in PBS for speciation 
by an ‘in house’ developed PCR assay targeting the 16S-23S rRNA intergenic spacer region of 
Mycoplasma spp. as described by Parker et al. (2017). The PCR products from this assay were 
then speciated via Sanger Sequencing (Australian Genome Research Facility Ltd, Sydney, NSW, 
Australia).  
For PCR assays, DNA extractions were performed on approximately 1 mL of milk, centrifuged 
at 13,000 x g for 5 minutes followed by the removal of fat and supernatant. The remaining pellet 
was resuspended in 90 µL of Buffer ATL (QIAGEN Pty Ltd, Chadstone Centre, VIC, Australia) 
and 10 µL of Proteinase K (QIAGEN Pty Ltd, Chadstone Centre, VIC, Australia) and incubated 
at 56ᵒC for 1-3hrs with occasional vortexing. The DNA extraction process was then continued 
using the BioSprint® 96 One-For-All Vet kit (QIAGEN Pty Ltd, Chadstone Centre, VIC, 
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Australia) following the protocol for purification of Viral Nucleic Acids and Bacterial DNA 
from Animal Tissue Homogenates, Serum, Plasma, Other Body Fluids, Swabs and Washes. 
Briefly, 40 µL of proteinase K was added to the bottom of each well of a 96-well S-Block. 
Prepared samples were then added to the wells in 100 µL volumes. A Buffer RLT mixture was 
prepared containing buffer RLT (35 mL), Isopropanol (35 mL), MagAttract suspension G (3 mL) 
and carrier RNA (1 µg/µL, 310 µL), and added to each well in 600 µL volumes. One additional 
96-well S-Block was prepared containing Buffer AW1 (700 µL per well), while two additional 
96-well S-Blocks were prepared with each containing Buffer RPE (500 µL per well). Two 96-
well microplates were prepared, with one containing elution Buffer AVE (75 µL per well), and 
the other containing a 96-Rod Cover. Extraction plates were then run on the BioSprint 96 
(QIAGEN Pty Ltd, Chadstone Centre, VIC, Australia), using the BS96 Vet 100 protocol. Each 
extraction plate included a blank extraction control which was analysed by PCR alongside the 
milk samples. The PCR assay used was a Mycoplasma species specific real time probe based 
multiplex PCR assay as described by Parker et al. (2017) targeting M.bovis, Mycoplasma 
californicum and Mycoplasma bovigenitalium. To validate the DNA extraction process, an ‘in-
house’ developed control PCR assay targeting the Bos Taurus mitochondrial cytochrome B gene 
was also used on all samples as described by Parker et al. (2017). All samples were analysed in 
triplicate for the Mycoplasma assay, and in singletons for the control mitochondrial cytochrome 
B assay, and were considered positive if a cycle threshold (Ct) <40 was achieved. 
4.3.3 Factors potentially associated with BTM ELISA ODC% in previously 
exposed herds 
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For factors potentially associated with BTM ELISA ODC% in previously exposed herds, BTM 
samples (n=186) were collected from the 19 previously exposed study herds (Figure S4.1), 
including 13 herds which had ongoing BTM samples collected on a fortnightly to monthly basis 
when possible (Table S4.1). During the sampling period, close communication was maintained 
with each farm, and all M. bovis test results were recorded including those from individual 
animals and BTM samples. Calving dates for cows in each herd were also obtained, with the 
exception of one herd. The following potential explanatory factors for BTM ELISA ODC% were 
analysed: 
 Herd size: continuous data, defined for year-round calving herds as the average number 
of cows in the milking herd during the study period, and for seasonal and split calving 
herds as the approximate number of cows calved in the 12 month period. 
 BTM M. bovis PCR result from the same BTM sample: binary data, where all BTM 
samples were analysed by PCR with each result classified as either positive or negative 
 BTM M. bovis culture result from the same BTM sample: binary data, where all BTM 
samples were analysed by culture with each result classified as either positive or negative 
 Time since the start of calving period: categorical data, where each BTM sample was 
categorized based on time from the beginning of the most recent calving period to BTM 
sampling date. Categories were year-round calving, and, for seasonal and split calving 
herds: 1-4 weeks, 5-8 weeks, 9-12 weeks, 13-20 weeks, 21-28 weeks and >28 weeks. 
 Time since most recent M. bovis positive culture and/or PCR: categorical data, where 
each BTM sample was categorized based on time from the herd's most recent positive M. 
bovis test to BTM sampling date. Positive M. bovis tests were any recorded positive 
culture and/or PCR tests on samples from individual animals and BTM samples collected 
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by the herd veterinarian or herd manager. Categories were 0-3 weeks, 4-6 weeks, 7-12 
weeks, 13-18 weeks, 19-30 weeks, 31-42 weeks, 43-54 weeks and >54 weeks  
 Time since initial M. bovis outbreak: categorical data, where each BTM sample was 
categorized based on time from the initial M. bovis outbreak of clinical disease of that 
herd to BTM sampling date. An outbreak was defined as a herd experiencing one or more 
cases of clinical disease caused by M. bovis as confirmed by culture and/or PCR. The 
categories consisted of 0-4 months, 5-8 months, 9-12 months, 13-16 months, 17-20 
months, 21-24 months and >24 months 
 
4.3.4 Association between the proportion of cows that were ELISA positive 
and the BTM ELISA ODC% 
A total of 23 of the 25 study herds were included in this analysis (17 previously exposed herds 
and 6 control herds; Figure S4.1), with three of those herds sampled twice on separate occasions, 
and one herd sampled three times on separate occasions. All other herds were sampled once. 
This gave a total of 28 samplings. For each sampling, a BTM sample was collected, and blood 
samples were collected from 50 systematically selected cows (e.g. every 2nd cow for a herd of 
100) that were contributing to the main BTM on the day of sampling. For the 3 control herds that 
were extensively examined for the presence of M. bovis as previously described, the same 50 
animals were used for blood collection. The sample size of 50 cows was chosen for both 
statistical and practical reasons, allowing reasonable precision but also being acceptable to herd 
managers and staff. At an observed seroprevalence of 20%, precision (assessed as half of the 
exact mid-p 95% confidence interval) was approximately ±10%. Blood samples were collected 
during or immediately following a milking session. The BTM sample was collected from the 
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main BTM at the end of that milking session, and as such contained 1 or 2 milking sessions as 
the bulk tanks were emptied once daily. This was with the exception of herd 11 where milking 
occurred continuously, most cows were milked 3 times daily, 3 bulk tanks were used and these 
tanks were emptied several times throughout the day. In this herd, each BTM sample was from 
milk from a subset of all lactating cows being milked in the herd at that time. The within-herd 
seroprevalence of M. bovis antibody-positive lactating cows from the main milking herd was 
calculated as the proportion of the 50 sampled cows whose individual ELISA sample coefficient 
(ODC%) value was ≥37 as per manufacturer’s directions for individual animal-testing and as 
previously described (Petersen et al., 2016). 
4.3.5 Agreement between ELISA vs PCR and Culture 
Using the manufacturer’s recommended cutoff of 37 ODC% (i.e. ≥37 was classified as positive) 
for individual animal-testing, the ELISA value for each BTM sample (n=192 from the 19 
previously exposed herds and 6 control herds; Figure S4.1) was classified as either positive or 
negative. These were then used to assess agreement between BTM ELISA category and each of 
the conventional tests of PCR and culture, using prevalence-adjusted bias-adjusted kappa 
(PABAK) values as described under Statistical Analyses. 
4.3.6 Main BTM vs ‘Hospital’ BTM ELISA ODC% 
Concurrent paired BTM samples were collected from the main herd and the ‘hospital’ herd from 
a single split calving study herd of approximately 2000 lactating cows (herd 5, Table S4.1). The 
‘hospital’ herd contained lactating cows isolated from the main herd due to sickness, recent 
parturition or antimicrobial residues. Their milk was collected separately from the main herd's 
bulk milk tank. Samples were collected on 16 occasions, on a fortnightly to monthly basis for 
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one year from 1 February 2015 to 31 January 2016. This first sample was collected 
approximatly19 months after the herd’s initial outbreak, and approximately 10 months after the 
herd's most recent M. bovis positive culture and/or PCR of an individual animal or BTM. During 
the sampling period, no known clinical cases of M. bovis, as diagnosed by PCR or culture, were 
detected.  All BTM samples from the main herd (n=16) and the ’hospital’ herd (n=16) were 
analysed by PCR and culture, with a single BTM sample from the main herd positive by PCR 
(12-Oct-2015). 
4.3.7 Statistical Analysis 
To assess whether BTM ELISA ODC% were continuous data, a 10-fold dilution series on three 
serum samples (very high ODC%, high ODC% and medium ODC%) and three milk samples 
(very high ODC%, high ODC% and medium ODC%) was performed using the supplied dilution 
buffer and analysed by ELISA. This was followed by a 2-fold serial dilution series on five serum 
samples (starting value of approximately 100 ODC%) and four milk samples (starting value of 
approximately 100 ODC%) analyzed by ELISA. These results demonstrated that the ODC% 
increased approximately linearly with concentration, indicating that it adequately met the 
assumption that it was continuous (interval) data for statistical purposes. 
For all statistical analyses, statistical significance was declared at P < 0.05. An Anderson-Darling 
test for normality was first performed on the BTM ELISA ODC% data; values were loge 
transformed to fulfill normality requirements.  Explanatory variables considered for analysis of 
factors affecting BTM ELISA ODC% were herd size, BTM M. bovis PCR result, BTM M. bovis 
culture result, Time since the start of calving season, Time since most recent M. bovis positive 
test and Time since initial M. bovis outbreak. Herd of origin and sample collection date were 
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included as random effects. A first order autoregressive (AR1) residual correlation structure was 
used to account for correlation between herd-samplings within the same herd. The 'herd-
sampling' was the unit of analysis where a BTM result in one herd constituted one herd-
sampling. A univarable linear mixed restricted maximum likelihood (REML) model was first 
constructed (GenStat 16th Edition) for each explanatory variable. Significant variables (P< 0.05 
on univariable analysis) were then included in a multivariable linear mixed restricted maximum 
likelihood (REML) model. A backwards elimination approach was used to determine the final 
model in which all explanatory variables were significant (P< 0.05), and 2-way interactions 
investigated. Once eliminated, variables were not eligible for re-entry. Correlations between the 
final explanatory variables were assessed using Spearman’s rank correlation coefficient. To 
assess for confounding, effect estimates were compared with and without potential confounding 
variables fitted. Model-based means were calculated as fitted means on the loge scale with 
random effects for herd of origin and sample collection date set to zero; these means were then 
back-transformed so were geometric means. Effect estimates were exponentiated to provide 
estimated ratios of geometric means.  
For analysis of the association between within-herd (i.e. cow-level) seroprevalence and BTM 
ELISA ODC%, the BTM ELISA ODC values were plotted against the within-herd 
seroprevalence. A linear mixed restricted maximum likelihood (REML) analysis was performed 
(GenStat 16th Edition) using loge transformed BTM ELISA ODC% as the dependent variable, 
with herd seroprevalence and herd size as the explanatory variables, and herd of origin fitted as a 
random effect. A variable was eliminated from the model if statistical significance was not 
achieved (i.e. if P was > 0.05).  
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Due to the possibility that BTM samples from herd 11 containing an inconsistent number of 
animals, analysis of factors affecting BTM ELISA ODC% and analysis of the association 
between within-herd seroprevalence and BTM ELISA ODC% was also performed with these 
samples excluded. Similar results were achieved so therefore these samples were included in the 
final analyses.  
For comparison of diagnostic tools, two-sided McNemar’s tests were performed (GenStat 16th 
Edition) and Prevalence-adjusted bias-adjusted kappa (PABAK) values were calculated 
separately for BTM ELISA category and PCR, and for BTM ELISA category and culture. 
Clustering of samples within herds was disregarded so the p-values and 95% confidence 
intervals may have been spuriously smaller and narrower, respectively, than if there had been no 
clustering. For comparison of mean BTM ELISA ODC% values from the main herd and the 
‘hospital’ herd, a paired two sample t-test was performed using loge transformed data (GenStat 
16th Edition). 
4.4 Results 
4.4.1 Factors affecting variation in BTM ELISA ODC% 
The final multivariable model contained only the two variables with significant effects when 
adjusted for the other, and included 185 observations from 18 of the 19 previously exposed study 
herds; one observation and herd was excluded due to missing data for time since the beginning of 
the calving period. Descriptive statistics of herd size, samples used per herd and the BTM ELISA 
ODC% are shown in Table 4.1. The p values for the univariable models, multivariable model 
(i.e. the model with the 2-way interaction term included) and final multivariable model 
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(interaction term removed) are shown in Table 4.2. The final multivariable model including two 
explanatory variables: Time since initial M. bovis outbreak (P<0.001) and Time since the start of 
calving season (P<0.001).  These two explanatory variables were weakly positively correlated (r 
= 0.31). Effect estimates are shown in Table 4.3. The unadjusted effect estimate for year-round 
calving was confounded by time since initial M. bovis outbreak; the estimated ratio increased 
from 0.86 before adjustment to 1.41 after adjustment. Changes for other effect estimates were 
smaller.  
 
Table 4.1. Descriptive statistics for analysis of factors affecting bulk tank milk (BTM) ELISA optical 
density coefficient (ODC%) in 19 previously exposed herds (185 samples). 
Item Minimum Median Maximum 
Herd size
a 
340 840 3000 
No. samples per herd 1 11 32 
BTM ELISA ODC% 10 33 179 
a
In Australia in 2016 the average dairy herd size was 284 cows (Dairy Australia Limited, 2016) 
 
 
Table 4.2. P values for the univariable models, multivariable model with interaction term and final 
multivariable model for the analysis of factors affecting bulk tank milk (BTM) ELISA optical density 
coefficient (ODC%). 
Explanatory variables 
Univarable model 
P values 
Multivariable 
model P values 
Final 
multivariable 
model P values 
Herd size 0.904   
BTM M. bovis PCR result 0.801   
BTM M. bovis culture result 0.786   
Time since the start of calving period <0.001 <0.001
a
 <0.001 
Time since most recent M. bovis positive culture 
and/or PCR 
0.494   
Time since initial M. bovis outbreak <0.001 <0.001
a
 <0.001 
Two-way interaction between Time since the start 
of calving period, and Time since initial M. bovis 
outbreak 
 0.360 
 
a
P-value for this explanatory variable at the reference category of the other explanatory variable 
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Table 4.3. Back-transformed variances and effect estimates (estimated ratios of geometric means) for the 
final model of bulk tank milk (BTM) ELISA optical density coefficient (ODC%).  
Explanatory variables Variance
a
 
Estimated ratio 
of geometric 
means
b
 Standard error
c
 
Random effects     
  Herd of origin  1.05  0.03 
  Sample collection date  1.82  0.51 
  Residuals  1.07  0.01 
Fixed effects     
  Constant   48.67
d
 7.87 
  Time since the start of calving period Year round  1.41 0.33 
 
1-4 weeks
5
  - - 
 5-8 weeks
 
 1.27 0.16 
 9-12 weeks  1.11 0.14 
 13-20 weeks  0.96 0.13 
 21-28 weeks  0.76 0.11 
 > 28 weeks  0.80 0.10 
  Time since initial M. bovis outbreak 0-4 months
c
  - - 
 5-8 months
 
 1.19 0.14 
 
9-12 months  0.74 0.10 
 13-16 months  0.53 0.10 
 17-20 months  0.54 0.07 
 21-24 months  0.59 0.08 
 > 24 months  0.40 0.06 
a
Variances are on the back-transformed scale, calculated as the loge transformed value exponentiated.  
b
Effect estimates were exponentiated (back-transformed) to provide estimated ratios of geometric means for each 
category relative to the reference category 
c
Standard errors are on the back-transformed scale, calculated as the standard error on the loge transformed scale 
multiplied by the relevant back-transformed estimate or variance 
d
Fitted BTM ELISA ODC% value for a seasonal or split calving herd 1-4 weeks after the start of the calving period 
and 0-4 months after the herd's initial M. bovis outbreak with random effects for herd of origin and sample collection 
date set to zero then back-transformed 
c
Reference category 
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The model-based means for Time since initial M. bovis outbreak are shown in Figure 4.1. The 
model-based mean BTM ELISA ODC% started above the positive/negative cutoff of 37 ODC% 
at 0-4 months, with a model-based mean ODC% of 50, varying from 20 to 77 for individual 
herds. This was significantly higher than all other time since outbreak categories with the 
exception of 5-8 months, where the model-based mean ODC% peaked at 59 (varying from 28 to 
91 for individual herds). A gradual decline in means was then observed through to >24 months 
with a model-based mean ODC% of 20 (varying from 12 to 40 for individual herds), which was 
significantly lower than all other time since outbreak categories with the exception of 13-16 
months.  
 
Figure 4.1. Model-based mean bulk tank milk Mycoplasma bovis ELISA ODC%, with model-based 
minimum and maximum ODC% for individual herds for time since initial Mycoplasma bovis outbreak, 
and adjusted for time since the start of calving season. Model-based means for time categories not sharing 
the same superscript are significantly different (P<0.05).  
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The model-based means for Time since the start of calving period are shown in Figure 4.2. Year 
round calving had the highest model-based mean BTM ELISA ODC%, with a model-based 
mean ODC% (min, max) of 46 (varying from 16 to 51 for individual herds), and was 
significantly higher than seasonal and split calving herd categories of 13-20 weeks and later. For 
seasonal and split calving herds, at 1-4 weeks the model-based mean ODC% was 33 (varying 
from 17 to 43 for individual herds), before peaking at 5-8 weeks with a model-based mean 
ODC% of 41 (varying from 19 to 64 for individual herds). This was significantly higher than all 
other seasonal and split calving herd categories with the exception of 1-4 weeks and 9-12 weeks. 
There was then a gradual decline through to >28 weeks with a model-based mean ODC% of 26 
(varying from 9 to 56 for individual herds). The model-based mean BTM ELISA ODC% was 
above the positive/negative cutoff of 37 ODC% for year round calving herds, and at 5-8 weeks 
for seasonal and split calving herds. 
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Figure 4.2. Model-based mean bulk tank milk ELISA ODC%, with model-based minimum and 
maximum ODC% for individual herds for time since the start of calving period, and adjusted for time 
since initial Mycoplasma bovis outbreak. Model-based means for calving categories not sharing the same 
superscript are significantly different (P<0.05). 
 
4.4.2 Association between the proportion of cows that were ELISA positive 
and the BTM ELISA ODC% 
The model included 28 samplings from 23 herds. Descriptive statistics of herd size, within-herd 
seroprevalence, and BTM ELISA ODC% are shown in Table 4.4. The association between 
within-herd seroprevalence and BTM ELISA ODC% is shown in Figure 4.3. Bulk tank milk 
ELISA ODC% was significantly associated with within-herd seroprevalence (P=0.027; estimated 
increase in BTM ELISA ODC% per 10% increase in within-herd seroprevalence was 1.14 (95% 
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CI 1.02 to 1.27). However the R
2
 value of 16% indicated that within-herd seroprevalence 
explained little of the variation in BTM ELISA ODC%. The effect of herd size was not 
significant (P = 0.978 after accounting for within-herd seroprevalence) so this variable was 
removed from the model. 
Table 4.4. Descriptive statistics for the analysis of the association between the proportion of cows that 
were ELISA positive and the bulk tank milk (BTM) ELISA optical density coefficient (ODC%) from 23 
herds (28 samplings). 
Item Minimum Median Maximum 
All herds (n=28) Herd size
a
 100 600 3000 
 
Within-herd seroprevalence of cows 
 6 14 76 
 BTM ELISA ODC%  17 36 85 
Exposed herds (n=22) Herd size 330 800 3000 
 Within-herd seroprevalence of cows  6 15 76 
 BTM ELISA ODC%  17 43 85 
Control herds (n=6) Herd size 100 325 650 
 Within-herd seroprevalence of  6 14 22 
 BTM ELISA ODC%  23 28 34 
a
In Australia in 2016, the average dairy herd size was 284 cows (Dairy Australia Limited, 2016).  
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Figure 4.3. Scattergraph of the proportion of cows within Mycoplasma bovis exposed and uninfected 
herds that were ELISA positive and the bulk tank milk Mycoplasma bovis ELISA ODC%.  
 
4.4.3 Agreement between ELISA vs PCR and Culture on BTM samples 
Analysis included 192 BTM samples from the 25 study herds. Descriptive statistics of herd size, 
samples used per herd, and the distribution of BTM ODC% values between the PCR and culture 
positive and negative samples are shown in Table 4.5. Of the BTM samples analysed, 39% 
(n=74) were ELISA positive, while only 4% (n=7) and 1% (n=2) were PCR and culture positive, 
respectively. Apparent prevalences differed significantly (P<.0.001) between ELISA and each of 
PCR and culture. Results matched for 61% of ELISA category and PCR results (both positive: 
n= 3; both negative: n= 114; ELISA positive PCR negative: n=71; ELISA negative PCR 
positive: n=4), and for 63% of ELISA category and culture results (both positive: n= 2; both 
negative: n= 118; ELISA positive culture negative: n=72; ELISA negative culture positive: n=0) 
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and there was virtually no agreement above that expected by chance; prevalence-adjusted bias-
adjusted kappa (PABAK) values were 0.22 (95% CI, 0.08 to 0.36) and 0.25 (95% CI, 0.11 to 
0.39) for ELISA category versus each of PCR and culture, respectively. 
Table 4.5. Descriptive statistics for analysis of the agreement between ELISA vs PCR and Culture from 
25 herds (192 observations); samples used per herd, and the distribution of bulk tank milk (BTM) ELISA 
optical density coefficient (ODC%) values between PCR and culture results.  
Item Minimum Median Maximum 
Herd size
a 
100 840 3000 
Samples used per herd 1 6 32 
ELISA ODC% for M. bovis PCR positive results (n=7) 18 26 56 
ELISA ODC% for M. bovis PCR negative results (n=185) 10 32 179 
ELISA ODC% for M. bovis culture positive results (n=2) 44 49 55 
ELISA ODC% for M. bovis culture negative results (n=190) 10 32 179 
a
In Australia in 2016, the average dairy herd size was 284 cows (Dairy Australia Limited, 2016).  
 
4.4.4 Main BTM vs ‘Hospital’ BTM ELISA ODC% 
Throughout the sampling period, the temporal pattern in the ‘hospital’ herd BTM ELISA ODC% 
generally mirrored that for the main herd but at higher ODC% values. The mean ODC% was 
significantly higher in the ’hospital’ herd compared to the main milking herd (P<0.001), with 
means (minimum, maximum) of 54 ODC% (26, 124) and 24 ODC% (14, 43), respectively. 
4.5 Discussion 
This study examined the potential use of the commercially available Bio-X Bio K 302 
Mycoplasma bovis ELISA kit (Bio-X Diagnostics) as a biosecurity tool for identifying herds 
with past exposure to M. bovis. The BTM ODC% was higher in year-round calving herds and in 
seasonal and split calving herds 5-8 weeks after the commencement of the calving period, and 
was highest sooner after M. bovis clinical disease outbreaks. Clinical mycoplasma disease in 
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dairy cattle is often observed post-partum, presumably reflecting the stress of calving, with first 
lactation heifers at higher risk (Al-Abdullah and Fadl, 2006, Radaelli et al., 2011). It has been 
demonstrated that following exposure, seroconversion takes approximately 2-3 weeks (Nicholas 
et al., 2002, Wawegama et al., 2014). Given that cows in the seasonal and split calving study 
herds calved over several weeks, it is not surprising that the model-based mean BTM ELISA 
ODC% was significantly higher at 5-8 weeks compared to ≥13 weeks after the commencement 
of the calving period in these herds (Figure 4.2). The subsequent decline in the model-based 
mean BTM ELISA ODC% from 5-8 weeks onwards is also consistent with studies that have 
demonstrated that total individual milk IgG concentrations decrease as the number of days in 
lactation increase (Liu et al., 2009, Eisenberg et al., 2015). Therefore the relationship between 
time after the commencement of the calving period and BTM ELISA ODC% may be due not just 
to the temporal relationship to calving but also to individual cow milk production factors. Effects 
of herd size on BTM ELISA ODC% may also be affected by interactions between individual 
cow milk production and ELISA ODC% values. While herd size was included as a factor in the 
analysis and found to have no significant effect, milk production data including individual cow 
daily milk production would be beneficial in further exploring the impacts of time after the 
commencement of the calving period on BTM ELISA ODC%. Interestingly, BTM samples from 
year-round calving herds had a higher model-based mean BTM ELISA ODC% compared to 
seasonal and split calving herds (Figure 4.2), possibly due to the continued presence of recently 
calved cows in the lactating herd throughout the year, or to differences in individual cow milk 
production characteristics between calving systems.  
While it has been suggested that serum M. bovis antibody concentrations remain high for several 
months following an outbreak (Byrne et al., 2000), little work has been conducted investigating 
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the persistence of antibodies in milk. When looking at the model-based mean BTM ELISA 
ODC% over time since the initial M. bovis disease outbreak, the model-based mean BTM ELISA 
ODC% were high at 0-4 months and at 5-8 months, with no significant difference between the 
two categories (Figure 4.1). This can be expected as seroconversion occurs approximately 2-3 
weeks after cows are challenged with M. bovis (Nicholas et al., 2002, Wawegama et al., 2014). 
Not surprisingly, following the observed peak at 5-8 months the model-based mean BTM ELISA 
ODC% gradually decreased with time from the initial outbreak. After 12 months, the model-
based mean BTM ELISA ODC% was less than the manufacturer’s recommended cutoff of 37 
ODC%. These results suggest that the greatest chance of identifying a herd which has had past 
exposure to M. bovis is 0-8 months after the commencement of an initial outbreak. They also 
indicate that, commonly, M. bovis antibodies can be detected in BTM for only 8-12 months 
following an initial outbreak. Interestingly, mean BTM ELISA ODC% was low by 12 months 
after the initial outbreak despite further positive M. bovis culture or PCR results. While there is 
the possibility that this poor antibody response may be due to antigenic shift of M. bovis, this 
seems unlikely as recent studies have demonstrated minimal genomic variability in Australian M. 
bovis isolates collected over a 9 year period (Parker et al., 2016). Antigenic variation over time 
through phase switching (ON-OFF) is another possible explanation. The mechanisms behind this 
phenomenon are not entirely understood (Burki et al., 2015). In summary, an important antibody 
response in the BTM is only likely to occur when a previously unexposed herd becomes 
exposed, with individual cases or secondary outbreaks thereafter unlikely to alter the BTM 
ODC% substantially. 
When analysing herds with a clinical history of M. bovis, the present study found no significant 
effect of herd size on the BTM ODC%. Petersen et al. (2016) also used a stepwise variable 
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selection process when modeling BTM ODC% in Danish dairy herds, including 8 herds with no 
clinical signs related to M. bovis in the past 3 years. Herd size was excluded by that process. 
Results from cross-sectional studies using PCR and culture have shown that, while M. bovis can 
be isolated in the BTM from both small and large dairy herds, there is a positive association 
between herd size and detection of M. bovis (Fox et al., 2003, APHIS-USDA, 2008). The 
disparity between these results may have been due to the fact that all BTM samples included in 
the current study were obtained from herds specifically selected due to their history of M. bovis 
disease, whereas the herds included in the studies by Fox et al. (2003) and APHIS-USDA (2008) 
were part of a national survey and were not selected based on their M. bovis history. Secondly, 
most of the BTM samples included in the present study were from large herds ≥500 in size. 
Thirdly, while the likelihood of a herd being infected with M. bovis may be higher with increased 
herd size, if within-herd prevalence of exposure declines as herd size increases, the BTM ODC% 
may be lowered due to the dilution effect from increased milk volume, as demonstrated in 
dilution series of individual positive milk samples (Vanzini et al., 2001, Tittarelli et al., 2011). 
Lastly, the outcome variables analysed differed, with the present study using continuous data in 
the form of BTM ODC%, while Fox et al. (2003) and APHIS-USDA (2008) analysed the 
presence or absence of the M.bovis organism. 
While BTM ODC% was significantly associated with the proportion of cows that were ELISA 
positive for M. bovis, the R
2
 value was low (16%), indicating that within-herd seroprevalence 
explained little of the variation in BTM ELISA ODC%. Furthermore, several herds with positive 
ELISA BTM (≥37 ODC %) had within-herd seroprevalences lower than herds with negative 
ELISA BTM (<37 ODC %). These results demonstrate that the BTM ELISA has limited utility 
in determining the within-herd seroprevalence of M. bovis exposure in Australian dairy herds. 
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They are in contrast to those from a previous study investigating M. bovis (Petersen et al., 2016) 
where the association was closer. Petersen et al. (2016) also observed a much stronger 
association, with an increase of 9 ODC% per 10% increase in the proportion of cows ELISA 
positive for M. bovis, compared to the current study where the estimated increase was just 1 
ODC% per 10% increase. The low R
2
 value and weaker association in the current study may 
have been due, in part, to imperfect specificity of the ELISA in Australian dairy production 
systems. Although the specificity of this ELISA was high when used on individual serum 
samples from non-exposed calves (Wawegama et al., 2016), we observed seroprevalences in 
lactating cows varying from 6% to 22% in the 6 control herds with no known clinical history of 
mycoplasmosis. This may have been due to antigen cross-reactivity with other pathogens. For 
example in humans, acute Q-Fever has been shown to elicit a non-specific immunological 
response in some patients, including elevated IgM levels for Mycoplasma pneumoniae (Vardi et 
al., 2011). It is also possible that these control herds contained previously exposed animals which 
were causing positive serology results, but their infections had not resulted in a clinical outbreak. 
The absence of a close association between BTM ODC% and the proportion of cows that were 
ELISA positive for M. bovis may also have been due to sampling occurring further away from 
the herds' clinical outbreaks. Further, with the exception of a few outlier herd-samplings with 
high within-herd seroprevalences, the range of within-herd seroprevalence results was quite 
narrow compared to the range of BTM ODC% (Figure 3), a similar finding to a Mycobacterium 
avium subsp. paratuberculosis ELISA (Nielsen and Toft, 2014). The association may be closer 
in populations with more variation in the proportion of cows that are ELISA positive. Finally, the 
absence of a close association may have been partly due to poor sensitivity of the Bio-X ELISA 
at the individual animal level. Sensitivity of this ELISA has been estimated as 37% (95% CI 22 
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to 54) relative to an IgG ELISA in sera from individual animals (Wawegama et al., 2016) and 
60% (95% PCI 38 to 96) in BTM (Nielsen et al., 2015). However, while not all herds with a 
known history of M. bovis disease had a positive BTM (≥37 ODC %), the BTM ELISA may be 
more useful in identifying absence or presence of previous exposure to M. bovis at herd level. 
Given the reported relative poor sensitivity of the assay (Nielsen et al., 2015, Wawegama et al., 
2016), in order to increase the chance of identifying a previously exposed herd, when possible, 
sampling in seasonal and split calving herds should be targeted to 5-8 weeks after the start of 
calving period, the period where mean BTM ODC% was highest. If the BTM ELISA is to be 
effective as a biosecurity tool for avoiding purchase of cattle infected with M. bovis, negative 
BTM ELISA results must indicate that the probability that M. bovis is present in the vendor's 
herd is very low (i.e. the negative predictive value must be very high). In any randomly selected 
Australian dairy herd, the probability that M. bovis is present is currently low as the herd-level 
prevalence of M. bovis in Australia is low (Morton et al., 2014). This probability would be 
slightly lower in herds with no clinical history suspicious of M. bovis, and negative BTM ELISA 
results from these herds would indicate that the probability that M. bovis is present is even lower, 
even if the sensitivity of the BTM ELISA is only modest. Although the reduction in probability 
between such herds without and those with negative BTM ELISA results would generally be 
small, given the serious consequences of introducing M. bovis into unexposed (and hence 
immunologically naïve) herds, this additional information may be valuable. 
A much higher percentage of BTM samples were ELISA positive (39%) than were PCR (4%) or 
culture (1%) positive, resulting in low prevalence-adjusted bias-adjusted kappa (PABAK) values 
of 0.22 (95% CI, 0.08 to 0.36) and 0.25 (95% CI, 0.11 to 0.39) for ELISA category versus each 
of PCR and culture, respectively. This poor agreement can be expected given that ELISA 
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measures antibodies for past exposure, while PCR and culture measure the presence of the 
pathogen. The study by Nielsen et al. (2015) also found a high proportion of BTM samples were 
positive by ELISA yet negative by PCR. This has also been demonstrated with individual 
animals (Byrne et al., 2000, Akan et al., 2014). Assuming the specificity of the ELISA is at least 
modest, this indicates that past M. bovis exposure may be far more common than shedding of the 
pathogen. If so, the presence of both bacterial DNA and antibodies in the BTM sample at the 
same time is unlikely, particularly given that clinically-affected animals, which are most likely to 
be shedding the pathogen, are often in a separate ‘hospital’ herd and may or may not have 
developed an immune response to a new infection. For this reason, the use of the BTM ELISA as 
a biosecurity tool to identify herds which have been exposed to M. bovis may be of value in 
providing additional information from a different biological perspective and may complement 
the use of PCR or culture in identifying higher risk herds from which animals are being 
considered for purchase.  
In the study by Petersen et al. (2016), while there was an association between the within-herd 
apparent prevalence of the main milking herd and the BTM ODC% results, this was not the case 
for the within-herd seroprevalence of young stock (0-12 months of age). This would be expected 
as the BTM ODC% is only reflective of the animals which are contributing milk to the BTM 
sample. However, when considering to purchase non-lactating animals (e.g. heifers) that were 
bred in the herd, the BTM ELISA ODC% would provide information about their herd of origin. 
Milk from lactating animals in the ‘hospital’ herd is also excluded from this sample type, with 
the status of these animals also not being reflected in the main herd BTM ODC%. This is an 
important point, since a recommended strategy for controlling transmission of Mycoplasma spp. 
within a herd is to identify and segregate infected animals into a separate herd (Fox et al., 2005). 
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Therefore, currently infected animals are often not contributing to the main herd BTM. This may 
result in negative main herd BTM PCR and culture results, despite cows with Mycoplasma 
clinical disease having been recently removed from that herd. Therefore sampling of the 
‘hospital’ herd BTM may be beneficial in addition to sampling the main herd BTM to assess the 
joint status of both herds. When comparing BTM samples from the main herd and the ‘hospital’ 
herd on one farm with a history of M. bovis, the mean BTM ELISA ODC% for the ‘hospital’ 
herd was significantly higher. When comparing patterns over time, the ‘hospital’ herd BTM 
ELISA ODC% generally mirrored that of the main herd, however at higher concentrations. 
While the main herd BTM ELISA ODC% rarely rose above the recommended cutoff to be 
considered positive, the ‘hospital’ herd was positive at most sampling points. This may be due to 
a higher chance of M. bovis exposed animals being in the ‘hospital’ herd compared to the main 
herd due to disease management strategies. While these results are only based on a single herd 
and therefore should be interpreted with caution, we suggest that ‘hospital’ herd BTM samples 
may be more effective than main herd BTM samples in identifying herds with a history of M. 
bovis. However, we recommend both ‘hospital’ herd and main herd BTM samples be collected, 
as ‘hospital’ herd BTMs may practically be a more difficult sample to obtain. These results also 
suggest that, from a disease management point of view, the ‘hospital’ herd BTM sample may be 
useful for internal monitoring of M.bovis activity within a herd. Additional work is required to 
further explore the role of ‘hospital’ herd BTM sampling. 
If BTM ELISA is to be used as a biosecurity tool to screen herds from which animals are being 
considered for purchase, along with high sensitivity, high specificity is desirable, to minimise the 
number of follow-up investigations required in vendors' herds due to false positive results. All 6 
control herds were negative (<37 ODC %). These results, coupled with an estimated BTM 
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specificity of 97.3% (95% PCI 94.0 to 99.8) by Nielsen et al. (2015), are suggestive of at least 
modest specificity at the herd level when used on BTM samples. However given that all 6 
control herds included in this study were from one state and all used the year-round calving 
system, further sampling of control herds expanding to other regions and calving systems is 
required to assess specificity of the BTM ELISA. However, these observations in our control 
herds are consistent with findings by Petersen et al. (2016) who, with the exception of a control 
herds which experienced a clinical outbreak during the trial, had few positive ELISA BTM 
samples collected from 7 control herds with no known clinical signs of M. bovis in the past three 
years (personal communications). Although it is not known if the herds included in the control 
group by Petersen et al. (2016) had a clinical history of M. bovis disease greater than 3 years ago, 
or if they were subclinically infected. In the current study we selected 6 herds with no clinical 
signs of M. bovis disease within the last 5 years as control herds, and due to the long-standing 
close association with the University of Sydney LVT&RU, it is likely that all of these herds had 
no clinical signs of M. bovis disease for many years. 
4.6 Conclusions 
This study was conducted to evaluate the use of the commercially available Bio-X Bio K 302 
Mycoplasma bovis ELISA kit (Bio-X Diagnostics) on BTM samples as a biosecurity tool for 
identifying herds with past exposure to M. bovis and, as such, pose a biosecurity risk to 
unexposed herds planning to purchase and introduce new stock. Following an initial outbreak of 
M. bovis, the greatest window of opportunity to identify herds with past exposure via ELISA was 
0-8 months post outbreak. In seasonal and split calving herds, significantly higher model-based 
mean BTM ELISA ODC% results were observed 5-8 weeks following the commencement of the 
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calving season, presumably due to the effects of calving stress. While the BTM ELISA ODC% 
was significantly associated with the within-herd seroprevalence, the BTM ELISA had limited 
utility in determining the within-herd seroprevalence of M. bovis exposure in study herds. There 
was a significant difference in results obtained from the BTM ELISA assay and PCR or culture. 
A much higher percentage of BTM samples were ELISA positive and there was virtually no 
agreement between ELISA category and either PCR or culture other than that expected by 
chance. Finally, the ‘hospital’ herd BTM ELISA ODC% mirrored that of the main herd BTM but 
at higher concentrations and therefore the ‘hospital’ herd BTM may be a more effective sample 
type at detecting herds with past exposure to M. bovis. While further work is needed in regards to 
investigating the herd-level specificity of this assay, this study demonstrates that the use of the 
BTM ELISA may be complementary to the use of BTM PCR or culture as a pre-purchase herd 
screening tool to mitigate the risk of purchasing infected stock. 
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4.10 Supplementary material 
Table S4.1. Dairy herd study population 
Herd Herd Size
D Calving 
System
E State 
Month Of 
Initial 
Outbreak 
No. BTM 
Samples 
Collected 
No. 
ELISA 
positive 
BTM 
samples 
No. PCR 
positive 
BTM 
samples 
No. 
culture 
positives 
BTM 
samples 
Sampling 
Period 
duration 
Sampling Period 
In Relation To 
Initial Outbreak
F 
Most recent 
culture and/or 
PCR positive 
sample in 
relation to 
initial 
outbreak
G
 
1
A 
330 Not recorded TAS February 1 0 0 0 N/A 3 months < 1 month 
2
A 
650 
Seasonal 
 (spring)
 VIC October 1 0 0 0 N/A < 1 month < 1 month 
3 800 
Seasonal 
(autumn) 
TAS May 9 4 0 0 13 months 11-24 months 12 months 
4
A 
800 
Seasonal 
(autumn) 
TAS May 11 5 0 0 21 months 2-24 months 11 months 
5
B 
2000 
Split 
(autumn/spring) 
SA July 21 7 3 1 29 months < 1-30 months 27 months 
6
A 
360 
Seasonal  
(spring) 
TAS November 1 1 0 0 N/A 2 months < 1 month 
7
A 
1200 
Split 
(autumn/spring) 
TAS May 17 9 0 0 19 months 7-27 months 20 months 
8 900 
Seasonal 
(autumn) 
TAS May 11 2 1 0 13 months 11-24 months 12 months 
9
A 
475 
Seasonal  
(spring) 
VIC October 1 1 0 0 N/A 1 month < 1 month 
10
A 
500 
Seasonal  
(spring) 
TAS September 10 10 0 0 7 months 1-8 months 1 month 
11
B 
3000 Year round NSW February 32 8 3 0 17 months 88-106 months 106 months 
12
A 
800 
Split 
(autumn/spring) 
TAS May 14 3 0 0 18 months 10-29 months 25 months 
13
A 
840 
Split 
(autumn/spring) 
TAS December 15 4 0 0 7 months 1-8 months 8 months 
14
A 
340 
Seasonal  
(spring) 
TAS October 6 2 0 0 20 months 3-23 months 19 months 
15
A 
900 Seasonal TAS July 11 8 0 0 13 months 9-22 months 11 months 
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(autumn) 
16
A 
530 
Seasonal  
(spring) 
TAS November 1 1 0 0 N/A 2 months < 1 month 
17
C 
500 
Split 
(autumn/spring) 
TAS September 13 4 0 1 21 months 4-25 months 23 months 
18
B 
800 
Seasonal  
(spring) 
TAS May 10 5 0 0 19 months 7-27 months 11 months 
19
A 
800 Year round NSW October 1 0 0 0 N/A 36 months 35 months 
20
A 
650 Year round NSW Control herd 1 0 0 0 N/A N/A N/A 
21
A 
100 Year round NSW Control herd 1 0 0 0 N/A N/A N/A 
22
A 
300 Year round NSW Control herd 1 0 0 0 N/A N/A N/A 
23
A 
350 Year round NSW Control herd 1 0 0 0 N/A N/A N/A 
24
A 
150 Year round NSW Control herd 1 0 0 0 N/A N/A N/A 
25
A 
350 Year round NSW Control herd 1 0 0 0 N/A N/A N/A 
Blood samples taken once
A
, twice
B
 and three times
C
 from 50 systematically selected lactating cows 
D
Herd size: defined for year-round calving herds as the average number of cows in the milking herd during the study period, and for seasonal and split calving 
herds as the approximate number of cows calved in the 12 month period 
E
In Australia spring is classified as the months of September-November, while autumn is classified as March-May. 
F
Time from the initial outbreak to the start and end of the sampling period. 
G
Includes samples from individual animals and BTM samples that were positive for M. bovis by culture and/or PCR.
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Figure S4.1. Flow chart of the number of herds included for each component of the study
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American spelling has been used in this chapter to fulfill requirements for publication 
CHAPTER 5: MILK ACIDIFICATION TO CONTROL 
THE GROWTH OF MYCOPLASMA BOVIS AND 
SALMONELLA DUBLIN IN CONTAMINATED MILK 
 
 
 
 
 
 
 
This chapter appears as the following published paper in the international, peer-reviewed, 
scientific Journal of Dairy Science (citation below). The format has been changed for the 
purposes of consistency of style in this thesis. 
 
Parker, A. M., J. K. House, M. S. Hazelton, K. L. Bosward, V. L. Mohler, F. P. Maunsell, and 
P. A. Sheehy. 2016. Milk acidification to control the growth of Mycoplasma bovis and 
Salmonella Dublin in contaminated milk. J Dairy Sci 99(12):9875-9884. 
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5.1 Abstract 
Bacterial contamination of milk fed to calves compromises calf health. Several bacterial 
pathogens that infect cows, including Mycoplasma bovis and Salmonella enterica subsp. enterica 
serovar Dublin, are shed in milk, providing a possible route of transmission to calves. Milk 
acidification lowers the milk pH so that it is unsuitable for bacterial growth and survival. The 
objectives of this study were to (1) determine the growth of M. bovis and Salmonella Dublin in 
milk, and (2) evaluate the efficacy of milk acidification using a commercially available 
acidification agent (Salstop, Impextraco, Heist-op-den-Berg, Belgium) to control M. bovis and 
Salmonella Dublin survival in milk. For the first objective, 3 treatments and a positive control 
were prepared in 10 mL of milk and broth, respectively, and inoculated with M. bovis or 
Salmonella Dublin to an approximate concentration of 10
4
 cfu/mL. Each treatment was retained 
at 5, 23, or 37 °C with the positive control at 37 °C. Aliquots were taken at 4, 8, 24, 28, 32, 48, 
52, and 56 h after inoculation and transferred onto agar medium in triplicate following a 10-fold 
dilution series in sterile phosphate-buffered saline. All plates were incubated and colonies 
counted. For the second objective, 4 treatments and a positive control were prepared with 100 
mL of milk and inoculated with M. bovis or Salmonella Dublin to an approximate concentration 
of 10
6
 cfu/mL. With the use of Salstop, treatments were adjusted to an approximate pH of 6, 5, 4, 
or 3.5. The positive control was left untreated. At 1, 2, 4, 6, 8, and 24 h after treatment, triplicate 
aliquots were taken, the pH measured, and then the aliquots were transferred onto agar medium 
and into broth for enrichment. Following incubation, agar colonies were counted, while broths 
were plated and incubated prior to colonies being counted. All trials were repeated. Mycoplasma 
bovis did not grow in milk, but Salmonella Dublin proliferated. The pH of all acidification 
treatments remained stable for 24 h. No viable M. bovis organisms were detected at 1 h of 
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exposure to pH 3.5 and 4 or at 8 h of exposure to pH 5. Following 24 h of exposure to pH 6 M. 
bovis remained viable. No viable Salmonella Dublin organisms were detected at 2 and 6 h of 
exposure to pH 3.5 and 4, respectively. Salmonella Dublin remained viable following 24 h of 
exposure to pH 5 and 6. These results demonstrate that milk acidification using Salstop is 
effective at eliminating viable M. bovis and Salmonella Dublin organisms in milk if the 
appropriate pH and exposure time are maintained. 
5.2 Introduction 
Mycoplasma bovis can cause severe disease in cattle of all ages, and it is most commonly 
associated with mastitis and arthritis in adults (Wilson et al., 2007) as well as pneumonia, 
arthritis, and otitis media in calves (Maunsell and Donovan, 2009). Animals affected with 
clinical and subclinical mycoplasma mastitis can shed the organism through their milk at 
concentrations ≥108 and ≤106 cfu/mL, respectively (Byrne et al., 2005). Cow-to-calf 
transmission of M. bovis can occur through the ingestion of infected milk (Maunsell et al., 2012). 
Because of the organism’s highly contagious nature, unresponsiveness to antimicrobial 
treatment, and the role of subclinical carrier animals, elimination is difficult, and therefore, the 
focus is on preventing pathogen transfer (Maunsell et al., 2011). 
Salmonella enterica subsp. enterica serovar Dublin is one of the most common Salmonella 
serotypes isolated from cattle, causing acute and subclinical disease in calves aged 2 wk to 3 mo 
(Wray and Davies, 2000). Clinical symptoms in calves include fever, ill thrift, depression, 
pneumonia, diarrhea, septicemia, and death (Mohler et al., 2009). Salmonella Dublin is host 
adapted to cattle and has a propensity to cause chronic subclinical infections. Calves infected 
with Salmonella Dublin that fail to clear the infection can remain as carrier animals within the 
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herd, shedding the organism in feces and milk (Smith et al., 1989; House et al., 1993). As a 
result, approximately 50 % of dairy herds that experience a Salmonella Dublin outbreak become 
persistently infected (Veling, 2004). Oral ingestion is the most common route of infection with a 
dose of 10
6
 cfu or greater leading to clinical symptoms (Wray and Sojka, 1977). 
Current options to minimize exposure of calves to bacterial pathogens in milk include feeding 
milk replacer to eliminate access to contaminated milk, milk acidification, and pasteurization. 
Pasteurization may be achieved via heat or UV irradiation. Heat pasteurization of waste milk 
improves weight gain and reduces morbidity and mortality compared with feeding unpasteurized 
waste milk (Jamaluddin et al., 1996). Heat pasteurization is also an effective method of 
eliminating M. bovis and Salmonella Dublin to enable effective utilization of contaminated milk 
(Butler et al., 2000; Stabel et al., 2004). Despite this, the cost of purchasing an effective 
pasteurization unit is significant, with an economic analysis proposing a break-even point of 315 
calves on milk per day, which equates to a herd milking 1,260 cows year-round (Jamaluddin et 
al., 1996). Treatment of waste milk by UV irradiation is less effective at reducing bacterial 
counts compared with heat pasteurization (Teixeira et al., 2013). 
Although feeding of milk replacer avoids an initial capital outlay, it can be costly over time, and 
past evaluations have suggested that routine feeding with it may result in a poorer nutrient intake 
compared with whole pasteurized milk (Godden et al., 2005). Although both options provide a 
liquid feed that is initially free from viable M. bovis and Salmonella Dublin, both have the 
potential to become contaminated if placed into contaminated storage or feeding equipment. An 
alternative treatment approach is milk acidification, which involves lowering the pH of milk to a 
level that is unsuitable for bacterial growth and survival but still of nutritional benefit to calves 
(Anderson, 2008). A continued preservative effect persists while the pH remains at the effective 
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level, and milk acidification is an economical alternative for smaller producers. A pilot trial in 
2005 indicated that the total bacterial count in raw bulk tank milk (BTM) is reduced when the pH 
is lowered to 4.1 with the addition of formic acid (Anderson, 2005b). However, very little 
information is available on specific contact times required to inactivate particular bacterial 
species. Furthermore, formic acid has substantial work health and safety hazards associated with 
its use. Recently in light of these work health and safety issues, powdered forms have been made 
commercially available utilizing a combination of acids, but these have yet to be evaluated 
thoroughly for their efficacy. 
The first objective of this study was to determine the growth and survival of M. bovis and 
Salmonella Dublin in inoculated milk over the course of 56 h at various incubation temperatures. 
The second objective of this study was to evaluate the efficacy of milk acidification using a 
commercially available feed acidification agent (Salstop, Impextraco, Heist-op-den-Berg, 
Belgium) to inhibit the growth and survival of M. bovis and Salmonella Dublin in inoculated 
milk over a period of 24 h. In addition, the pH stability of “hospital herd” waste milk with high 
levels of bacterial contamination was evaluated following acidification using Salstop. 
5.3 Materials and methods 
5.3.1 Acidifying agent 
The commercially available product Salstop SD (Impextraco) was used as the acidifying agent 
throughout the trial. Salstop SD was selected based on its availability, feed grade status, and 
work health and safety characteristics (powder vs. liquid). According to the product information 
insert provided by the manufacturer, Salstop SD is a dry white powder preservative used to 
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control Salmonella species and other pathogenic bacteria in raw materials and finishing feeds, 
and it prevents the recontamination of these materials. It contains a mixture of propionic, acetic, 
formic, sorbic, and lactic acids on a silica carrier. 
5.3.2 Preparing bacterial cultures 
Mycoplasma bovis type strain (ATCC 25523) was inoculated onto Mycoplasma agar 
[Mycoplasma agar base (Oxoid CM0401; Oxoid Inc., Basingstoke, UK); distilled water; 0.2 % 
wt/vol calf thymus DNA (Sigma D1501, Sigma-Aldrich, St. Louis, MO); Mycoplasma Selective 
Supplement G (Oxoid SR0059C); prepared by Elizabeth Macarthur Agricultural Institute 
(EMAI), NSW Department of Primary Industries, NSW, Australia] and incubated at 37 °C in 
candle jars with elevated CO2 levels for 5 to 10 d. Following positive growth, several colonies 
were selected and subcultured into 2 mL of Mycoplasma broth [Mycoplasma broth base (Oxoid 
CM0403); Milli-Q water; 0.2 % wt/vol calf thymus DNA (Sigma D1501); Mycoplasma 
Selective Supplement Q (Oxoid SR0059C); 0.4 % phenol red (Sigma P-3532); prepared by 
EMAI] at 37 °C for 48 h. After 48 h of incubation, M. bovis growth reached a concentration of 
approximately 10
9
 cfu/mL (data not shown). 
Salmonella Dublin strain 380, a kanamycin-resistant field isolate collected from the feces of a 
calf with scours (Izzo et al., 2011), was chosen for use in this study. The isolate allowed for the 
addition of kanamycin to the agar medium to prevent the growth of unwanted organisms that 
may have made plate reading difficult. Salmonella Dublin was inoculated onto xylose lysine 
deoxycholate (XLD) agar with kanamycin (50 μg/mL; EMAI) and incubated at 37 °C for 24 to 
48 h. Following positive growth, several colonies were selected and subcultured into 2 mL of 
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Luria broth (BD 241420) and incubated at 37 °C for 24 h. After 24 h of incubation, Salmonella 
Dublin 380 growth reached a concentration of approximately 10
9
 cfu/mL (data not shown). 
5.3.3 Milk collection and heat treatment 
The milk used for all trials was BTM collected from The University of Sydney dairy. The 
University of Sydney dairy had no known history of M. bovis infection, but it did have a history 
of Salmonella Dublin infection. To reduce any existing bacterial contamination, the collected 
BTM was heat treated to 63 ± 2 °C for 30 min. All BTM was cultured for Mycoplasma spp. and 
Salmonella spp. as described above, before and after heat treatment. For all trials, no 
Mycoplasma spp. or Salmonella spp. growth was observed before or after heat treatment. 
However, because of the known history of Salmonella Dublin infection in this herd, a negative 
control was included for the Salmonella Dublin milk acidification trials. 
5.3.4 Bacterial proliferation in inoculated milk 
Trials were performed independently for each organism. For all experiments involving M. bovis, 
Mycoplasma agar and Mycoplasma broth were used as described above. For all experiments 
involving Salmonella Dublin, XLD + kanamycin agar and Luria broth were used as described 
above. 
Three treatment groups and a positive control broth were prepared in sterile 15 mL 
polypropylene tubes (Biologix, Jinan, China) with 10 mL of milk (heat treated to 63 ± 2 °C for 
30 min) and broth, respectively. Each treatment and the positive control were inoculated with a 
volume of prepared organism broth culture to achieve a starting concentration of approximately 
10
4
 cfu/mL. To estimate the starting concentration of each treatment and control, an aliquot from 
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each was removed and a 10-fold serial dilution in sterile PBS was performed. Each dilution was 
plated out in triplicate 10 μL volumes onto the appropriate agar and incubated as previously 
described, followed by colony counting. Each treatment group was maintained at their assigned 
temperature of 5 °C (refrigerator), 23 °C (bench top), or 37 °C (incubator), with the positive 
control broth placed in the incubator at 37 °C. Following inoculation and treatment, sampling 
occurred at 4, 8, 24, 28, 32, 48, 52, and 56 h. At each sampling interval, each treatment and 
control was subjected to a sampling protocol that involved vortexing followed by removal of 200 
μL, which was subjected to a 10-fold serial dilution in sterile PBS, with each dilution inoculated 
onto the appropriate agar in triplicate 10 μL volumes. All plates were incubated under the 
appropriate conditions for that bacterial species followed by colony counting. Each trial was 
repeated, and the results are reported as the mean of the replicated trials. 
5.3.5 Milk acidification to reduce the bacterial load in milk 
Trials were performed independently for each organism. For trials with inoculated M. bovis or 
Salmonella Dublin, heat-treated milk was used (63 ± 2 °C for 30 min). For trials involving M. 
bovis, Mycoplasma agar and Mycoplasma broth were used as previously described, with the 
broth incubated for 4 d. For trials involving Salmonella Dublin, XLD + kanamycin agar was 
used as previously described, and mannitol selenite broth, which was incubated at 37 °C for 24 h. 
To ensure that Salmonella Dublin was not already present within the milk, a negative treatment 
control was included containing 100 mL of heat-treated milk (63 ± 2 °C for 30 min), which was 
not inoculated with Salmonella Dublin or treated with Salstop. 
Four treatment groups and a positive control were prepared in sterile glassware with 100 mL of 
heat-treated milk. For each treatment and control, the milk was inoculated with the prepared 
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organism in broth culture to achieve a starting concentration of approximately 10
6
 cfu/mL. To 
estimate the starting concentration in each treatment and control tube, an aliquot from each was 
removed and a 10-fold serial dilution in sterile PBS was performed. Each dilution was plated out 
in triplicate 10 μL volumes onto the appropriate agar and incubated under the appropriate 
conditions for each bacterial species followed by colony counting. For each treatment and 
control tube, three 2 mL aliquots were also removed to measure the starting pH with a benchtop 
pH meter (labCHEM-pH, TPS, Brendale, QLD, Australia). Small increments of Salstop were 
added to each of the 4 treatment tubes followed by gentle but thorough mixing to ensure the 
entire additive was dissolved. A 2 mL aliquot was removed and the pH measured. This process 
was repeated on each of the 4 treatment tubes until they reached their approximate desired 
starting pH of 6, 5, 4, and 3.5. Once the desired pH was achieved, the pH was measured in 
triplicate 2-mL aliquots. The control tube remained untreated. All treatments and the control 
were placed on a benchtop at ambient temperature after which they were sampled following 1, 2, 
4, 6, 8, and 24 h of pH treatment exposure. At each sampling interval, the air temperature was 
recorded, and the following procedures were performed for each treatment and control. Visual 
observations of each milk treatment and control were noted. Milk was thoroughly mixed by 
gentle swirling of the tube and three 2-mL aliquots were removed. To evaluate growth and 
viability of the organism, 10 μL of each aliquot was inoculated onto the appropriate agar. To 
confirm the organism’s viability and ensure that the concentration was not below the limit of 
detection by agar alone, a broth enrichment step was also included. This step involved 
transferring 10 μL of each aliquot into 4 mL of the appropriate broth and incubating the mixture 
under appropriate conditions for each bacterial species. The pH of each aliquot was measured. 
Following incubation, each broth was inoculated onto the appropriate agar in 10 μL volumes and 
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incubated. Following incubation, colony counting was performed on all plates where possible or 
otherwise determined as “too many to count.” The trial was repeated and results reported as the 
combined replicate trials. 
5.3.6 Stability of pH in acidified high-bacteria-count milk 
For total plate count trials to assess the pH stability of milk with a high bacterial load of mixed 
organisms, the method described in the previous section was used with the following 
modifications. Bulk hospital herd waste milk collected from the University of Sydney dairy was 
used. This milk was inoculated onto sheep blood agar (SBA; MicroMedia MM1337, Moe, VIC, 
Australia), but a broth enrichment step was not performed. At 24 h all treatments and the control 
had an aliquot of milk removed, which underwent a 10-fold serial dilution in sterile PBS 
followed by inoculation onto SBA in triplicate 10 μL volumes. All SBA plates were incubated at 
37 °C for 24 h before analysis. 
5.3.7 Statistical analysis 
For statistical analysis of bacterial proliferation in inoculated milk, a REML (GenStat 16th 
edition, VSN International, Hemel Hempstead, UK) analysis was performed on bacterial growth 
(loge) with trial as a random effect. Statistical significance was declared at P < 0.05. 
For milk acidification trials, bacterial growth results were converted to binary data as either 
growth (1) or no growth (0). A generalized linear mixed model (Gen- Stat) analysis was 
performed on bacterial growth for time and treatment separately with trial as a random effect. 
This analysis was completed on bacterial growth before the enrichment broth and after 
221 
 
enrichment broth for M. bovis and Salmonella Dublin. For Salmonella Dublin, the negative 
control data were excluded from analysis because no growth occurred at any sample time point. 
5.4 Results 
5.4.1 Bacterial proliferation in inoculated milk 
For the M. bovis type strain (ATCC 25523) trials, the mean temperatures (±SE) were 36.91 °C (± 
0.07) for the control and incubated milk, 22.94 °C (± 0.17) for milk held at ambient temperature, 
and 5.77 °C (± 0.23) for the refrigerated milk. The mean starting concentration (± SE) of M. 
bovis for all treatment groups was 5.30 × 10
3
 cfu/mL (± 4.56 × 10
3
). Results of M. bovis 
proliferation in milk and broth are shown in Figure 5.1. The medium (milk or broth), temperature 
treatment, and time had a significant effect on bacterial growth and survival (P < 0.001). 
Proliferation occurred in the control broth tube incubated at 37 °C, achieving a peak mean 
concentration (± SE) of 4.19 × 10
9
 cfu/mL (± 4.43 × 10
8
) after 52 h. Milk treatment tubes 
incubated at 37 or 23 °C had no viable organisms after 24 h. For the milk treatment tubes 
refrigerated at 5 °C, the concentration of viable M. bovis organisms declined gradually over time 
but remained detectable at 56 h at a mean concentration (± SE) of 2.5 × 10
2
 cfu/mL (± 1.83 × 
10
2
). This amount is a 1.18 log10 reduction from the starting concentration. 
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Figure 5.1 Mycoplasma bovis proliferation in milk at varying incubation temperatures over 56 h. Results 
are expressed as the mean counts (cfu/mL; ± SE) of triplicates from 2 independent experiments. 
 
For the Salmonella Dublin strain 380 trials, the mean temperatures (± SE) were 37 °C (± 0.11) 
for the control and incubated milk, 23.3 °C (± 0.18) for milk held at ambient temperature, and 
6.2 °C (± 0.05) for the refrigerated milk. The mean starting concentration (± SE) of Salmonella 
Dublin for all treatment groups was 5.90 × 10
3
 cfu/mL (± 4.17 × 10
3
). Results of Salmonella 
Dublin proliferation in milk and broth are shown in Figure 5.2. The temperature treatment and 
time had a significant effect on bacterial growth (P < 0.001). Proliferation of Salmonella Dublin 
was substantial in the control broth tubes incubated at 37 °C, as well as milk treatments held at 
37 and 23 °C. For the control broth tubes incubated at 37 °C, the mean peak concentration of 
Salmonella Dublin (± SE) was reached at 24 h with a concentration of 9.14 × 10
8
 cfu/mL (± 1.19 
× 10
8
). This concentration remained stable, with a final concentration of 8.02 × 10
8
 cfu/mL (± 
1.43 × 10
8
) at 56 h. For the milk treatment tubes incubated at 37 °C the mean peak concentration 
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of Salmonella Dublin (± SE) of 2.03 × 10
9
 cfu/mL (± 1.41 × 10
9
) was reached at 28 h with a 
decline in concentration to 3.25 × 10
6
 cfu/mL (± 2.29 × 106) at 56 h. For milk treatment tubes 
incubated at 23 °C, the mean peak concentration of Salmonella Dublin (± SE) of 9.89 × 10
9
 
cfu/mL (± 6.04 × 10
9
) was reached at 52 h. For the milk treatment tubes refrigerated at 5°C, the 
concentration of Salmonella Dublin remained stable throughout the 52 h treatment period, with a 
final mean concentration (± SE) of 5.30 × 10
3
 cfu/mL (± 7.67 × 10
2
). 
 
Figure 5.2 Salmonella Dublin proliferation in milk at varying incubation temperatures over 56 h. Results 
are expressed as the mean counts (cfu/mL; ± SE) of triplicates from 2 independent experiments. 
 
5.4.2 Milk acidification to reduce the bacterial load in milk 
For the M. bovis type strain (ATCC 25523) trials, the mean ambient temperature (± SE) for 24 h 
for the treatment tubes placed on the laboratory benchtop was 23.6 °C (± 0.03). The pH of all 
treatment groups remained stable throughout 24 h to give a mean pH (± SE) of 7.13 (± 0.05) for 
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the positive control tubes and 5.99 (± 0.03), 5.18 (± 0.11), 4.08 (± 0.02), and 3.65 (± 0.03) for the 
different treatment groups. The mean starting concentration (± SE) of M. bovis for the control 
and all treatments was 1.36 × 10
6
 cfu/mL (± 2.8 × 10
4
). A significant difference existed in M. 
bovis survival between pH treatment groups before broth enrichment (P < 0.001) and following 
broth enrichment (P < 0.001). Results are shown in Table 5.1 and are reported as either growth or 
no growth. For milk treated to pH 4 and pH 3.5, no M. bovis growth was detected after 1 h of 
exposure time. For milk treated at pH 5, no M. bovis growth was detected at 8 h. Milk treated to 
pH 6 had no M. bovis growth detected at 24 h, but viable M. bovis organisms remained 
detectable at 24 h in non-acidified milk (positive control). Following enrichment in Mycoplasma 
broth, M. bovis viability was confirmed for all treatment tubes with the exception of pH 6 (Table 
5.1). Milk adjusted to pH 6 showed no growth with direct inoculation onto Mycoplasma plates at 
24 h; however, following broth enrichment, viable M. bovis organisms were recovered.  
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Table 5.1 Viability of Mycoplasma bovis in milk over 24 h following pH treatment with the 
commercially available milk acidifier Salstop (Impextraco, Heist-op-den-Berg, Belgium)
a
 
 Duration of pH treatment (h) 
Treatment 0 1 2 4 6 8 24 
Growth following acidification treatment
b
 
       Positive control G G G G G G G 
pH 6 G G G G G G NG 
pH 5 G G G G
c
 G
c
 NG NG 
pH 4 G NG NG NG NG NG NG 
pH 3.5 G NG NG NG NG NG NG 
Growth following acidification and broth enrichment
b
 
       Positive control G G G G G G G 
pH 6 G G G G G G NG
c
 
pH 5 G G G G
c
 G
c
 NG NG 
pH 4 G NG NG NG NG NG NG 
pH 3.5 G NG NG NG NG NG NG 
a
Results are from triplicates of 2 independent trials and are represented by trial 1. 
b
Colonies grown on Mycoplasma agar: G = growth; NG = no growth. 
c
Results that differed between trial 1 and 2. 
 
For the Salmonella Dublin strain 380 trials, the mean ambient temperature (± SE) for the 
treatment tubes placed on the laboratory benchtop for 24 h was 23.54 °C (± 0.01). The mean pH 
(± SE) over 24 h was 7.13 (± 0.04) (negative control), 7.05 (± 0.14) (positive control), 6.19 (± 
0.03), 5.13 (± 0.03), 4.05 (± 0.03), and 3.67 (± 0.03) for the treatment groups. The pH remained 
stable for 24 h for all treatment groups with the exception of the positive control, which 
experienced a slight decrease in pH at 24 h to 6.59. The mean starting concentration (± SE) of 
Salmonella Dublin for all inoculated treatment tubes was 6.83 × 10
5
 cfu/mL (± 6.33 × 103). A 
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significant difference existed in Salmonella Dublin survival between pH treatment groups before 
broth enrichment (P < 0.001) and following broth enrichment (P < 0.008). Results are shown in 
Table 5.2 and are reported as either growth or no growth. No Salmonella spp. were isolated from 
the negative control tubes. Milk adjusted to pH 3.5 showed no Salmonella Dublin growth at 2 h. 
Milk adjusted to pH 4 showed no Salmonella Dublin growth at 6 h. Salmonella Dublin growth 
was still detected at 24 h in milk adjusted to pH 5; however, a reduction in the heaviness of 
growth was noted through visual observations. Milk adjusted to pH 6 and the positive control 
had Salmonella Dublin growth detected at all sampling time points. The positive control had 
visibly heavier growth at 8 h as compared with 0 h. Following enrichment in mannitol selenite 
broth, Salmonella Dublin viability was confirmed for all pH treatments with the exception of pH 
5 at 24 h, which showed no growth with direct inoculation onto XLD + kanamycin plates; 
however, viable Salmonella Dublin organisms were recovered following broth enrichment 
(Table 5.2). No growth of Salmonella spp. was observed in the negative control tubes at any 
sampling points.  
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Table 5.2 Viability of Salmonella Dublin in milk over 24 h following pH treatment with the 
commercially available milk acidifier Salstop (Impextraco, Heist-op-den-Berg, Belgium)
a
 
  Duration of pH treatment (h) 
Treatment 0 1 2 4 6 8 24 
Growth following acidification treatment
b
               
Negative control NG NG NG NG NG NG NG 
Positive control G G G G G G G 
pH 6 G G G G G G G 
pH 5 G G G G G G NG
c 
pH 4 G G G G
c 
NG NG NG 
pH 3.5 G G
c 
NG NG NG NG NG 
Growth following acidification and broth enrichment
b
 
       Negative control NG NG NG NG NG NG NG 
Positive control G G G G G G G 
pH 6 G G G G G G G 
pH 5 G G G G G G G 
pH 4 G G G G NG NG NG 
pH 3.5 G G NG NG NG NG NG 
a
Results are from triplicates of 2 independent trials and are represented by trial 1. 
b
Colonies grown on xylose lysine deoxycholate agar (XLD agar) with kanamycin: G = growth; NG = no growth. 
c
Results that differed between trial 1 and 2. 
 
5.4.3 Stability of pH in acidified high-bacterial-count milk 
For the trials involving hospital herd waste milk to assess the pH stability of milk with a high 
initial bacterial load of mixed organisms, the mean ambient temperature (± SE) for the treatment 
tubes placed on the laboratory benchtop for 24 h remained stable at 23.18 °C (± 0.12). The mean 
starting concentration (± SE) of total colony counts in the hospital herd milk was 8.53 × 10
5
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cfu/mL (± 8.93 × 10
4
). For sampling time points of 1 through 8 h, the total numbers of colonies 
grown were too many to count. At 24 h, when the 10-fold serial-dilution in PBS was performed, 
the mean concentration (± SE) for the positive control was 1.82 × 10
10 
cfu/mL (± 1.40 × 10
10
), 
and for each treatment group was 1.35 × 10
10
 cfu/mL (± 1.18 × 10
10
), 1.16 × 10
7
 cfu/mL (± 3.92 
× 10
5
), 3.48 × 10
5
 cfu/mL (± 8.17 × 10
4
), and 7.35 × 10
3
 cfu/mL (± 4.35 × 10
3
) for pH 6, pH 5, 
pH 4, and pH 3.5, respectively. The mean pH (± SE) of milk over the course of 24 h following 
pH treatment using Salstop remained stable for 8 h, with a mean pH (± SE) of 6.75 (± 0.00) 
(positive control), 6.20 (± 0.1), 5.09 (± 0.07), 4.22 (± 0.09), and 3.55 (± 0.07). At 24 h, pH 5, 4, 
and 3.5 remained stable; however, the pH of milk treated to an initial pH of 6 and the positive 
control decreased to a mean pH (± SE) of 4.58 (± 0.10) and 4.36 (± 0.10), respectively. 
5.4.4 Visual observations of milk quality 
For all the milk acidification trials, treatments less than or equal to pH 5 experienced milk 
separation with an obvious clear liquid top layer after 1 h of exposure. However, gentle swirling 
of the tube by hand returned the milk to a homogenous solution. Where the milk came into 
contact with the inside of the glassware during swirling, a thin film of fat adhered to the sides. 
Milk treated to pH 3.5 was visibly thicker with a yogurt-like consistency, which was not evident 
in the other treatment groups. 
5.5 Discussion 
Analysis of the growth of M. bovis type strain (ATCC 25523) in milk at 3 different temperatures 
(5, 23, and 37 °C) demonstrated the organism’s inability to proliferate in milk. When milk 
inoculated with M. bovis to a mean concentration (± SE) of 3.79 × 10
3
 cfu/mL (± 3.29 × 10
3
) was 
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refrigerated at 5 °C, a slight decline in viable organisms was observed; however, M. bovis could 
still be recovered from the milk at 56 h. This latter finding is consistent with previous reports that 
demonstrated the ability of M. bovis to survive in milk refrigerated at 5°C, with colony counts 
reduced by approximately 0.3 log10 cfu/mL in 5 d (Boonyayatra et al., 2010) and 0.46 log10 
cfu/mL in 5 wk (Vyletelova, 2010). In contrast, in the present study, milk maintained at 23 °C 
and incubated at 37 °C saw a rapid decline in M. bovis growth with no viable organisms 
detectable at 24 h. This trend was also observed in the M. bovis acidification trial with a higher 
starting concentration, whereby the concentration of viable M. bovis organisms decreased in the 
positive control over the course of 24 h. This finding highlights the importance of appropriate 
storage and handling conditions for samples collected for diagnostic culture for M. bovis in the 
laboratory and supports the current recommendation that samples should be maintained at 4°C 
and transported to the laboratory as soon as possible if microbiological culture is to be performed 
(Maunsell et al., 2011). This observation also demonstrates that although milk is an adequate 
transport medium, it is not a sufficient nutrient source for M. bovis growth, a finding that is 
interesting in light of other studies that have suggested that Mycoplasma spp. could survive for 
up to 8 mo in sand bedding, with the ideal temperature for survival being 15 to 20 °C and the 
organism replicating at 4 °C (Justice-Allen et al., 2010).  
In contrast to M. bovis type strain (ATCC 25523), Salmonella Dublin strain 380 proliferated in 
milk at 23 and 37 °C, with maximum concentrations of 9.89 × 10
9
 cfu/mL (± 6.04 × 10
9
) and 
2.03 × 10
9
 cfu/mL (± 1.41 × 10
9
) reached, respectively, while survival remained stable at 5 °C. 
Therefore, although storage of milk at ≥ 23 °C may result in a decline in viable M. bovis 
organisms, the opposite effect was observed for Salmonella Dublin growth. Furthermore, 
although results suggest that M. bovis is unable to survive in milk for prolonged periods of time 
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when left unrefrigerated, this study was conducted using milk that had been previously heat-
treated to reduce the existing bacterial load before the inoculation of M. bovis, as well as using 
sterile glassware. Previous studies involving contaminated sand bedding have suggested the 
possibility of Mycoplasma spp. biofilm formation, with a positive association found between 
Mycoplasma spp. survival and the growth of gram-negative bacteria (Justice-Allen et al., 2010). 
Therefore, the use of heat-treated milk and sterile glassware may have affected the ability of M. 
bovis to survive in milk. As such, under normal farm conditions where it is likely that the milk 
being collected and fed to calves contains a mixed bacterial load and the containers used for 
storage and feeding of the milk may not be sterile (Stewart et al. 2005), the ability of M. bovis to 
survive in untreated milk may be altered. Although M. bovis was not shown to proliferate in 
milk, its ability to remain viable in milk for up to 8 h at ambient temperature explains how 
contaminated milk is able to infect calves because milk is often fed within a couple of hours of 
collection. This finding, in combination with the observed increase in Salmonella Dublin 
concentration over time at ambient temperature, means that seeking milk treatment options to 
reduce the bacterial load before feeding is warranted. Although treatment methods including heat 
pasteurization and UV treatment may reduce the total bacterial load of milk initially (Butler et 
al., 2000; Godden et al., 2006; Gelsinger et al., 2014; Pereira et al., 2014), the milk has the 
potential to become reinoculated once placed into nonsterile collection and feeding equipment 
(Stewart et al., 2005), allowing further proliferation of bacteria and as such limiting the health 
benefit of such treatments. Therefore, acidification of the milk has benefits in providing a 
continued preservative effect when combating the challenging issue of bacterial contamination 
commonly experienced when feeding calves. 
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Milk acidification against M. bovis type strain (ATCC 25523) using Salstop to pH 3.5 and pH 4 
led to elimination of viable M. bovis after just 1 h of exposure time. This result may not be 
surprising given the bacteria’s lack of cell wall, as well as its fastidious growth requirements 
with an ideal pH for the growth of M. bovis in broth being 7.6 (Nicholas et al., 2008). The 
sensitivity of Mycoplasma spp. to changes in pH was highlighted in an earlier study looking at 
porcine Mycoplasma hyorhinis, with significantly less growth found when the broth pH was 
reduced to just 6.5 (Dinter and Taylor- Robinson, 1969). For Salmonella Dublin strain 380, 
elimination of the organisms at pH 3.5 and pH 4 was slower and was not observed until 2 and 6 h 
of exposure, respectively. This outcome is similar to a previous trial that evaluated total aerobic 
colony counts of bacteria following acidification of BTM with formic acid, with no bacterial 
growth observed after 3 to 21 h of contact at a pH of 4.2 (Anderson, 2005b). Our results indicate 
that M. bovis is more sensitive to changes in pH than other bacterial species commonly found in 
milk. 
For milk treated to pH 5, slight differences were observed in results between replicate trials 1 
and 2 for M. bovis type strain (ATCC 25523). In trial 1, growth decreased at 6 h, with no growth 
from 8 h onwards. However in trial 2, growth decreased earlier, at 2 h, with no growth after 4 h. 
This pattern may have been due to the slight difference in the actual mean pH for each trial. Trial 
1 had a slightly higher mean pH of 5.29, while trial 2 had a mean pH of 5.07. Although this 
difference in pH is only minor, it suggests that pH 5 may be the critical level at which only slight 
variances can cause changes in the necessary exposure time required to affect M. bovis growth 
and viability. From our data looking at M. bovis type strain (ATCC 25523) and Salmonella 
Dublin strain 380, acidification of milk to pH 4 would be necessary to ensure elimination of 
viable M. bovis organisms after 1 h of exposure. Dropping milk to pH 4 has the added benefit of 
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eliminating viable Salmonella Dublin organisms after 6 h of exposure. However, because these 
trials were only performed on 1 strain of each pathogen, it is possible that not all strains would 
behave the same and, as such, some variation in responses may be seen. While beyond the scope 
of this paper, future studies could be directed at investigating strain variation. 
During the milk acidification process, slight milk separation was observed for treatments pH 5 
and lower. However, gentle mixing returned the milk to a homogenous solution with some fat 
remaining fixed to the inside of the glassware. Separation occurs as the pH of milk is reduced 
because of the coagulation of casein into a solid mass (Kruif, 1996). Casein is a protein that 
makes up 82 % of total milk proteins, with 18 % of total proteins remaining in the whey (Fox et 
al., 2015). Total separation to the point of a “cottage cheese–like” consistency that cannot be 
resuspended into solution has been reported in acidification of warm or hot milk (Anderson, 
2008) and in preliminary trials conducted as part of this study in which constant agitation of the 
acidified milk occurred (results not shown). This modification to the milk components may 
affect calf nutrition because of the possibility of calves only consuming the milk whey. 
Therefore, if milk acidification is being considered as a treatment option for calf milk, managing 
its preparation and delivery to calves to avoid complete milk separation to the point that it cannot 
be returned to a homogenous solution is very important. For example, piping acidified milk over 
long distances may cause excessive agitation and milk separation, with the milk solids coating 
the inside of the pipes and only the whey being received and consumed by the calves. A much 
simpler system involving preparation of milk in buckets that are directly transported to calf 
feeders may therefore be necessary. As such, from a practical viewpoint, milk acidification may 
be more suitable for smaller dairy systems. Apart from physical separation, little information is 
available on the direct effect of acidification on the nutritional value of milk as a whole. 
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However, studies assessing its impact on calf performance attributes including weight gain, feed 
intake, and feed efficiency have found no significant difference between calves fed acidified and 
normal milk (Jaster et al., 1990; Guler et al., 2006; Metin et al., 2006). These studies did provide 
positive outcomes including the reporting of significantly lower fecal consistency scores and a 
significantly lower incidence of diarrhea for calves receiving acidified milk. 
Throughout the 24 h sampling period for milk acidification trials against M. bovis type strain 
(ATCC 25523) and Salmonella Dublin strain 380 in heat-treated milk, the pH remained stable 
for each treatment group once the desired pH was achieved, with the exception of the Salmonella 
Dublin positive control, which showed a slight decline at 24 h. This outcome is an important 
aspect for 2 reasons. First, it has been suggested that with a pH below 4, calves find acidified 
milk less appealing (Anderson, 2005a). It is therefore important that the pH does not continue to 
decrease once the milk has been adjusted to the desired pH. Second, if the pH increases over 
time, this will affect the ability to eliminate viable M. bovis and Salmonella Dublin should the 
milk become contaminated following treatment. The stability of pH at 3.5, 4, and 5 was 
confirmed in acidified hospital herd milk containing a mixed bacterial load. However, the control 
hospital herd waste milk and that acidified to a pH of 6 experienced a sharp decline in pH at 24 
h, consistent with microbial fermentation and production of lactate. Therefore, if it is necessary 
to feed acidified waste milk with an initial high mixed bacterial load, ensuring an adequately low 
starting pH is essential for pH stability. 
5.6 Conclusion 
This study is the first of its kind to evaluate the use of milk acidification at various pH values and 
exposure times to eliminate viable M. bovis and Salmonella Dublin organisms in infected milk 
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for type strains ATCC 25523 and strain 380, respectively. Although M. bovis was unable to 
proliferate in milk, its viability was dependent on the concentration of organisms and storage 
temperature conditions. Conversely, Salmonella Dublin was able to exponentially proliferate in 
milk at 23 and 37 °C. Therefore, treating milk infected with M. bovis and Salmonella Dublin is 
necessary before calf consumption to eliminate viable organisms and to assist in preventing 
possible disease transmission via this route. Although the safest and recommended option is to 
not feed waste milk to calves, on farms where it may be necessary, acidification of milk using 
the acidifying agent Salstop is effective at eliminating viable M. bovis and Salmonella Dublin 
organisms in milk if the appropriate pH and exposure times are maintained. This trial provides 
evidence to support that the ideal pH to achieve these results is pH 4 with an exposure time of 1 
h for M. bovis and 6 h for Salmonella Dublin, with the pH remaining stable over a period of 24 h. 
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CHAPTER 6: GENERAL DISCUSSION 
6.1 Introduction 
Mycoplasma species can be isolated from cattle worldwide, causing serious disease and 
economic loss. Of particular importance is Mycoplasma bovis, first isolated in 1961 from a 
severe case of mastitis in a dairy herd in the U.S.A (Hale et al., 1962). While M. bovis has 
persisted in Australia since 1970 (Cottew, 1970), it was not until more recent years that there was 
an observed increase in its prevalence and impact.  As such, prior to this thesis, little research 
into mycoplasma infection in Australian dairy production systems had been undertaken. With 
extensive research having been performed internationally, this thesis began with a review of the 
literature surrounding mycoplasma infection, with a particular focus on M. bovis and dairy 
production systems. Through this, several knowledge gaps were identified which were then 
addressed in Chapters 2 to 5.  
6.2 Genetic characterisation of Australian Mycoplasma bovis 
isolates through whole genome sequencing analysis 
Microbial whole genome sequencing allows highly detailed genetic characterisation of isolates, 
which can be used for gaining a greater understanding of the specific pathogen, and potentially 
informing disease control programs. With little genetic information available on Mycoplasma 
spp. in Australia, it was identified that there was a need for genetic analysis and characterisation 
of mycoplasma isolates infecting cattle within Australia. At the time of this thesis, M. bovis was 
considered to be the most frequently isolated and pathogenic Mycoplasma species in cattle, and 
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as such was chosen as the species to characterise. In Chapter 2, it was demonstrated at the 
genetic level that between 2006 and 2015 there was a single M. bovis strain circulating 
throughout Australian dairy production systems, with marked genetic homogeneity.  
Bergey's Manual of Systematic Bacteriology defines a strain as “being made up of the 
descendants of a single isolation in pure culture, and usually is made up of a succession of 
cultures ultimately derived from an initial single colony” (Parte et al., 2011).  However this may 
be considered the definition of the term “strain” in an artificial sense under laboratory conditions. 
Under natural conditions through natural infection, transmission and spread of a strain, the 
descendants would not be derived from a single colony. The bacterial strain would also be 
expected to undergo mutations over time as it spreads, however the degree of mutation and 
change in genetic profile (genotype) that would constitute a new strain is not clear. In this study, 
the terminology of a single “strain” was chosen for several reasons. Firstly, all isolates analysed 
could be traced back to isolate Mb07, a milk sample from New South Wales (NSW) collected in 
2007. As such, all isolates analysed appeared to be descendants or have been derived from a 
single isolate. Secondly, there was a maximum of just 50 SNPs separating any two isolates 
analysed, suggesting minimal mutation and genetic diversity. This would be expected amongst 
closely related isolates that were originally derived from a single isolate, yet had encountered 
different hosts and environmental sources over time through its spread and transmission. The 
European Society of Clinical Microbiology of Infectious Diseases includes in their definition of 
a strain “An isolate or group of isolates exhibiting phenotypic and/or genotypic traits which are 
distinctive from those of other isolates of the same species” (Struelens, 1996). While phenotypic 
characteristics of the isolates analysed were not explored, their genetic profiles (genotypes) were 
remarkably similar, again supporting the statement of a single strain.  
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A similar within country genetic homogeneity has also been demonstrated in Danish M. bovis 
isolates collected over a 17 year period (Kusiluka et al., 2000), suggesting that population 
evolution based on geographical isolation may occur.  Similar observations have been made in 
other cattle pathogens such as Escherichia coli 0157, with cattle and sheep isolates from within 
Scotland being genetically indistinguishable (Strachan et al., 2015), as were cattle isolates from 
within Sweden (Soderlund et al., 2014). Comparisons of E. coli 0157 isolates from Australia and 
the U.S.A also suggested divergent evolution based on geographical isolation (Mellor et al., 
2013).  In a global study by Rosales et al. (2015), M. bovis isolates from diverse geographical 
origins underwent MLST analysis, with clear clustering based on their country of origin. In this 
study, Australian isolates clustered closely with isolates from Israel and China, which is 
reflective of Australia’s live export relationship with these countries. These isolates formed part 
of a larger clonal complex (CC2) which included European, Asian and Australian samples, and 
were distinct from clonal complex 1 (CC1) which contained mostly British and German samples 
as well as reference strain PG45. This global study may be a demonstration of divergent 
evolution amongst M. bovis, with the possibility of the formation of two subspecies in the future. 
Such evolutionary outcomes may lead to significant impacts for live animal trade, and in 
Australia’s case, the importation of semen and embryos, to avoid the introduction of a subspecies 
or clonal complex which the country is naïve to and as such could have detrimental 
consequences on the cattle population. This may also increase the importance of screening 
imported semen for M. bovis, as discussed in chapter 2.  
When comparing M. bovis isolates within a herd, it was demonstrated that the pathogen can 
persist within a single large herd of approximately 4000 milking animals (Herd B) for up to at 
least 7 years, highlighting the difficulty of eradication. This has important consequences on 
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diagnostic tests and biosecurity protocols. For example, as was the case with Herd B, while M. 
bovis had persisted for at least 7 years, it was not causing constant clinical disease or being shed 
into the BTM at all times. As such the likelihood of detecting such a herd as ‘positive’ would be 
difficult, despite the pathogen being present within the herd. For producers looking to purchase 
animals from such a herd, performing an ELISA on the BTM in addition to PCR or culture may 
increase the likelihood of detection as described in Chapter 4. For the herd itself, the persistence 
of M. bovis means that maintaining stringent biosecurity procedures to control the pathogen 
within the herd is of high importance, particularly in regards to naïve animals such as calves. 
Therefore treating milk prior to its consumption by calves, such as through milk acidification 
described in Chapter 5, would be an important control measure for herds with endemic M. bovis. 
When comparing isolates from different anatomical locations from cattle [milk, joints and 
mucosal surfaces (prepuce, vaginal, nose)] as an indicator of disease manifestation, and isolates 
from animals clinically affected and healthy carrier animals, minimal genomic variation was 
observed. From a diagnostic perspective, this lack of genetic diversity is a good indicator that 
diagnostic tests such as PCR and ELISA explored in Chapters 3 and 4, which rely on the 
presence of certain genes and proteins, would have the same level of efficacy on all isolates in 
Australia. This is important as it is these tests which are used as biosecurity tools to identify 
individual animals or herds which are infected or have been exposed to M. bovis, assisting in the 
control of disease within infected herds and preventing pathogen introduction into naïve herds.  
The minimal genomic variation observed amongst isolates from different anatomical locations 
suggests disease manifestation may not be determined by the isolate type, but rather by host and 
environmental factors predisposing animals to different disease forms. In the dairy industry the 
most common clinical presentation of mycoplasma disease is mastitis. The spread of 
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mycoplasma mastitis is linked to contamination of teats at milking time and intra-mammary 
infection (Fox, 2012). Risk factors for developing mastitis include increased herd size, lack of 
bedding material, early stage of lactation, increased parity, poor udder hygiene, and a flat or 
rounded teat end shape as opposed to a pointed shape (Abebe et al., 2016). In Australia, the 
arthritic presentation of Mycoplasma spp. infection appears to be the second most common 
disease manifestation in adults. Given that isolates from the joint fluid of arthritic animals, and 
isolates from the milk of mastitic animals showed minimal genetic variation, it may be 
hypothesized that animals which succumb to the arthritic form have a different route of infection 
and/ or other risk factors compromising and contributing to limb stress. For example in pasture-
based dairy farming, it has been identified that increased rainfall, rough concrete surfaces, 
excessive pushing and rough cattle handling practices during herding, and the amount of space 
available per cow in holding yards are risk factors associated with increased lameness in dairy 
cows (Ranjbar et al., 2016). While a pasture-based dairy farming setup may not be relevant for 
all types of farms affected by M. bovis, a similar theory that certain environmental and animal 
handling factors may lead to compromised joints, allowing a greater opportunity for disease 
development, should be considered. However further research into the pathogenesis and risk 
factors associated with different forms of M. bovis disease needs undergone. 
Similarly, when comparing isolates from healthy carrier animals and those causing disease, 
minimal genetic variation was also observed, suggesting that all M. bovis isolates are equally 
capable of causing disease, and with a variety of clinical manifestations. Therefore isolates from 
carrier animals are likely to be just as much of a biosecurity concern as isolates from animals 
with clinical disease. This presence of M. bovis in asymptomatic carrier animals may explain 
why M. bovis is so difficult to eradicate from a herd. Asymptomatic (sub-clinical) carrier animals 
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may go unnoticed while harboring the organism which has the potential to cause clinical disease 
at a later date (Nicholas et al., 2016), with some asymptomatic cattle shedding M. bovis 
intermittently for months or up to a year (Bennett and Jasper, 1977, Punyapornwithaya et al., 
2010). This hypothesis has been suggested as the cause of several M. bovis outbreaks, with the 
introduction of asymptomatic carrier animals into the herd being the most plausible origin of the 
pathogen (Wilson et al., 2007, Punyapornwithaya et al., 2010, Punyapornwithaya et al., 2011). It 
is unknown whether these carrier animals break with disease themselves, or act as a reservoir, 
shedding the organism to other animals that then break with disease, although it has been 
demonstrated that over a 1 year period, asymptomatic carrier animals can remain disease free, 
and animals can have no detectable colonization of M. bovis in body sites prior to clinical disease 
(Punyapornwithaya et al., 2010).  
While it is not known exactly what triggers animals to succumb and exhibit clinical symptoms, 
stress is likely to play an important role due to its immunosuppressive effect (Carroll and 
Forsberg, 2007). Stressors elicit physiological responses within the body in an attempt to 
reestablish homeostasis. This includes a release of glucocorticoids which affect the primary 
defense response (fight or flight), however they also suppress certain aspects of immune 
function, and if excessively stimulated at any one time, could be harmful to the animal (Carroll 
and Forsberg, 2007). For example, clinical mastitis caused by M. bovis often affects animals 
during the post-partum stage of lactation, with first lactation heifers at a higher risk, presumably 
due to the stress associated with calving (Al-Abdullah and Fadl, 2006, Radaelli et al., 2011). 
Suppressed immunity during the periparturient period can be attributed to not only the stress of 
calving and the resulting release of glucocorticoids, but also the effects of colostrogenesis, 
lactogenesis, hypocalcemia and negative energy balance (Aleri et al., 2016). This link with 
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calving stress was further suggested in Chapter 4, where it was demonstrated that time since the 
beginning of the calving season has a significant effect on the M. bovis ELISA BTM ODC%. 
Therefore priorities should be made to optimise the health and wellbeing of all animals, 
particularly during stressful events as previously mentioned, in order to ensure they are not 
compromised and therefore vulnerable to disease development. Additional actions may include 
segregation or grouping of particularly vulnerable animals during known stressful events, to 
reduce the spread of disease if an outbreak was to occur.  
While only briefly investigated, it was found that the presence of vsp genes was greatly reduced 
in Australian M. bovis isolates, compared to reference strain PG45 which was isolated in 1962 in 
the U.S.A.  Vsp genes are one of the most studied virulence factors of M. bovis, and have been 
thought to play an important role in contributing to its pathogenicity by assisting the organism in 
avoiding the host immune system. However this study suggests that the presence of vsp genes 
may not be necessary for establishing infection and causing severe disease, at least for Australian 
M. bovis isolates but potentially for strains isolated from other geographical locations as well. 
Given that mycoplasmas are one of the smallest and simplest self-replicating organisms, the 
reduction of vsp genes may be a further evolutionary step in eliminating non-essential genes.  
This theory is consistent with previous sequencing studies which found a reduction from 13 vsp 
genes in M. bovis PG45 isolated in 1962 from mastitic cow milk, to six vsp genes in M. bovis 
HB0801 and none in M. bovis Hubei-1, both of which were isolated in 2008 from lesioned 
bovine lung tissue of infected animals in China (Qi et al., 2012).  
The lack of association between the presence or absence of vsp genes, or virulence genes from 
the virulence factor database (VFDB), with clinical disease or anatomical site, again suggests 
host factors are likely to play a greater role in disease development than pathogen factors. 
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Similar observations have been made in other pathogens. In a study utilising whole genome 
sequencing to analyse Mycoplasma pneumoniae isolates from asymptomatic and ill children, a 
specific genotype was not found to be associated with virulence (Spuesens et al., 2016). In 
inoculation trials with clinical (n=2) and asymptomatic (n=4) strains of M. agalactiae, it was 
demonstrated that virulent strains can be isolated from apparently healthy sheep herds (Sanchis 
et al., 2000). In this trial, following intramammary inoculation into healthy sheep, clinical 
isolates produced severe clinical mastitis, while two of the asymptomatic strains produced severe 
clinical mastitis, and two produced less severe clinical symptoms. However the level of excretion 
in the milk and the level of infection in regional lymph nodes were similar amongst all isolates.  
While Chapter 2 identified that the vsp genes found in M. bovis PG45 were very dissimilar to 
Australian M. bovis isolates, it is possible that the Australian M. bovis isolates contain unique vsp 
related genes. This was the case with M. bovis HB0801, for which 6 vsp related genes have been 
identified, however only one (vspL) has a high identity (99.9%) with those identified in M. bovis 
PG45 (Qi et al., 2012). When analysing M. bovis HB0801 and M. bovis Hubei-1, to confirm the 
vsp gene sequences, primer pairs amplifying the flanking sequences of the entire vsp cluster 
region were designed and PCR assays performed (Qi et al., 2012). This may be one approach 
that could be employed in future work to further investigate vsp genes in Australian M. bovis 
isolates. The difficulty with identifying the true presence/absence of vsp genes and their 
changing identity suggests they should not be used as targets in diagnostic tests for M. bovis such 
as PCR and ELISA as investigated in Chapters 3 and 4 respectively.  
Chapter 2 provided a good foundation and overview of the genetic characteristics of Australian 
M. bovis isolates. However the isolates selected for analysis in this chapter were based on what 
was available in a bank of isolates stored at the Livestock Veterinary Teaching and Research 
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Unit Milk Quality Laboratory, Faculty of Veterinary Science at the University of Sydney. This 
bank of isolates included those from samples submitted by clients for diagnosis due to clinical 
symptoms, as well as those from samples collected as part of previous research studies. As such, 
there was the potential of sampling bias. In order to minimise such bias, an attempt was made to 
select isolates, from those available, which provided a good representation of different 
anatomical locations of the animal, date of isolation and geographical location across Australia. 
Despite this, all carrier isolates available in this study were from a group of closely related farms 
in one particular state of Australia that were a part of a previous research study which involved 
sampling several cohorts of animals over a period of 2 years. In section 2.4.2.1, comparison of 
defined populations, to ensure an even comparison was made, all clinical isolates chosen for 
analysis were therefore also from this region. As a result, a possible limitation of this study is 
that this particular region was overrepresented for these comparisons. To avoid this, future 
studies should have a more targeted sampling approach across Australia to ensure an even 
representation of carrier isolates. However, given the low prevalence of Mycoplasma in 
Australian dairy herds, extensive sampling would be required. 
While beyond the scope and objectives of this thesis, there is potential for additional analysis of 
the isolates. Single nucleotide polymorphisms were investigated in Chapter 2, resulting in the 
formation of a phylogenetic tree. However, further work may include looking at isolate specific 
sequence polymorphisms such as frame-shift mutations, premature stop codons, or critical amino 
acid substitutions in potential virulence genes, and their effect on isolate phenotype, which may 
also underlie virulence. Additionally, there is scope for investigation into gene expression 
compared to gene content, proteomic analysis, or biofilm formation trials. These aspects may 
reveal differences between isolates from clinical vs non-clinical carrier animals, as well as from 
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different anatomical sites, which genome analysis alone could not. Currently, further analysis of 
the Australian M. bovis isolates is being conducted through international sharing of these 
genomes with research groups in China, Denmark and Israel. 
6.3 Comparison of culture and a multiplex probe PCR for 
identifying Mycoplasma species in bovine milk, semen, and swab 
samples 
Due to the disease severity and the impact that mycoplasma infection can have within a herd, 
diagnosis is a very important aspect of a biosecurity program for control and prevention. The 
most common methods of diagnosis are culture and PCR. When deciding between these two 
options, several aspects need to be considered, including cost, urgency, sample handling and 
availability. Mycoplasma culture has been the traditional method of diagnosis, as it is relatively 
cheap and simple compared to PCR. Cost is an important factor when considering different 
diagnostic options, as quite often numerous samples are required to be tested, particularly when 
an outbreak is occurring. However, culture is limited in that it can take up to a week for a result 
to be achieved. As such, PCR has become a more common diagnostic method due to a quick 
turnaround of 1-2 days. Yet, this does incur a significantly higher cost (3 to 4 times more) than 
culture. In addition, culture requires more care to be taken with sample storage to prevent the 
organisms from dying or being overgrown by contaminants which may result in false negatives. 
This is less of a concern with PCR as it amplifies the organism’s DNA, irrespective of whether it 
is still viable although does require the DNA to be intact even in dead organisms. While PCR has 
definite advantages over microbiological culture, due to a more complicated and separate setup 
required for PCR, including specific equipment, few commercial laboratories in Australia 
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currently offer a PCR to detect Mycoplasma species. Those that do typically only offer an M. 
bovis PCR assay, excluding the possibility of identifying other pathogenic species such as M. 
californicum.  
A fourth factor to consider is how culture and PCR perform with respect to diagnostic utility in 
comparison to one another. In Chapter 3, an in-house multiplex probe PCR, modified from three 
existing singleplex PCRs, was developed and optimised to be able to amplify M. bovis, M. 
californicum and M. bovigenitalium in a single reaction. In Chapter 2 it was demonstrated that 
the same virulent M. bovis strain in Australia can be isolated from milk, semen and swab 
samples. Therefore these three sample types were chosen to evaluate the analytic performance of 
PCR with traditional culture. In terms of the ability of PCR and culture to diagnose a positive 
result, when considering all samples types (n=474) there was no significant difference between 
the two tests. This would suggest that both methods perform equally as well, and the decision of 
which method to use may come down to weighing up the practical factors previously mentioned. 
However, the analytical performance described in Chapter 3 does not take into account several 
factors. Firstly, the study in Chapter 3 was designed to evaluate PCR against culture. Due to a 
low prevalence of Mycoplasma spp. in Australia, many samples collected and received for 
diagnosis by the Livestock Veterinary Teaching and Research Unit Milk Quality Laboratory, 
Sydney School of Veterinary Science at the University of Sydney (USYD), are negative. 
Therefore to ensure a robust comparison with adequate positive samples and the inclusion of all 
three target species, all the samples chosen for analysis (excluding the BTM samples) were 
chosen based on their culture and subsequent speciation analysis. As such, all culture positive 
samples were true positives. Yet it is not uncommon for culture positive samples to be 
Acholeplasma spp. due to the inability to differentiate between them and Mycoplasma spp. based 
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on colony morphology on agar (Kirk et al., 1997, Nicholas et al., 2008). As PCR is able to 
differentiate between species based on the DNA sequence of the species, this limitation is 
removed and it is therefore recommended that culture should always be followed up by PCR 
speciation where possible. Secondly, because the analysed samples were selected based on their 
culture result, this gives the culture outcome a slight advantage over the PCR outcome, which is 
reflected in the results achieved in Chapter 3. For examples, for individual milk samples, two 
more samples were identified as positive by culture than by PCR. However, when we look at the 
BTM samples, which were not chosen based on the culture results, 7 more samples were 
identified as positive by PCR than by culture. Therefore PCR may in fact perform better than 
culture as demonstrated in previous comparison studies (Hirose et al., 2001, Justice-Allen et al., 
2011), although this was not reflected in Chapter 3 due to the study design. To better explore this 
concept, further studies may involve the analysis of randomly collected samples, though this 
would result in fewer positive samples or have to involve much larger numbers of test samples. 
Semen samples are one of the most difficult sample types to work with for PCR analysis due to 
the complex nature of the sample type, which contains a very high level of DNA and protein 
(Cole and Cupps, 2013). While an equal number of semen samples were identified as positive by 
culture and PCR, the samples identified were different with a level of agreement of 73%. This 
suggests that for semen samples, the two diagnostic methods complement one another. The 
samples which PCR did not identify as positive are likely due to PCR inhibitors or low 
concentrations of Mycoplasma spp. DNA. The samples which culture did not identify as positive 
are likely due to sample contamination or storage conditions which may have negatively 
impacted the survival of Mycoplasma spp. prior to culture, prevented the growth or limiting the 
detection of Mycoplasma spp. on agar. Bacterial contamination of semen was found to be 
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common throughout this study. This highlights the point that no test is ideal, and in the case for 
the semen samples analysed in Chapter 3, results would be improved if both culture and PCR 
were used for diagnosis. 
Swabs (vaginal, preputial, nose and eye) were the only sample type for which there was a 
significant difference between culture and PCR positive diagnostic results with culture being 
more sensitive. This may have been due to a true lower sensitivity of PCR compared to 
microbiological culture or due to study limitations. The first and most important study limiting 
factor was the sample processing protocol. All swabs were first inoculated onto culture plates 
before being processed by PCR. For those swabs containing mycoplasma, there may have been 
limited DNA on the swab and, once inoculated onto culture media, a large proportion of this 
DNA may have been transferred onto the agar leaving limited DNA left for extraction and PCR 
analysis. In the future, if both culture and DNA extraction followed by PCR were to be 
performed on a swab, a better approach would be to begin with the extraction method. This 
would involve cutting the tip off the swab into 400 µL of sterile PBS solution and vortexing. 
This solution would then be used for culture and extraction. Taking 2 swabs is a less favorable 
option as there is no guarantee that the 2 swabs would have been the same and had equivalent 
amounts of organism present.  The second limiting factor in the study may have been that the 
reagents used negatively impacted the PCR limit of detection, which was particularly poor across 
all sample types for the M. bovigenitalium PCR.  The limit of detection however may have been 
improved for all sample types and all PCRs by using a commercially prepared PCR master mix 
designed specifically for multiplex probe-based PCR, to better tolerate inhibitors, and to work 
with challenging template types. However, the cost of a commercially prepared PCR master mix 
was prohibitive for the purposes of this study and as such an in-house prepared master mix was 
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used. Lastly, the PCR limit of detection may also have been improved by utilizing primer and 
probe pairs designed specifically for multiplex PCRs as opposed to using those previously 
published primers and probe pairs utilized in this study that were designed for use in singleplex 
assays.  
Chapter 3 highlighted that 1 % of the samples analysed contained 2 species; either M. bovis and 
M. californicum, or M. californicum and M. bovigenitalium. Therefore mixed infections within a 
herd can occur, and has been previously reported (Justice-Allen et al., 2011). Yet, due to M. 
bovis currently being the most significant mycoplasma pathogen in cattle, many diagnostic 
assays are specific only for this species, including the commercial ELISA used in Chapter 4. 
This failure to detect other species may result in misdiagnosis or under-reporting the severity of 
Mycoplasma spp. exposure, negatively impacting biosecurity control and prevention strategies. 
This is of particular concern with M. californicum, which is second to M. bovis in terms of 
significance and isolation (Kirk et al., 1997). Therefore other pathogenic Mycoplasma species 
should be considered in the development of biosecurity protocols to maximize their 
effectiveness, to ensure that infected animals or herds do not go undetected.   
6.4 Bulk tank milk antibody-ELISA as a biosecurity tool for 
detecting dairy herds with past exposure to Mycoplasma bovis 
Another approach for diagnosing Mycoplasma spp. infection is through an ELISA which detects 
antibodies against Mycoplasma spp. in either milk or serum samples. While the diagnostic 
methods of culture and PCR rely on the direct detection of the organism, an ELISA is an indirect 
method, identifying past exposure and the subsequent immune response. In Chapter 4, a 
commercially available ELISA was evaluated for its use on BTM samples as a biosecurity tool 
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for detecting dairy herds with past exposure to M. bovis. A BTM sample is commonly used when 
testing a herd for Mycoplasma spp. infection, as it gives a good representation of the lactating 
herd. In the past, PCR and culture have been used for herd level assessment of disease 
prevalence however they are limited in that animals within the main herd need to be shedding the 
organism at the time of sampling. Given that Mycoplasma spp. are known to be shed 
intermittently, and clinical animals are often segregated from the main herd, they may not be 
contributing to the BTM sample thus reducing the chances of identifying an infected herd via 
these methodologies. In Chapter 4, 39 % of the BTM samples analysed were positive by ELISA, 
while just 4 % and 1 % were positive by PCR and culture respectively. This suggests that by 
targeting antibodies against M. bovis, the window of opportunity is increased for detecting herds 
which have been exposed to M. bovis. The extreme dynamics of M. bovis infection including the 
varied routes of transmission, and the presence of sub-clinically infected carrier animals makes 
complete eradication of M. bovis from a herd very challenging. This was demonstrated in 
Chapter 2, where M. bovis was shown to persist in a single dairy herd for up to at least 7 years. 
As such, identifying herds with past exposure through ELISA may be just as important as 
identifying herds with a current M. bovis infection through PCR and culture.  
While PCR and culture are very useful tools in diagnosing individual animals, the use of an 
ELISA for this purpose is questionable.  In Chapter 4 it was identified that there was a poor 
association between the within herd seroprevalence and the BTM ODC%, suggesting that the use 
of the ELISA on individual animal samples to identify and target infected animals for culling is 
limited. In the analysis, 6 control herds with no known clinical cases of mycoplasmosis were 
included, with the seroprevalence for each herd ranging from 6 % to 22 %. From a diagnostic 
perspective, this would suggest that several animals within each of these herds are M. bovis 
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positive. This is despite coming from herds which based on a long-standing and close association 
with the University of Sydney LVT&RU, have not had any clinical signs of Mycoplasma spp. 
disease. Due to the high specificity of PCR, and culture if followed up by PCR, the chances of 
false positives by these diagnostic tools are low. Yet the findings of the study described in 
Chapter 4 would suggest that, on the individual animal level, the risk of false positive diagnosis 
by ELISA is higher. Non-specific antibody binding in an ELISA can lead to false positive 
results, and may be due to antigenic cross-reactivity with other pathogens. For example, cross-
reactivity between Coxiella burnetii (the causative agent of Q-fever) and Mycoplasma 
pneumoniae on ELISA has been demonstrated in humans, which can lead to the misdiagnosis 
and overestimation of M. pneumoniae, and underestimation of Q-fever (Lai et al., 2013). In pigs, 
cross-reactivity was observed in an ELISA designed to detect antibodies against Mycoplasma 
hyorhinis and antibodies obtained from pigs infected with Mycoplasma hyopneumoniae and 
Mycoplasma flocculare. Similarly an ELISA designed to be specific for M. hyopneumoniae also 
identified antibodies in pigs infected with Mycoplasma hyosynoviae and M. flocculare (Gomes 
Neto et al., 2014). While M. hyopneumoniae and M. hyosynoviae are known to cause clinical 
disease in pigs, M. hyorhinis and M. flocculare are considered to be commensals or low virulent 
pathogens (Kobisch and Friis, 1996). Therefore it may be possible that the M. bovis ELISA used 
in Chapter 4 can cross-react with other less pathogenic Mycoplasma species such as M. 
bovirhinis or M. bovoculi, or with other organisms associated with cattle, including Coxiella 
burnetii. Other causes of undesired antibody activity include non-specific binding of other 
antibodies to the antigen or plastic surfaces, which can be minimized by diluting the test sample 
and adding protein blocking agents (Schrijver and Kramps, 1998).  
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While Chapter 4 suggested several false positive results occurred on individual animal serum 
from control herds, this does not seem to be the case at the herd level with all BTM samples from 
control herds being negative by ELISA. This may be due to the different sample type; serum 
compared to milk. As milk based buffers are used for blocking (Crowther, 2000), the milk 
samples may be acting as a blocking buffer, preventing non-specific binding of antibodies, 
reducing the incidence of false positive results. However, results were based on just 6 BTM 
samples from 6 control herds (1 sample per herd), and as such analysis of additional control 
herds is warranted to enhance our understanding of this observation. This highlights the 
complementary role that each diagnostic test has, with PCR and culture being better suited for 
diagnosing individual animals, and ELISA being better suited for diagnosing high risk herds.   
The greater ability of M. bovis BTM ELISA to identify high risk herds compared to PCR and 
culture through the greater window of opportunity provided by measuring immune response over 
shed organism may be further enhanced by when the sample is taken. The time since the initial 
M. bovis outbreak on a farm, and the time since the start of the calving period were shown to 
have a significant effect on the BTM ODC%. The BTM ODC% was significantly higher 0-8 
months since an initial outbreak, after which it quickly declined. As such, the closer to the initial 
outbreak that a BTM sample is analysed, the higher the BTM ODC% and the greater the chances 
of identifying a high risk herd. Given that the reason you would test a herd is because you don’t 
know their mycoplasma history, analysing a BTM samples in regards to the initial outbreak may 
be redundant. Importantly, this finding does provide an idea of the expected antibody longevity 
in the BTM for the purposes of using the ELISA as a biosecurity tool in order to assess the risk 
of introduction of infected cows to a naïve herd. The BTM ODC% was also found to be highest 
5-8 weeks following the commencement of the calving period, presumably due to the stress 
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associated with calving. Therefore from a biosecurity perspective, targeted sampling during this 
time period may provide a greater chance of identifying high risk herds. As several BTM 
samples did experience an ODC% above the positive/negative cutoff outside of these time 
periods (possibly from outbreaks of greater severity or less well managed herds) it is still 
worthwhile to assess BTM samples obtained at other times and to consider the 5 – 8 week post 
calving period recommendation as just a guideline for increasing the sensitivity of the assay, 
interpreting the results and improving the biosecurity potential of the assay.  
A sample type which is often overlooked is the BTM sample obtained from the hospitalised 
cows. Given that the hospital herd is the most likely location of animals infected with M. bovis, 
as well as animals under higher stress due to sickness or injury, it is logical to target this sample 
type not only for analysis by ELISA, but also by PCR and culture as investigated in Chapter 3. In 
Chapter 4 the BTM from the hospital herd was compared to the BTM from the main herd of a 
single dairy. The ODC% of the hospital BTM mirrored that of the BTM taken from the main 
herd however was significantly higher. While these are the results from just one herd and further 
investigation is required to assess whether this phenomenon is evident in all infected and control 
herds, this suggests that the likelihood of identifying a high risk herd is further  increased by 
analysing the hospital BTM. While this sample type is more difficult to acquire from a herd as a 
biosecurity tool prior to purchase of new stock, it is worth the effort to remove the bias obtained 
by just assessing the immune response of the healthiest animals in a herd.  
While this study provided much needed additional information in regards to the use of a bulk 
tank milk antibody-ELISA as a biosecurity tool for detecting dairy herds with past exposure to 
M. bovis, it was limited by the BTM samples available. Due to the dynamics of the disease, it is 
very difficult to identify true control herds, with a close longstanding relationship with the herd, 
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and as such an in depth knowledge of their history, often being the only way of knowing their 
true M. bovis status. As such, this study was limited in the quantity of control herds included. For 
‘positive’ herds, frequent and extensive sampling of a large number of herds is required, which is 
expensive and difficult to obtain. Furthermore, it is not known where or when a herd will 
experience an outbreak. With Australia being such a large country, this further increases the 
difficulty of reaching these herds and obtaining repetitive samples over a prolonged period of 
time. Therefore, further work within this area is needed to strengthen our understanding of how 
the BTM ELISA may be applied, with long-term studies being a necessity.  
6.5 Milk acidification to control the growth of Mycoplasma bovis 
and Salmonella Dublin in infected milk 
The diagnostic methods of PCR, culture and ELISA investigated in Chapters 3 and 4 are 
important tools for identifying infected animals and high risk herds, respectively and can be used 
to assist in preventing the introduction of Mycoplasma spp. into a naïve herd, and in removing 
infected animals from an exposed herd in order to manage clinical cases. However, if a herd does 
become infected, while it is very important to diagnose and remove positive animals, prevention 
of further cases in both the milking herd and the calf stock also needs to be a priority. If calves 
are being fed infected milk, they can become exposed to Mycoplasma spp. and succumb to 
disease (Maunsell et al., 2012). Young calves are the future of a dairy herd and as such their 
health and growth is vital but can be compromised by mycoplasmosis acquired at an early age 
with long term impacts. Therefore, to minimise clinical disease in calves, the transmission route 
from cows to calves needs to be broken. This is true not only for Mycoplasma spp., but for other 
pathogens including Salmonella Dublin.  
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One method for breaking this transmission route is by treating milk prior to its consumption by 
calves. Milk treatment using heat pasteurisation has been proven to be effective at eliminating 
viable M. bovis and Salmonella Dublin (Butler et al., 2000, Stabel et al., 2004). In the past, in 
order for the financial outlay of equipment and maintenance to be cost effective, a herd size of 
approximately 1,260 cows calving year round, with 315 calves on milk per day was required 
(Jamaluddin et al., 1996). As such, many smaller dairies could not afford such an expense, and 
alternative, affordable options needed to be explored. Today there are several smaller 
pasteurisation systems available, starting from approximately $12,000 in Australia, making them 
more economically attractive to most dairy herd sizes. However, many dairy producers still 
remain reluctant to invest in this initial financial outlay. In Chapter 5 milk acidification as a 
treatment option was evaluated as an alternative option. Prior to this study, the effects of milk 
acidification on specific bacterial species of concern in the dairy industry had not been 
investigated. Chapter 5 demonstrated that milk acidification using the product Salstop® is 
effective at eliminating viable M. bovis and Salmonella Dublin organisms in milk, assuming the 
appropriate pH and exposure times are maintained. At the recommended pH of 4, M. bovis was 
eliminated after 1 h of exposure, while Salmonella Dublin was eliminated after 6 h of exposure. 
While this exposure time is longer than pasteurisation, acidification has the advantage over 
pasteurisation of having an ongoing bactericidal effect as the treatment remains constant. This 
means there is less concern for the milk becoming re-infected from feeding equipment which 
may not be sterile. An exposure time of 6 h is also not an unreasonable time frame for dairies to 
achieve. For calves being fed twice daily, it may mean preparing the morning feed the evening 
before, and preparing the afternoon feed the morning of milk distribution. It also opens up the 
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option for free-access feeding, or for short-term storage of milk without the need for 
refrigeration.  
While most available information on milk acidification uses a single liquid acid to lower the pH 
of the milk (Anderson, 2005, 2008), in the study described in Chapter 5 the product Salstop® 
SD, presented in powdered form, was chosen as the acidification agent for several reasons. 
Firstly, it is a commercially available product, available worldwide. This means that it is readily 
available and is consistent in its quality and performance. Secondly, it is a feed additive that 
complies with the highest EU and worldwide feed safety regulations. Thirdly, its powder 
formulation is more favorable from a work health and safety perspective compared to a liquid in 
terms of its propensity to be spilt or have splash back and burn. Fourthly, it contains a mixture of 
several different acids, including propionic, acetic, formic, sorbic, and lactic acids which has 
been demonstrated to be important in its efficacy in that different acids vary in their ability to 
inhibit and kill bacteria, despite the same pH level being achieved (Anderson, 2008). Using a 
product with a combination of different acids makes the acidification effect more robust. 
The study described in Chapter 5 also explored the proliferation and survival of M. bovis and 
Salmonella Dublin in milk over 3 days. It was demonstrated that while M. bovis was unable to 
proliferate in milk, Salmonella Dublin proliferated substantially. This is an important factor to 
consider when contemplating performing culture or PCR on milk samples for Mycoplasma spp. 
as investigated in Chapter 3. When milk was stored at room temperature (23 ᵒC) or higher, there 
was a rapid decline in viable M. bovis organisms, to the point that detection was not possible by 
culture at 24 h. However when the milk was refrigerated (5 ᵒC), M. bovis remained detectable by 
culture at 56 h. Therefore if samples are being collected and sent for culture of Mycoplasma spp., 
they need to be kept cold, ideally at 5 ᵒC. If not, detection is compromised. Additionally, while 
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M. bovis viability declined at room temperature or higher, Salmonella Dublin proliferated. 
Again, when considering culture for Mycoplasma spp., contamination and subsequent 
proliferation of other organisms can make the growth and identification of Mycoplasma spp. 
colonies difficult, resulting in false negatives. While contamination with dirt or faeces can 
negatively impact upon PCR due to their inhibitory effect, bacterial contamination and viability 
do not. These factors may explain why in Chapter 3, culture and PCR results were not always in 
agreement. This is particularly true for semen samples for which PCR and culture identified 
equal numbers of positive samples, while the level of agreement was just 73 %, and also for the 
BTM samples, where 5 % were positive by PCR while just 2 % were positive by culture.  
Milk acidification is not a new concept, and has been adopted on many dairy farms in North 
America, predominantly in the form of free-access feeding and using liquid acids such as formic 
or citric acid (Anderson, 2008). Field trials have also demonstrated that feed intake, weight gain, 
and feed efficiency are not significantly affected by acidified milk or milk replacer using these 
liquid acids, while faecal consistency scores are significantly improved (Jaster et al., 1990, Guler 
et al., 2006, Metin et al., 2006). However, free-access feeding is uncommon in Australian dairy 
production systems, with the most likely form of milk acidification uptake being twice daily 
feeds. The use of pure liquid acids is also unattractive in Australia, due to their higher health and 
safety issues surrounding their use compared to powder, such as their ability to spill and splash 
causing irritation and burns. There is, therefore, still a need to assess the practicalities behind 
milk acidification in Australian diary production systems using powdered acid products. While 
Chapter 5 focused on the efficacy of milk acidification against M. bovis and Salmonella Dublin 
using the powdered feed additive Salstop® SD, this needs to be extended to field trials with 
calves to ensure that its use is logistically possible on a practical level. This includes everything 
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from the preparation of the acidified milk, to the method of delivery of the milk to calves, milk 
intake, calf growth and calf health (e.g. fecal scores). Further research into these aspects, coupled 
with the findings described in Chapter 5, would provide an in depth guide to the setup and 
implementation of milk acidification in Australian dairies.  
While M. bovis is currently the most commonly isolated and pathogenically significant 
Mycoplasma species, there are other species of concern such as M. californicum which need to 
be evaluated for their response to milk acidification. Heat pasteurisation trials have demonstrated 
variability between the response of M. bovis, M. californicum and M. canadense to heat exposure 
at different temperatures (Butler et al., 2000). Results suggested that M. canadense was the most 
resistant to heat, followed by M. californicum and M. bovis.  However the higher the 
temperature, the less the variability in exposure time required. Therefore while it is possible that 
different species may also have varying degrees of resistance to milk acidification, this 
variability may also be minimal if a consistent low pH of 4 is achieved. Furthermore, the study 
described in Chapter 5 was restricted to the inclusion of just a single M. bovis and Salmonella 
Dublin isolate. Intraspecies variability is less likely to be of concern than interspecies variability, 
particularly given the minimal genomic variability existing within Australian M. bovis isolates 
identified in the study described in Chapter 2. The M. bovis isolate used was a type strain rather 
than a field isolate like Salmonella Dublin. Therefore future milk acidification work may include 
several different species of Mycoplasma and Salmonella and isolates/strains within each species. 
6.6 Conclusion 
The research described within this thesis has provided insight into the characterisation, diagnosis 
and control of mycoplasmosis in Australian dairy production systems. These findings provide 
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valuable information which should be used to develop and implement biosecurity strategies 
within Australia to reduce the prevalence of mycoplasma infected herds across the country and 
reduce its clinical impact. 
Genetic characterisation of Australian M. bovis isolates identified a single M. bovis strain 
persisting throughout the country, with marked genomic homology. Therefore, in order to protect 
Australia from the introduction of additional strains of M. bovis, it may be necessary to 
implement stringent screening processes including the use of PCR assays for the importation of 
reproductive material such as embryos and semen. With minimal variance amongst isolates from 
different anatomical locations, and from clinically and sub-clinically affected animals, this 
suggests a single isolate is equally capable of causing a variety of different clinical 
manifestations. As such, the identification of any M. bovis isolate should be treated with extreme 
caution and considered a highly virulent pathogen, with the disease outcome likely to be 
significantly affected by host factors and environmental (including management) practices. 
While control methods should be tailored towards the disease and herd scenario, a control 
approach aimed at manipulating these factors should be instigated if M. bovis is found to be 
present within a herd.  
When diagnosing bovine samples for the presence of M. bovis, M. californicum and M. 
bovigenitalium, multiplex PCR was comparable to culture, with the superior method dependent 
on sample type (individual milk, BTM, semen or swabs), and the need to identify multiple 
species per samples. The use of PCR and culture may also be complemented by the use of 
ELISA on BTM samples, in identifying herds from which the purchase of animals may pose a 
higher biosecurity risk for introducing M. bovis into non-infected herds. As such, there is a need 
for commercial laboratories in Australia to offer PCR assays which target specific Mycoplasma 
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spp. and sample types in addition to M. bovis and milk, as well as the potential need for offering 
M. bovis BTM ELISA assays for immunological analysis of dairy herds.  
Lastly, in order to control mycoplasma disease within an infected herd, preventing it’s 
transmission to calves through the consumption of contaminated milk is essential, while also 
taking into account other potential pathogens. Milk acidification was effective at eliminating 
viable M. bovis and Salmonella Dublin organisms in milk, if the appropriate pH and exposure 
time is maintained.  However this system would require a high attention to detail and appropriate 
setup to ensure an optimal outcome, and as such would require consultation and involvement 
with the herd’s veterinarian to ensure its efficacy. 
Therefore, while Mycoplasma spp. can present as a serious challenge in infected herds, the 
studies within this thesis provide robust evidence that management practices coupled with 
diagnostic tools are necessary to assist in reducing the risk of pathogen introduction, and 
controlling its impact.  
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